No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4ko6A, 0.7804, 1.86, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
2, 2xv3B, 0.7804, 1.96, 0.145, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
3, 1jzgA, 0.7803, 1.91, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA REDUCED AZURIN (CU1+) RU(TPY)(PHEN) (HIS83)
4, 3fszB, 0.7798, 1.96, 0.145, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
5, 2idfA, 0.7798, 1.90, 0.146, 128, 123, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
6, 3ft0A, 0.7796, 1.96, 0.145, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
7, 2idfB, 0.7796, 1.90, 0.146, 128, 123, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
8, 1jzfA, 0.7795, 1.92, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA OXIDIZED AZURIN(CU2+) RU(TPY)(PHEN) (HIS83)
9, 2gi0B, 0.7793, 1.95, 0.146, 128, 123, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
10, 2gi0A, 0.7793, 1.93, 0.146, 128, 123, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
11, 1jvlB, 0.7790, 1.91, 0.146, 128, 123, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
12, 1jvlA, 0.7790, 1.91, 0.146, 128, 123, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
13, 2ghzA, 0.7789, 1.94, 0.146, 128, 123, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
14, 2ghzB, 0.7788, 1.95, 0.146, 128, 123, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
15, 1jzhA, 0.7787, 1.92, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RU(TPY)(BPY)(HIS83)
16, 3fszA, 0.7785, 1.96, 0.145, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
17, 2xv3A, 0.7784, 1.96, 0.145, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
18, 1jzeA, 0.7784, 1.93, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RU(BPY)2(IM)(HIS83)
19, 4mfhB, 0.7779, 1.91, 0.138, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
20, 1ag0B, 0.7779, 1.91, 0.138, 128, 123, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
21, 1ag0A, 0.7779, 1.91, 0.138, 128, 123, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
22, 4ko7A, 0.7778, 1.93, 0.154, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
23, 1jzjB, 0.7777, 2.00, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
24, 4ko7B, 0.7773, 1.92, 0.154, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
25, 3fq1A, 0.7772, 1.92, 0.130, 128, 123, AZURIN C112D/M121I
26, 3np3A, 0.7771, 1.93, 0.138, 128, 123, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
27, 5azuC, 0.7770, 1.99, 0.146, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
28, 4ko6D, 0.7770, 1.92, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
29, 1iluB, 0.7770, 1.82, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
30, 1e5zC, 0.7769, 1.99, 0.146, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
31, 4ko7C, 0.7767, 1.94, 0.154, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
32, 4ko5A, 0.7767, 1.90, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
33, 3ugeC, 0.7767, 2.01, 0.146, 128, 123, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
34, 3azuC, 0.7767, 1.82, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
35, 1vlxC, 0.7767, 2.02, 0.146, 128, 123, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
36, 3ft0B, 0.7766, 1.99, 0.145, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
37, 1iluD, 0.7766, 1.82, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
38, 1jziA, 0.7765, 1.96, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
39, 1nzrC, 0.7764, 2.02, 0.146, 128, 123, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
40, 4kobD, 0.7762, 1.92, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
41, 1vlxA, 0.7762, 1.82, 0.148, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
42, 1jziB, 0.7762, 1.96, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
43, 1e65C, 0.7762, 2.01, 0.146, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
44, 3fqyA, 0.7761, 1.95, 0.138, 128, 123, AZURIN C112D
45, 3azuB, 0.7761, 1.82, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
46, 1azrC, 0.7761, 2.01, 0.146, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
47, 5azuA, 0.7759, 1.82, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
48, 4azuC, 0.7758, 2.02, 0.146, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
49, 1e5zA, 0.7757, 1.82, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
50, 4mfhA, 0.7756, 1.93, 0.138, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
51, 4azuA, 0.7756, 1.83, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
52, 1iluF, 0.7755, 1.82, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
53, 1e65A, 0.7755, 1.82, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
54, 4ko9D, 0.7754, 1.93, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
55, 2azuC, 0.7754, 1.83, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
56, 1iluI, 0.7754, 1.84, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
57, 2tsaC, 0.7753, 1.84, 0.139, 128, 122, AZURIN MUTANT M121A
58, 1iluE, 0.7752, 1.84, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
59, 1gr7D, 0.7752, 1.88, 0.148, 126, 122, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
60, 3u25A, 0.7751, 1.82, 0.156, 127, 122, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
61, 1jzjA, 0.7751, 1.92, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
62, 1iluK, 0.7751, 1.85, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
63, 1gr7B, 0.7751, 1.74, 0.149, 125, 121, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
64, 4azuD, 0.7750, 1.83, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
65, 2azuA, 0.7750, 1.82, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
66, 1gr7C, 0.7750, 1.74, 0.149, 125, 121, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
67, 1e67C, 0.7750, 2.03, 0.146, 128, 123, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
68, 1azrD, 0.7750, 1.83, 0.148, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
69, 4kobA, 0.7749, 1.92, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
70, 4ko9A, 0.7749, 1.92, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
71, 4hz1D, 0.7749, 1.88, 0.146, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
72, 4hz1C, 0.7749, 1.84, 0.148, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
73, 1xb3A, 0.7749, 1.93, 0.146, 128, 123, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
74, 1nzrA, 0.7749, 1.83, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
75, 1jvoF, 0.7749, 1.83, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
76, 1iluM, 0.7749, 1.84, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
77, 1e5yC, 0.7749, 2.04, 0.146, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
78, 1e5zB, 0.7748, 1.86, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
79, 5azuD, 0.7747, 1.83, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
80, 4azuB, 0.7747, 1.85, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
81, 1gr7A, 0.7747, 1.87, 0.148, 126, 122, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
82, 3np4A, 0.7746, 1.94, 0.130, 128, 123, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
83, 3azuA, 0.7746, 1.83, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
84, 1jvoC, 0.7746, 1.83, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
85, 1jvoB, 0.7746, 1.83, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
86, 4ko6C, 0.7745, 1.93, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
87, 1etjC, 0.7745, 1.84, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
88, 1e65D, 0.7745, 1.83, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
89, 1e65B, 0.7745, 1.86, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
90, 4kobB, 0.7744, 1.93, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
91, 4ko5B, 0.7744, 1.90, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
92, 1etjD, 0.7744, 1.82, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
93, 1e5yA, 0.7744, 1.84, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
94, 3u25B, 0.7743, 1.82, 0.156, 127, 122, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
95, 2azuB, 0.7743, 1.85, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
96, 1ilsC, 0.7743, 2.03, 0.138, 128, 123, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
97, 1ezlA, 0.7743, 1.83, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
98, 1etjB, 0.7743, 1.81, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
99, 1e67A, 0.7743, 1.84, 0.148, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
100, 6mjsA, 0.7742, 1.93, 0.163, 128, 123, AZURIN 122W/124W/126RE 
101, 3fpyA, 0.7742, 1.93, 0.130, 128, 123, AZURIN C112D/M121L
102, 2tsbC, 0.7742, 1.84, 0.139, 128, 122, AZURIN MUTANT M121A-AZIDE
103, 1ilsA, 0.7742, 1.84, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
104, 4ko6B, 0.7741, 1.93, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
105, 3iboB, 0.7741, 1.95, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
106, 1jvoG, 0.7741, 1.83, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
107, 1jvoE, 0.7741, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
108, 1e5yD, 0.7741, 1.83, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
109, 5azuB, 0.7740, 1.87, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
110, 1jvoA, 0.7740, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
111, 3iboA, 0.7739, 1.94, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
112, 2oj1B, 0.7739, 1.92, 0.146, 128, 123, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
113, 1vlxD, 0.7739, 1.85, 0.148, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
114, 1azrA, 0.7739, 1.83, 0.148, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
115, 3azuD, 0.7738, 1.82, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
116, 2tsbA, 0.7738, 1.83, 0.139, 128, 122, AZURIN MUTANT M121A-AZIDE
117, 1aznC, 0.7738, 1.83, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
118, 1jvoL, 0.7737, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
119, 4ko7D, 0.7736, 1.95, 0.154, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
120, 1jvoI, 0.7736, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
121, 1jvoH, 0.7736, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
122, 6mjrA, 0.7735, 2.04, 0.163, 128, 123, AZURIN 122W/124F/126RE 
123, 6iavC, 0.7735, 1.84, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
124, 1jvoJ, 0.7735, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
125, 1jvoD, 0.7735, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
126, 1ilsD, 0.7735, 1.84, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
127, 1e67B, 0.7735, 1.86, 0.148, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
128, 1nzrB, 0.7734, 1.87, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
129, 2tsaB, 0.7733, 1.85, 0.139, 128, 122, AZURIN MUTANT M121A
130, 1nzrD, 0.7733, 1.85, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
131, 1jvoK, 0.7733, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
132, 4qlwB, 0.7732, 2.03, 0.138, 128, 123, AZURIN MUTANT M121E WITH IRON
133, 4ko9B, 0.7732, 1.94, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
134, 3fq2A, 0.7732, 1.96, 0.130, 128, 123, AZURIN C112D/M121F
135, 3jt2B, 0.7731, 1.83, 0.139, 128, 122, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
136, 1e5zD, 0.7731, 1.85, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
137, 1e5yB, 0.7731, 1.87, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
138, 2fnwB, 0.7730, 1.87, 0.148, 128, 122, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
139, 1ilsB, 0.7730, 1.87, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
140, 4wkxB, 0.7729, 1.96, 0.130, 128, 123, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
141, 3ugeD, 0.7729, 1.83, 0.148, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
142, 2tsbB, 0.7729, 1.85, 0.139, 128, 122, AZURIN MUTANT M121A-AZIDE
143, 1iluC, 0.7729, 1.87, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
144, 1e67D, 0.7729, 1.85, 0.148, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
145, 2tsbD, 0.7728, 1.82, 0.139, 128, 122, AZURIN MUTANT M121A-AZIDE
146, 1azrB, 0.7728, 1.87, 0.148, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
147, 4mfhC, 0.7727, 1.95, 0.146, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
148, 4ko9C, 0.7727, 1.96, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
149, 1vlxB, 0.7727, 1.87, 0.148, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
150, 3ugeB, 0.7726, 1.87, 0.148, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
151, 1etjA, 0.7726, 1.86, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
152, 5i28H, 0.7725, 1.98, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
153, 4jknC, 0.7725, 1.86, 0.148, 128, 122, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
154, 2i7sC, 0.7725, 1.96, 0.146, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
155, 1bexA, 0.7725, 2.05, 0.146, 128, 123, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
156, 6gyiC, 0.7724, 2.04, 0.146, 128, 123, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
157, 3fswB, 0.7724, 1.85, 0.148, 128, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
158, 2i7sB, 0.7724, 1.95, 0.146, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
159, 1cuoA, 0.7723, 2.02, 0.169, 129, 124, CRYSTAL STRUCTURE ANALYSIS OF ISOMER-2 AZURIN FROM METHYLOMONAS J
160, 3ugeA, 0.7722, 1.84, 0.148, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
161, 2tsaD, 0.7722, 1.83, 0.139, 128, 122, AZURIN MUTANT M121A
162, 1bexB, 0.7722, 2.05, 0.146, 128, 123, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
163, 2fnwA, 0.7721, 1.97, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
164, 4kobC, 0.7720, 1.96, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
165, 2oj1A, 0.7720, 1.95, 0.146, 128, 123, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
166, 6iavA, 0.7719, 1.83, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
167, 2azuD, 0.7718, 1.86, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
168, 2tsaA, 0.7717, 1.85, 0.139, 128, 122, AZURIN MUTANT M121A
169, 1xb3B, 0.7717, 1.97, 0.146, 128, 123, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
170, 3iboD, 0.7716, 1.97, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
171, 1iluL, 0.7716, 1.89, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
172, 1iluH, 0.7716, 1.89, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
173, 2i7sD, 0.7715, 1.98, 0.146, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
174, 3jtbD, 0.7714, 1.85, 0.148, 128, 122, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
175, 1xb6A, 0.7714, 1.97, 0.146, 128, 123, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
176, 6gyiB, 0.7713, 1.86, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
177, 3in0D, 0.7712, 1.88, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
178, 1i53A, 0.7712, 2.01, 0.146, 128, 123, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
179, 4jknA, 0.7711, 1.86, 0.148, 128, 122, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
180, 1aznA, 0.7711, 1.84, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
181, 1i53B, 0.7710, 1.99, 0.146, 128, 123, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
182, 1ezlD, 0.7710, 1.93, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
183, 1azcA, 0.7710, 2.06, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
184, 1azbA, 0.7710, 2.06, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
185, 1xb8C, 0.7709, 1.79, 0.149, 126, 121, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
186, 4kocA, 0.7707, 1.99, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I/Y108F)
187, 4jknB, 0.7707, 2.07, 0.146, 128, 123, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
188, 1ezlB, 0.7707, 1.89, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
189, 1aznD, 0.7707, 1.86, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
190, 5i28J, 0.7706, 1.98, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
191, 1xb6B, 0.7706, 1.99, 0.146, 128, 123, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
192, 1iluA, 0.7706, 1.88, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
193, 6mjsD, 0.7704, 1.80, 0.165, 126, 121, AZURIN 122W/124W/126RE 
194, 4qlwA, 0.7704, 1.88, 0.139, 128, 122, AZURIN MUTANT M121E WITH IRON
195, 2i7sA, 0.7704, 1.97, 0.146, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
196, 4qlwC, 0.7703, 1.87, 0.139, 128, 122, AZURIN MUTANT M121E WITH IRON
197, 3in0B, 0.7703, 1.86, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
198, 2i7oA, 0.7703, 1.97, 0.146, 128, 123, STRUCTURE OF RE(47-DIMETHYL-PHEN)(THR124HIS)(LYS122TRP)(HIS83GLN) AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
199, 1aznB, 0.7703, 1.87, 0.156, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
200, 5i28O, 0.7702, 2.01, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
201, 4hz1A, 0.7702, 1.88, 0.148, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
202, 5i26B, 0.7701, 1.95, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM I
203, 6gyiD, 0.7700, 1.85, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
204, 3fswA, 0.7700, 1.87, 0.148, 127, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
205, 3iboC, 0.7699, 1.96, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
206, 5i28G, 0.7697, 1.98, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
207, 4hz1B, 0.7696, 1.96, 0.148, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
208, 1rkrC, 0.7694, 2.11, 0.169, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
209, 5i28I, 0.7693, 2.02, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
210, 1rkrB, 0.7692, 2.11, 0.169, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
211, 6mjtB, 0.7691, 1.87, 0.164, 128, 122, AZURIN 122F/124W/126RE 
212, 5i28P, 0.7691, 2.08, 0.154, 127, 123, AZURIN T30R1 CRYSTAL FORM II
213, 5i26A, 0.7691, 2.05, 0.154, 127, 123, AZURIN T30R1 CRYSTAL FORM I
214, 1rkrD, 0.7690, 2.12, 0.169, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
215, 3jtbB, 0.7689, 1.89, 0.148, 128, 122, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
216, 3jt2A, 0.7689, 1.88, 0.139, 128, 122, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
217, 1rkrA, 0.7689, 2.11, 0.169, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
218, 1iluG, 0.7689, 1.91, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
219, 1aizA, 0.7689, 2.12, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
220, 3n2jG, 0.7688, 1.95, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
221, 5i28M, 0.7687, 2.02, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
222, 6mjsB, 0.7686, 1.81, 0.165, 126, 121, AZURIN 122W/124W/126RE 
223, 3n2jH, 0.7686, 1.95, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
224, 1r1cA, 0.7686, 1.90, 0.172, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
225, 5i28F, 0.7685, 2.00, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
226, 5i28D, 0.7684, 2.02, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
227, 3n2jA, 0.7684, 1.97, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
228, 6mjrC, 0.7683, 1.89, 0.164, 128, 122, AZURIN 122W/124F/126RE 
229, 2azaA, 0.7682, 1.97, 0.171, 129, 123, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
230, 5i28N, 0.7681, 2.02, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
231, 5i28A, 0.7680, 2.08, 0.154, 127, 123, AZURIN T30R1 CRYSTAL FORM II
232, 3n2jL, 0.7680, 1.97, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
233, 1uriA, 0.7680, 1.97, 0.163, 129, 123, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
234, 5i28C, 0.7679, 1.83, 0.149, 127, 121, AZURIN T30R1 CRYSTAL FORM II
235, 3fswD, 0.7679, 1.89, 0.148, 127, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
236, 4bwwA, 0.7678, 2.14, 0.138, 127, 123, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
237, 1xb8A, 0.7678, 1.91, 0.148, 127, 122, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
238, 5i28B, 0.7677, 1.83, 0.149, 127, 121, AZURIN T30R1 CRYSTAL FORM II
239, 3n2jB, 0.7677, 2.15, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
240, 3jtbC, 0.7676, 1.91, 0.148, 128, 122, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
241, 2hxaA, 0.7676, 1.75, 0.158, 125, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
242, 2hxaB, 0.7675, 1.99, 0.156, 127, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
243, 2hx7B, 0.7675, 1.97, 0.156, 127, 122, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
244, 1dz0A, 0.7675, 1.98, 0.138, 129, 123, REDUCED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
245, 6iavD, 0.7674, 1.87, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
246, 1dyzA, 0.7674, 1.98, 0.138, 129, 123, OXIDISED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
247, 5i28L, 0.7673, 2.03, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
248, 1azbB, 0.7673, 2.12, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
249, 5i28E, 0.7672, 2.02, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
250, 3n2jE, 0.7672, 1.97, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
251, 3n2jC, 0.7672, 2.16, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
252, 1joiA, 0.7672, 2.10, 0.138, 128, 123, STRUCTURE OF PSEUDOMONAS FLUORESCENS HOLO AZURIN
253, 6iavB, 0.7670, 1.89, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
254, 3n2jJ, 0.7670, 2.15, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
255, 2azaB, 0.7670, 2.18, 0.169, 129, 124, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
256, 1r1cD, 0.7670, 1.98, 0.171, 128, 123, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
257, 1azcB, 0.7669, 2.13, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
258, 4qlwD, 0.7666, 1.93, 0.139, 128, 122, AZURIN MUTANT M121E WITH IRON
259, 3n2jD, 0.7666, 1.98, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
260, 4k9jA, 0.7665, 1.91, 0.164, 127, 122, STRUCTURE OF RE(CO)3(47-DIMETHYL-PHEN)(THR126HIS)(LYS122TRP) (HIS83GLU)(TRP48PHE)(TYR72PHE)(TYR108PHE)AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
261, 4jknD, 0.7665, 1.92, 0.148, 128, 122, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
262, 3n2jI, 0.7665, 2.15, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
263, 2iweA, 0.7665, 2.09, 0.146, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
264, 2hx8B, 0.7663, 1.99, 0.156, 127, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
265, 1aizB, 0.7662, 2.15, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
266, 3in0C, 0.7661, 1.92, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
267, 5i28K, 0.7657, 2.11, 0.154, 127, 123, AZURIN T30R1 CRYSTAL FORM II
268, 3n2jK, 0.7657, 1.97, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
269, 1a4aA, 0.7657, 1.98, 0.163, 129, 123, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
270, 4bwwC, 0.7656, 1.98, 0.139, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
271, 1r1cB, 0.7656, 1.95, 0.172, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
272, 6gyiA, 0.7652, 1.95, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
273, 3in2A, 0.7651, 1.92, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
274, 2iweG, 0.7651, 2.17, 0.138, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
275, 1nwoB, 0.7648, 2.00, 0.130, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
276, 3n2jF, 0.7646, 2.00, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
277, 2iweD, 0.7645, 2.19, 0.138, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
278, 2hx9A, 0.7645, 1.79, 0.158, 124, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
279, 4bwwB, 0.7644, 1.97, 0.139, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
280, 3jtbA, 0.7644, 1.94, 0.148, 128, 122, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
281, 1a4cD, 0.7644, 2.22, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
282, 3in0A, 0.7643, 1.94, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
283, 1uriB, 0.7642, 2.12, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
284, 1nwpB, 0.7642, 1.98, 0.130, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
285, 1azuA, 0.7642, 1.89, 0.140, 126, 121, STRUCTURAL FEATURES OF AZURIN AT 2.7 ANGSTROMS RESOLUTION
286, 1ezlC, 0.7638, 2.04, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
287, 2iweJ, 0.7637, 2.15, 0.138, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
288, 1a4cC, 0.7635, 2.09, 0.163, 129, 123, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
289, 1a4bA, 0.7634, 2.16, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
290, 6mjrB, 0.7633, 1.98, 0.164, 128, 122, AZURIN 122W/124F/126RE 
291, 2hx8A, 0.7632, 1.80, 0.158, 125, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
292, 6mjtA, 0.7631, 1.95, 0.164, 128, 122, AZURIN 122F/124W/126RE 
293, 6mjrD, 0.7628, 1.96, 0.164, 128, 122, AZURIN 122W/124F/126RE 
294, 1nwpA, 0.7627, 1.99, 0.130, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
295, 2hx7A, 0.7626, 1.81, 0.158, 125, 120, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
296, 4bwwD, 0.7624, 1.98, 0.139, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
297, 5i26D, 0.7619, 2.15, 0.139, 126, 122, AZURIN T30R1 CRYSTAL FORM I
298, 2ccwA, 0.7617, 2.09, 0.138, 129, 123, CRYSTAL STRUCTURE OF AZURIN II AT ATOMIC RESOLUTION (1.13 ANGSTROM)
299, 4hhgA, 0.7613, 2.01, 0.164, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN RUH107NO YOH109
300, 1nwoA, 0.7613, 2.03, 0.130, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
301, 4wkxA, 0.7611, 2.11, 0.130, 128, 123, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
302, 6mjsC, 0.7608, 1.83, 0.167, 125, 120, AZURIN 122W/124W/126RE 
303, 1cc3B, 0.7607, 2.39, 0.136, 130, 125, PURPLE CUA CENTER
304, 1a4aB, 0.7604, 2.20, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
305, 4hhwB, 0.7601, 2.02, 0.164, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
306, 4hhwA, 0.7597, 1.92, 0.165, 127, 121, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
307, 1r1cC, 0.7597, 2.04, 0.164, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
308, 4qktA, 0.7591, 1.99, 0.140, 125, 121, AZURIN MUTANT M121EM44K WITH COPPER
309, 4hipB, 0.7589, 2.12, 0.164, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
310, 4hipA, 0.7589, 2.03, 0.164, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
311, 2hx9B, 0.7588, 2.07, 0.148, 125, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
312, 1a4cB, 0.7588, 2.16, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
313, 1cc3A, 0.7587, 2.50, 0.136, 130, 125, PURPLE CUA CENTER
314, 2h47C, 0.7586, 2.08, 0.122, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 1)
315, 4qktB, 0.7582, 2.01, 0.140, 125, 121, AZURIN MUTANT M121EM44K WITH COPPER
316, 1a4cA, 0.7579, 2.26, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
317, 1uatA, 0.7575, 2.27, 0.185, 129, 124, THE SIGNIFICANCE OF THE FLEXIBLE LOOP IN THE AZURIN (AZ-ISO2) FROM THE OBLIGATE METHYLOTROPH METHYLOMONAS SP. STRAIN J
318, 1a4bB, 0.7561, 2.24, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
319, 2aanA, 0.7560, 1.81, 0.202, 123, 119, AURACYANIN A: A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUMCHLOROFLEXUS AURANTIACUS
320, 5i26C, 0.7546, 1.82, 0.151, 124, 119, AZURIN T30R1 CRYSTAL FORM I
321, 3fswC, 0.7546, 1.83, 0.151, 124, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
322, 2iaaC, 0.7538, 2.16, 0.106, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 2)
323, 2h3xF, 0.7529, 2.16, 0.114, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
324, 2h3xC, 0.7529, 2.16, 0.114, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
325, 2ftaC, 0.7527, 1.87, 0.151, 124, 119, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
326, 1ov8A, 0.7508, 2.43, 0.185, 139, 124, AURACYANIN B STRUCTURE IN SPACE GROUP P65
327, 1ov8C, 0.7504, 2.43, 0.185, 139, 124, AURACYANIN B STRUCTURE IN SPACE GROUP P65
328, 1ov8B, 0.7502, 2.43, 0.185, 139, 124, AURACYANIN B STRUCTURE IN SPACE GROUP P65
329, 1ov8D, 0.7500, 2.44, 0.185, 139, 124, AURACYANIN B STRUCTURE IN SPACE GROUP P65
330, 3oqrA, 0.7497, 1.94, 0.134, 123, 119, C112D/M121E AZURIN PH 10.0
331, 1qhqA, 0.7491, 2.44, 0.185, 139, 124, AURACYANIN A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUM CHLOROFLEXUS AURANTIACUS
332, 3ay2B, 0.7488, 2.08, 0.115, 126, 122, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
333, 2n0mA, 0.7486, 2.21, 0.114, 130, 123, THE SOLUTION STRUCTURE OF THE SOLUBLE FORM OF THE LIPID-MODIFIED AZURIN FROM NEISSERIA GONORRHOEAE
334, 3ay2A, 0.7478, 2.12, 0.115, 126, 122, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
335, 2ftaB, 0.7477, 1.86, 0.153, 123, 118, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
336, 2xv0A, 0.7462, 2.10, 0.133, 125, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.8
337, 2xv2A, 0.7415, 2.16, 0.133, 124, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.2
338, 2ftaD, 0.7402, 1.84, 0.154, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
339, 2ftaA, 0.7400, 1.85, 0.154, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
340, 3fs9A, 0.7382, 2.20, 0.125, 125, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM)
341, 3fsaA, 0.7349, 2.17, 0.126, 122, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM); CHEMICALLY REDUCED.
342, 2ft7A, 0.7340, 1.94, 0.154, 122, 117, STRUCTURE OF CU(I)AZURIN AT PH 6 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
343, 2ft6A, 0.7335, 1.95, 0.154, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
344, 2ft8A, 0.7333, 1.94, 0.154, 122, 117, STRUCTURE OF CU(I)AZURIN PH8 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
345, 5yt7B, 0.6876, 1.92, 0.138, 132, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
346, 5yt7A, 0.6850, 2.01, 0.128, 133, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
347, 5yt7D, 0.6849, 2.06, 0.128, 133, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
348, 5yt7C, 0.6827, 2.05, 0.128, 130, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
349, 3fsvA, 0.6489, 2.75, 0.119, 118, 109, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAHAAAM)
350, 1a8zA, 0.6416, 2.36, 0.171, 153, 105, STRUCTURE DETERMINATION OF A 16.8KDA COPPER PROTEIN RUSTICYANIN AT 2.1A RESOLUTION USING ANOMALOUS SCATTERING DATA WITH DIRECT METHODS
351, 2cakA, 0.6411, 2.36, 0.171, 154, 105, 1.27ANGSTROM STRUCTURE OF RUSTICYANIN FROM THIOBACILLUS FERROOXIDANS
352, 1a3zA, 0.6406, 2.38, 0.171, 150, 105, REDUCED RUSTICYANIN AT 1.9 ANGSTROMS
353, 1e30A, 0.6400, 2.39, 0.162, 153, 105, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
354, 1gy1B, 0.6399, 2.42, 0.171, 154, 105, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
355, 1gy2B, 0.6397, 2.39, 0.162, 155, 105, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
356, 1gy1A, 0.6396, 2.39, 0.171, 154, 105, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
357, 1rcyA, 0.6395, 2.39, 0.171, 151, 105, RUSTICYANIN (RC) FROM THIOBACILLUS FERROOXIDANS
358, 1e30B, 0.6388, 2.43, 0.162, 153, 105, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
359, 2calA, 0.6384, 2.41, 0.162, 153, 105, CRYSTAL STRUCTURE OF HIS143MET RUSTICYANIN
360, 1gy2A, 0.6384, 2.42, 0.162, 155, 105, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
361, 1gs6X, 0.6302, 2.20, 0.235, 336, 102, CRYSTAL STRUCTURE OF M144A MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
362, 1ntdA, 0.6299, 2.18, 0.235, 336, 102, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE MUTANT M150E THAT CONTAINS ZINC
363, 1ndsA, 0.6294, 2.20, 0.216, 330, 102, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
364, 1ndsB, 0.6293, 2.20, 0.216, 330, 102, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
365, 1et7A, 0.6293, 2.21, 0.245, 339, 102, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASP MUTANT FROM ALCALIGENES FAECALIS S-6
366, 1ndsC, 0.6292, 2.20, 0.216, 330, 102, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
367, 5ocfA, 0.6291, 2.22, 0.206, 455, 102, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND TO THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
368, 1et8A, 0.6291, 2.22, 0.245, 339, 102, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASN MUTANT FROM ALCALIGENES FAECALIS
369, 2dv6D, 0.6290, 2.21, 0.225, 422, 102, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
370, 1ndtA, 0.6287, 2.21, 0.245, 336, 102, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
371, 5tb7A, 0.6286, 2.23, 0.225, 312, 102, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
372, 5ue6F, 0.6285, 2.22, 0.225, 307, 102, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
373, 3h56A, 0.6285, 2.21, 0.235, 335, 102, MET150LEU/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
374, 5f7bA, 0.6283, 2.22, 0.245, 336, 102, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
375, 3zbmA, 0.6283, 2.22, 0.206, 455, 102, STRUCTURE OF M92A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII
376, 2afnC, 0.6283, 2.22, 0.245, 331, 102, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
377, 1j9rB, 0.6283, 2.19, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
378, 5ue6C, 0.6282, 2.23, 0.225, 310, 102, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
379, 2yqbA, 0.6282, 2.22, 0.216, 454, 102, STRUCTURE OF P93A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.4 A RESOLUTION
380, 2b08B, 0.6282, 2.22, 0.235, 336, 102, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
381, 2avfE, 0.6282, 2.21, 0.245, 315, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
382, 1mzzC, 0.6282, 2.22, 0.216, 334, 102, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
383, 5tb7C, 0.6281, 2.23, 0.225, 311, 102, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
384, 5ue6I, 0.6280, 2.23, 0.225, 311, 102, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
385, 2nrdA, 0.6280, 2.22, 0.245, 333, 102, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
386, 2dv6F, 0.6280, 2.22, 0.225, 422, 102, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
387, 2avfC, 0.6280, 2.12, 0.245, 316, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
388, 2dv6A, 0.6279, 2.23, 0.225, 422, 102, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
389, 1nieA, 0.6279, 2.22, 0.245, 333, 102, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
390, 1nicA, 0.6279, 2.22, 0.245, 333, 102, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
391, 5d4iA, 0.6278, 2.23, 0.245, 334, 102, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
392, 2bp8A, 0.6278, 2.23, 0.235, 335, 102, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
393, 1nibB, 0.6278, 2.22, 0.245, 333, 102, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
394, 1j9tB, 0.6278, 2.20, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
395, 1hauA, 0.6278, 2.23, 0.245, 336, 102, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9 A RESOLUTION
396, 1et5A, 0.6278, 2.22, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE REDUCTASE ASP98ASN MUTANT FROM ALCALIGENES FAECALIS S-6
397, 6gbyA, 0.6277, 2.23, 0.245, 333, 102, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: NON- POLYMORPH SEPARATED DATASET 1 
398, 6fjaA, 0.6277, 2.23, 0.206, 455, 102, CRYSTAL STRUCTURE OF T2D THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
399, 5f7aA, 0.6277, 2.23, 0.245, 336, 102, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
400, 2dv6B, 0.6277, 2.23, 0.225, 422, 102, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
401, 1nifA, 0.6277, 2.24, 0.245, 333, 102, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
402, 1kcbA, 0.6277, 2.21, 0.245, 333, 102, CRYSTAL STRUCTURE OF A NO-FORMING NITRITE REDUCTASE MUTANT: AN ANALOG OF A TRANSITION STATE IN ENZYMATIC REACTION
403, 1j9tC, 0.6277, 2.22, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
404, 5tb7B, 0.6276, 2.23, 0.225, 311, 102, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
405, 5f7bB, 0.6276, 2.23, 0.245, 337, 102, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
406, 2ppfC, 0.6276, 2.23, 0.245, 336, 102, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
407, 2dv6C, 0.6276, 2.23, 0.225, 422, 102, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
408, 1j9rC, 0.6276, 2.20, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
409, 5oboA, 0.6275, 2.23, 0.206, 456, 102, CRYSTAL STRUCTURE OF NITRITE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
410, 3ziyA, 0.6275, 2.23, 0.206, 457, 102, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE  FROM RALSTONIA PICKETTII AT 1.01 A RESOLUTION
411, 2dv6E, 0.6275, 2.23, 0.225, 422, 102, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
412, 2bwdA, 0.6275, 2.24, 0.245, 334, 102, ATOMIC RESOLUTION STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH ENDOGENOUSLY BOUND NITRITE AND NO
413, 2afnA, 0.6275, 2.23, 0.245, 331, 102, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
414, 1waeA, 0.6275, 2.23, 0.245, 334, 102, CRYSTAL STRUCTURE OF H129V MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
415, 1npnB, 0.6275, 2.21, 0.235, 336, 102, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
416, 1kbvD, 0.6275, 2.23, 0.225, 302, 102, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
417, 1hawA, 0.6275, 2.23, 0.245, 336, 102, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9A RESOLUTION
418, 6gcgA, 0.6274, 2.22, 0.245, 333, 102, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE POLYMORPH DATASET 15 
419, 5ue6H, 0.6274, 2.24, 0.225, 310, 102, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
420, 5n8hA, 0.6274, 2.24, 0.245, 333, 102, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 3.
421, 4yscB, 0.6274, 2.23, 0.245, 336, 102, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
422, 2bp8B, 0.6274, 2.23, 0.235, 335, 102, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
423, 2afnB, 0.6274, 2.23, 0.245, 331, 102, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
424, 1nidA, 0.6274, 2.22, 0.245, 333, 102, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
425, 6gb8A, 0.6273, 2.24, 0.245, 333, 102, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: SMALL CELL POLYMORPH DATASET 1 
426, 5ogfA, 0.6273, 2.23, 0.245, 332, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.27MGY 
427, 5og6A, 0.6273, 2.24, 0.245, 332, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.24MGY 
428, 5og3A, 0.6273, 2.24, 0.245, 332, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
429, 5ofhA, 0.6273, 2.24, 0.245, 332, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
430, 5f7aB, 0.6273, 2.23, 0.245, 337, 102, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
431, 4cspA, 0.6273, 2.23, 0.245, 335, 102, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
432, 2ppfB, 0.6273, 2.22, 0.245, 337, 102, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
433, 2ppdB, 0.6273, 2.21, 0.235, 337, 102, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
434, 6f1qA, 0.6272, 2.24, 0.206, 456, 102, CRYSTAL STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII IN I213 SPACE GROUP 
435, 5oggA, 0.6272, 2.24, 0.245, 332, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.30MGY 
436, 5og4A, 0.6272, 2.24, 0.245, 332, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.18MGY 
437, 5f7bC, 0.6272, 2.23, 0.245, 336, 102, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
438, 2bp0B, 0.6272, 2.23, 0.235, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
439, 2bp0A, 0.6272, 2.23, 0.235, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
440, 2b08C, 0.6272, 2.23, 0.235, 336, 102, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
441, 1niaC, 0.6272, 2.22, 0.245, 333, 102, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
442, 1j9sB, 0.6272, 2.23, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
443, 5ocbA, 0.6271, 2.24, 0.206, 453, 102, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
444, 5n8gA, 0.6271, 2.24, 0.245, 333, 102, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 2.
445, 2jfcA, 0.6271, 2.24, 0.235, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
446, 1zdsB, 0.6271, 2.23, 0.235, 336, 102, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
447, 1niaB, 0.6271, 2.23, 0.245, 333, 102, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
448, 6gtjA, 0.6270, 2.24, 0.245, 333, 102, NEUTRON CRYSTAL STRUCTURE FOR COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.8 A RESOLUTION 
449, 6gbbA, 0.6270, 2.24, 0.245, 333, 102, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE CELL POLYMORPH DATASET 1 
450, 5i6pA, 0.6270, 2.25, 0.245, 332, 102, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 27.60 MGY
451, 5f7aC, 0.6270, 2.23, 0.245, 336, 102, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
452, 4yscA, 0.6270, 2.23, 0.245, 336, 102, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
453, 1zdsC, 0.6270, 2.23, 0.235, 336, 102, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
454, 1l9qB, 0.6270, 2.23, 0.245, 336, 102, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
455, 1kbvA, 0.6270, 2.24, 0.225, 302, 102, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
456, 5n8fA, 0.6269, 2.24, 0.245, 333, 102, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 1.
457, 2ppeB, 0.6269, 2.21, 0.235, 337, 102, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
458, 2ppaB, 0.6269, 2.23, 0.245, 337, 102, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
459, 2pp8B, 0.6269, 2.23, 0.245, 336, 102, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
460, 2fjsC, 0.6269, 2.23, 0.245, 336, 102, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
461, 1l9rB, 0.6269, 2.23, 0.245, 336, 102, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
462, 1l9pB, 0.6269, 2.22, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
463, 1j9sC, 0.6269, 2.23, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
464, 1as8B, 0.6269, 2.23, 0.245, 336, 102, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
465, 5ue6E, 0.6268, 2.24, 0.225, 310, 102, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
466, 5ofgA, 0.6268, 2.23, 0.245, 332, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.06MGY 
467, 5offA, 0.6268, 2.24, 0.245, 332, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.03MGY 
468, 5d4hA, 0.6268, 2.24, 0.245, 337, 102, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
469, 4yseB, 0.6268, 2.24, 0.245, 337, 102, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
470, 4ax3C, 0.6268, 2.24, 0.206, 455, 102, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
471, 2fjsB, 0.6268, 2.23, 0.245, 337, 102, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
472, 2e86B, 0.6268, 2.23, 0.245, 337, 102, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
473, 1zdqB, 0.6268, 2.23, 0.235, 336, 102, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
474, 1npjB, 0.6268, 2.21, 0.235, 336, 102, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
475, 1nibC, 0.6268, 2.23, 0.245, 333, 102, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
476, 1l9oB, 0.6268, 2.22, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
477, 1aq8B, 0.6268, 2.23, 0.245, 331, 102, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
478, 5og2A, 0.6267, 2.23, 0.245, 332, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.09MGY 
479, 5d4iB, 0.6267, 2.24, 0.245, 341, 102, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
480, 2jfcF, 0.6267, 2.24, 0.235, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
481, 1sjmB, 0.6267, 2.23, 0.245, 336, 102, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
482, 1npnC, 0.6267, 2.22, 0.235, 336, 102, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
483, 1l9tB, 0.6267, 2.23, 0.245, 336, 102, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
484, 1l9sB, 0.6267, 2.23, 0.245, 336, 102, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
485, 1l9oC, 0.6267, 2.23, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
486, 1as7B, 0.6267, 2.23, 0.245, 337, 102, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
487, 6gtiA, 0.6266, 2.24, 0.245, 333, 102, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.0 
488, 5og5A, 0.6266, 2.23, 0.245, 332, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.21MGY 
489, 5d4iC, 0.6266, 2.24, 0.245, 334, 102, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
490, 4yscC, 0.6266, 2.24, 0.245, 335, 102, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
491, 1zdqC, 0.6266, 2.23, 0.235, 336, 102, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
492, 1snrB, 0.6266, 2.23, 0.245, 337, 102, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
493, 1nibA, 0.6266, 2.23, 0.245, 333, 102, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
494, 1l9pC, 0.6266, 2.23, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
495, 5onyA, 0.6265, 2.25, 0.245, 335, 102, AS-ISOLATED RESTING STATE COPPER NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
496, 5i6oA, 0.6265, 2.25, 0.245, 332, 102, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 20.70 MGY
497, 5b1jA, 0.6265, 2.25, 0.245, 334, 102, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
498, 2jfcD, 0.6265, 2.25, 0.235, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
499, 2e86C, 0.6265, 2.24, 0.245, 336, 102, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
500, 1snrC, 0.6265, 2.24, 0.245, 336, 102, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
501, 1sjmC, 0.6265, 2.24, 0.245, 336, 102, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
502, 1npjC, 0.6265, 2.23, 0.235, 336, 102, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
503, 1l9sC, 0.6265, 2.24, 0.245, 336, 102, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
504, 1kbvE, 0.6265, 2.24, 0.225, 302, 102, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
505, 1gs8A, 0.6265, 2.22, 0.245, 336, 102, CRYSTAL STRUCTURE OF  MUTANT D92N ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
506, 5ue6D, 0.6264, 2.26, 0.225, 309, 102, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
507, 2ppaC, 0.6264, 2.23, 0.245, 336, 102, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
508, 2pp7B, 0.6264, 2.24, 0.245, 337, 102, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
509, 2bwiA, 0.6264, 2.25, 0.245, 334, 102, ATOMIC RESOLUTION STRUCTURE OF NITRITE -SOAKED ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
510, 1rzqB, 0.6264, 2.23, 0.245, 328, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
511, 1rzpC, 0.6264, 2.25, 0.245, 332, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
512, 1ndrB, 0.6264, 2.21, 0.216, 330, 102, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
513, 1kbvB, 0.6264, 2.24, 0.225, 302, 102, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
514, 1j9qC, 0.6264, 2.24, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
515, 1j9qB, 0.6264, 2.23, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
516, 1as8C, 0.6264, 2.24, 0.245, 336, 102, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
517, 6gtkA, 0.6263, 2.25, 0.245, 333, 102, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.5 
518, 5ue6B, 0.6263, 2.25, 0.225, 310, 102, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
519, 5d4hB, 0.6263, 2.23, 0.245, 341, 102, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
520, 3h4fB, 0.6263, 2.23, 0.245, 336, 102, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
521, 2ppeC, 0.6263, 2.22, 0.235, 336, 102, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
522, 2ppdC, 0.6263, 2.22, 0.235, 336, 102, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
523, 2pp7C, 0.6263, 2.24, 0.245, 336, 102, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
524, 2p80B, 0.6263, 2.23, 0.245, 336, 102, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
525, 1rzpB, 0.6263, 2.25, 0.245, 328, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
526, 1ndrC, 0.6263, 2.21, 0.216, 330, 102, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
527, 1ndrA, 0.6263, 2.21, 0.216, 330, 102, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
528, 1l9qC, 0.6263, 2.23, 0.245, 336, 102, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
529, 5ofdA, 0.6262, 2.25, 0.245, 333, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
530, 4cspF, 0.6262, 2.23, 0.245, 335, 102, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
531, 4ax3B, 0.6262, 2.25, 0.206, 455, 102, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
532, 2ppcC, 0.6262, 2.24, 0.245, 336, 102, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
533, 2ppcB, 0.6262, 2.24, 0.245, 337, 102, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
534, 2p80C, 0.6262, 2.24, 0.245, 336, 102, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
535, 2bw5A, 0.6262, 2.25, 0.245, 334, 102, ATOMIC RESOLUTION STRUCTURE OF NO-BOUND ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
536, 1n70A, 0.6262, 2.26, 0.225, 334, 102, THE CRYSTAL STRUCTURE OF NITRITE REDUCTASE MUTANT HIS287ALA FROM RHODOBACTER SPHAEROIDES
537, 1l9tC, 0.6262, 2.24, 0.245, 336, 102, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
538, 1l9rC, 0.6262, 2.24, 0.245, 336, 102, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
539, 1kbwB, 0.6262, 2.25, 0.225, 302, 102, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
540, 1kbwA, 0.6262, 2.25, 0.225, 302, 102, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
541, 1bq5A, 0.6262, 2.22, 0.245, 333, 102, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS GIFU 1051
542, 1as7C, 0.6262, 2.23, 0.245, 337, 102, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
543, 5i6nA, 0.6261, 2.25, 0.245, 332, 102, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 11.73 MGY
544, 5d4jB, 0.6261, 2.23, 0.245, 336, 102, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
545, 3h4hB, 0.6261, 2.24, 0.245, 334, 102, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
546, 2vm4A, 0.6261, 2.25, 0.245, 334, 102, STRUCTURE OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE IN SPACE GROUP R3 - 2 OF 2
547, 2pp8C, 0.6261, 2.24, 0.245, 336, 102, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
548, 1niaA, 0.6261, 2.23, 0.245, 333, 102, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
549, 1kbwE, 0.6261, 2.25, 0.225, 302, 102, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
550, 1as6B, 0.6261, 2.23, 0.245, 336, 102, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
551, 5ue6G, 0.6260, 2.26, 0.225, 314, 102, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
552, 5ofcA, 0.6260, 2.25, 0.245, 334, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 21.65MGY 
553, 2zonC, 0.6260, 2.26, 0.245, 334, 102, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
554, 2vm3A, 0.6260, 2.26, 0.245, 333, 102, STRUCTURE OF ALCALIGENES XYLOSOXIDANS IN SPACE GROUP R3 - 1 OF 2
555, 2pp9B, 0.6260, 2.23, 0.245, 337, 102, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
556, 2b08A, 0.6260, 2.24, 0.235, 335, 102, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
557, 2a3tA, 0.6260, 2.26, 0.225, 328, 102, CU-CONTAINING NITRITE REDUCTASE
558, 1kbwD, 0.6260, 2.25, 0.225, 302, 102, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
559, 1kbwC, 0.6260, 2.25, 0.225, 302, 102, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
560, 5i6lA, 0.6259, 2.26, 0.245, 332, 102, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 2.76 MGY
561, 4ax3D, 0.6259, 2.25, 0.206, 457, 102, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
562, 1wa0X, 0.6259, 2.25, 0.245, 335, 102, CRYSTAL STRUCTURE OF W138H MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
563, 1rzqC, 0.6259, 2.23, 0.245, 332, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
564, 1mzzA, 0.6259, 2.24, 0.216, 334, 102, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
565, 1mzyA, 0.6259, 2.26, 0.225, 331, 102, CRYSTAL STRUCTURE OF NITRITE REDUCTASE
566, 1kbwF, 0.6259, 2.25, 0.225, 302, 102, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
567, 1as6C, 0.6259, 2.24, 0.245, 335, 102, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
568, 6gtlA, 0.6258, 2.26, 0.245, 333, 102, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.0 
569, 5zl1D, 0.6258, 2.10, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
570, 5zl1C, 0.6258, 2.10, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
571, 5zl1A, 0.6258, 2.10, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
572, 2ppeA, 0.6258, 2.23, 0.235, 336, 102, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
573, 1rzqA, 0.6258, 2.25, 0.245, 328, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
574, 1oe3A, 0.6258, 2.25, 0.245, 335, 102, ATOMIC RESOLUTION STRUCTURE OF  HALF APO  NIR
575, 1mzzB, 0.6258, 2.24, 0.216, 334, 102, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
576, 1aq8C, 0.6258, 2.24, 0.245, 331, 102, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
577, 5ofeA, 0.6257, 2.26, 0.245, 334, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
578, 5d4hC, 0.6257, 2.25, 0.245, 339, 102, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
579, 2dwsA, 0.6257, 2.26, 0.225, 328, 102, CU-CONTAINING NITRITE REDUCTASE AT PH 8.4 WITH BOUND NITRITE
580, 1wa1X, 0.6257, 2.24, 0.245, 335, 102, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
581, 5of8A, 0.6256, 2.26, 0.245, 333, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
582, 5b1kA, 0.6256, 2.26, 0.245, 334, 102, CRYSTAL STRUCTURE OF THE CHLORIDE-BOUND FORM OF BLUE COPPER NITRITE REDUCTASE
583, 2zooA, 0.6256, 2.27, 0.216, 438, 102, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM PSEUDOALTEROMONAS HALOPLANKTIS TAC125
584, 2pp9C, 0.6256, 2.24, 0.245, 336, 102, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
585, 1as8A, 0.6256, 2.25, 0.245, 336, 102, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
586, 6gtnA, 0.6255, 2.26, 0.245, 333, 102, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.5 
587, 5zl1B, 0.6255, 2.11, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
588, 5onxA, 0.6255, 2.26, 0.245, 335, 102, RESTING STATE COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY
589, 5i6mA, 0.6255, 2.26, 0.245, 332, 102, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 7.59 MGY
590, 5i6kA, 0.6255, 2.26, 0.245, 334, 102, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 0.69 MGY
591, 4yseA, 0.6255, 2.25, 0.245, 337, 102, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
592, 4cszA, 0.6255, 2.26, 0.245, 335, 102, STRUCTURE OF F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS WITH NITRITE BOUND
593, 2zonB, 0.6255, 2.25, 0.245, 334, 102, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
594, 2xx0A, 0.6255, 2.25, 0.245, 335, 102, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
595, 2vw6B, 0.6255, 2.24, 0.245, 334, 102, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
596, 2vw6A, 0.6255, 2.24, 0.245, 333, 102, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
597, 2bw4A, 0.6255, 2.26, 0.245, 334, 102, ATOMIC RESOLUTION STRUCTURE OF RESTING STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
598, 5of7A, 0.6254, 2.26, 0.245, 334, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
599, 4ax3A, 0.6254, 2.26, 0.206, 456, 102, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
600, 2fjsA, 0.6254, 2.25, 0.245, 336, 102, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
601, 5d4jA, 0.6253, 2.25, 0.245, 335, 102, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
602, 3h4hC, 0.6253, 2.25, 0.245, 334, 102, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
603, 2zonA, 0.6253, 2.26, 0.245, 334, 102, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
604, 2y1aA, 0.6253, 2.26, 0.245, 332, 102, CRYSTAL STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH BOUND NO
605, 2xx0B, 0.6253, 2.25, 0.245, 336, 102, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
606, 2ppfA, 0.6253, 2.25, 0.245, 336, 102, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
607, 2ppdA, 0.6253, 2.23, 0.235, 336, 102, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
608, 2pp8A, 0.6253, 2.25, 0.245, 336, 102, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
609, 1wa2X, 0.6253, 2.26, 0.245, 334, 102, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE WITH NITRITE BOUND
610, 5ue6A, 0.6252, 2.27, 0.225, 314, 102, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
611, 2xxfB, 0.6252, 2.24, 0.245, 335, 102, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
612, 2xx1A, 0.6252, 2.25, 0.245, 335, 102, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
613, 2vw4B, 0.6252, 2.24, 0.245, 333, 102, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
614, 2dwtA, 0.6252, 2.27, 0.225, 329, 102, CU-CONTAINING NITRITE REDUCTASE AT PH 6.0 WITH BOUND NITRITE
615, 1zv2A, 0.6252, 2.26, 0.225, 328, 102, CU-CONTAINING NITRITE REDUCTASE
616, 1zdsA, 0.6252, 2.25, 0.235, 335, 102, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
617, 5d4jC, 0.6251, 2.25, 0.245, 336, 102, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
618, 2xwzD, 0.6251, 2.26, 0.245, 335, 102, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
619, 2vw4A, 0.6251, 2.25, 0.245, 333, 102, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
620, 2dy2A, 0.6251, 2.26, 0.225, 329, 102, NITRITE REDUCTASE PH 6.0
621, 1kbvC, 0.6251, 2.26, 0.225, 302, 102, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
622, 5of6A, 0.6250, 2.26, 0.245, 334, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
623, 5akrA, 0.6250, 2.26, 0.245, 337, 102, ATOMIC RESOLUTION STRUCTURE OF NITRITE BOUND STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE AT 0.87 A RESOLUTION
624, 2xxfA, 0.6250, 2.24, 0.245, 335, 102, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
625, 2vw7B, 0.6250, 2.25, 0.245, 334, 102, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
626, 2vw7A, 0.6250, 2.25, 0.245, 335, 102, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
627, 2bo0A, 0.6250, 2.26, 0.235, 335, 102, CRYSTAL STRUCTURE OF THE C130A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
628, 1snrA, 0.6250, 2.25, 0.245, 336, 102, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
629, 1l9pA, 0.6250, 2.25, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
630, 6gt0A, 0.6249, 2.26, 0.245, 333, 102, NITRITE-BOUND COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
631, 2ppaA, 0.6249, 2.25, 0.245, 336, 102, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
632, 1zdqA, 0.6249, 2.25, 0.235, 335, 102, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
633, 1sjmA, 0.6249, 2.25, 0.245, 335, 102, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
634, 1oe2A, 0.6249, 2.24, 0.245, 334, 102, ATOMIC RESOLUTION STRUCTURE OF D92E MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
635, 1kbvF, 0.6249, 2.26, 0.225, 302, 102, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
636, 1gs7A, 0.6249, 2.24, 0.245, 336, 102, CRYSTAL STRUCTURE OF H254F MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
637, 6gsqA, 0.6248, 2.27, 0.245, 333, 102, OXIDISED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
638, 3h4fC, 0.6248, 2.24, 0.245, 336, 102, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
639, 2xwzA, 0.6248, 2.25, 0.245, 335, 102, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
640, 2e86A, 0.6248, 2.25, 0.245, 336, 102, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
641, 1rzpA, 0.6248, 2.25, 0.245, 328, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
642, 1npnA, 0.6248, 2.24, 0.235, 336, 102, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
643, 1npjA, 0.6248, 2.24, 0.235, 336, 102, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
644, 1j9tA, 0.6248, 2.26, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
645, 1j9sA, 0.6248, 2.25, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
646, 1j9rA, 0.6248, 2.26, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
647, 2xxgC, 0.6247, 2.27, 0.245, 335, 102, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
648, 2ppcA, 0.6247, 2.25, 0.245, 336, 102, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
649, 1l9tA, 0.6247, 2.26, 0.245, 336, 102, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
650, 1as7A, 0.6247, 2.23, 0.245, 337, 102, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
651, 2pp7A, 0.6246, 2.25, 0.245, 336, 102, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
652, 1l9sA, 0.6246, 2.26, 0.245, 336, 102, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
653, 1l9rA, 0.6246, 2.25, 0.245, 336, 102, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
654, 1l9oA, 0.6246, 2.25, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
655, 1j9qA, 0.6246, 2.25, 0.245, 336, 102, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
656, 5n8iA, 0.6245, 2.27, 0.245, 334, 102, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 100K REFERENCE DATASET.
657, 2xwzF, 0.6245, 2.25, 0.245, 334, 102, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
658, 1l9qA, 0.6245, 2.26, 0.245, 336, 102, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
659, 6gt2A, 0.6244, 2.26, 0.245, 333, 102, REDUCED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
660, 2xxgA, 0.6244, 2.27, 0.245, 334, 102, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
661, 2p80A, 0.6244, 2.25, 0.245, 335, 102, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
662, 1oe1A, 0.6244, 2.25, 0.245, 335, 102, ATOMIC RESOLUTION STRUCTURE OF THE WILDTYPE NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
663, 3h4fA, 0.6243, 2.26, 0.245, 336, 102, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
664, 2xx1F, 0.6243, 2.25, 0.245, 335, 102, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
665, 2pp9A, 0.6243, 2.25, 0.245, 336, 102, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
666, 1as6A, 0.6243, 2.24, 0.245, 335, 102, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
667, 1aq8A, 0.6243, 2.26, 0.245, 331, 102, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
668, 5b1jB, 0.6242, 2.25, 0.245, 334, 102, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
669, 3h4hA, 0.6242, 2.26, 0.245, 334, 102, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
670, 2jfcB, 0.6241, 2.26, 0.235, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
671, 1curA, 0.6241, 2.47, 0.171, 155, 105, REDUCED RUSTICYANIN NMR
672, 2xx1D, 0.6239, 2.28, 0.245, 335, 102, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
673, 2vn3A, 0.6239, 2.28, 0.245, 336, 102, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
674, 2jfcE, 0.6238, 2.26, 0.235, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
675, 2jfcC, 0.6236, 2.26, 0.235, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
676, 4yseC, 0.6235, 2.27, 0.245, 337, 102, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
677, 2xwzB, 0.6233, 2.28, 0.245, 335, 102, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
678, 2xwzE, 0.6232, 2.26, 0.245, 335, 102, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
679, 2xwzC, 0.6225, 2.28, 0.245, 335, 102, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
680, 5of5A, 0.6224, 2.30, 0.245, 333, 102, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 
681, 3gyrL, 0.6208, 2.07, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
682, 3gyrB, 0.6208, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
683, 3gyrA, 0.6207, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
684, 2xx1B, 0.6207, 2.32, 0.245, 335, 102, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
685, 2xx1C, 0.6206, 2.31, 0.245, 334, 102, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
686, 3gyrK, 0.6203, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
687, 3gyrI, 0.6203, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
688, 3gyrD, 0.6203, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
689, 2xx1E, 0.6202, 2.31, 0.245, 335, 102, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
690, 3gyrE, 0.6201, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
691, 2avfF, 0.6201, 2.58, 0.233, 323, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
692, 3gyrH, 0.6199, 2.08, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
693, 3gyrG, 0.6199, 2.09, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
694, 3gyrJ, 0.6196, 2.09, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
695, 3gyrC, 0.6190, 2.10, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
696, 3gyrF, 0.6189, 2.10, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
697, 4q89A, 0.6183, 2.82, 0.114, 501, 105, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
698, 4q8bA, 0.6176, 2.83, 0.114, 499, 105, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
699, 4yvnA, 0.6167, 2.85, 0.114, 505, 105, CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH ABTS AT A NOVEL BINDING SITE
700, 4yvuA, 0.6166, 2.84, 0.114, 506, 105, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME IN THE ACID CONDITION PH5.6
701, 5zlmA, 0.6163, 2.84, 0.114, 502, 105, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H491C MUTANT; PH 8.0 
702, 4q8bB, 0.6163, 2.88, 0.114, 499, 105, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
703, 1w8eA, 0.6163, 2.85, 0.114, 505, 105, 3D STRUCTURE OF COTA INCUBATED WITH HYDROGEN PEROXIDE
704, 2avfD, 0.6161, 2.36, 0.238, 320, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
705, 1w6wA, 0.6161, 2.85, 0.114, 502, 105, 3D STRUCTURE OF COTA INCUBATED WITH SODIUM AZIDE
706, 5zllA, 0.6160, 2.84, 0.114, 503, 105, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493C MUTANT; PH 8.0 
707, 4akqA, 0.6160, 2.85, 0.114, 505, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498D MUTANT
708, 4akpA, 0.6160, 2.85, 0.114, 504, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE:E498T MUTANT
709, 2x87A, 0.6160, 2.84, 0.114, 504, 105, CRYSTAL STRUCTURE OF THE RECONSTITUTED COTA
710, 1gskA, 0.6160, 2.85, 0.114, 502, 105, CRYSTAL STRUCTURE OF COTA AN ENDOSPORE COAT PROTEIN FROM BACILLUS SUBTILIS
711, 5zljA, 0.6159, 2.85, 0.114, 503, 105, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME; PH8.0 
712, 2x88A, 0.6159, 2.85, 0.114, 504, 105, CRYSTAL STRUCTURE OF HOLOCOTA
713, 1w6lA, 0.6159, 2.85, 0.114, 503, 105, 3D STRUCTURE OF COTA INCUBATED WITH CUCL2
714, 1of0A, 0.6159, 2.84, 0.114, 502, 105, CRYSTAL STRUCTURE OF BACILLUS SUBTILIS COTA AFTER 1H SOAKING WITH EBS
715, 4akoA, 0.6157, 2.85, 0.114, 505, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498L MUTANT
716, 2bhfA, 0.6157, 2.87, 0.114, 504, 105, 3D STRUCTURE OF THE REDUCED FORM OF COTA
717, 3zdwA, 0.6156, 2.88, 0.114, 502, 105, SUBSTRATE AND DIOXYGEN BINDING TO THE ENDOSPORE COAT LACCASE COTA FROM BACILLUS SUBTILIS
718, 5zlkA, 0.6155, 2.85, 0.114, 506, 105, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493A MUTANT; PH 8.0 
719, 4a68A, 0.6155, 2.85, 0.114, 502, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116N MUTANT
720, 4a67A, 0.6155, 2.85, 0.114, 504, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116E MUTANT
721, 4q89B, 0.6154, 2.86, 0.114, 499, 105, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
722, 4a66A, 0.6154, 2.85, 0.124, 501, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116A MUTANT
723, 2wsdA, 0.6154, 2.86, 0.114, 504, 105, PROXIMAL MUTATIONS AT THE TYPE 1 CU SITE OF COTA-LACCASE: I494A MUTANT
724, 2avfA, 0.6138, 2.30, 0.250, 314, 100, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
725, 2avfB, 0.6129, 2.70, 0.238, 316, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
726, 3wiaD, 0.6118, 2.03, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
727, 3wiaG, 0.6116, 2.03, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
728, 3wiaB, 0.6111, 2.05, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
729, 1sddA, 0.6109, 2.84, 0.143, 268, 105, CRYSTAL STRUCTURE OF BOVINE FACTOR VAI
730, 3x1nA, 0.6108, 2.03, 0.204, 298, 98, NITRITE-BOUND THERMOSTABLE COPPER NITRITE REDUCTASE AT 320 K
731, 3wiaA, 0.6107, 2.04, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
732, 4ysaA, 0.6106, 2.03, 0.214, 294, 98, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
733, 3wiaF, 0.6106, 2.05, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
734, 3g5wA, 0.6106, 2.43, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
735, 3wiaH, 0.6105, 2.05, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
736, 3wiaE, 0.6102, 2.05, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
737, 3wiaC, 0.6102, 2.05, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
738, 3x1gA, 0.6100, 2.04, 0.214, 296, 98, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS SHOWING TWO COORDINATION GEOMETRIES AT THE T2CU SITE
739, 3g5wE, 0.6099, 2.44, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
740, 5ytlA, 0.6098, 2.05, 0.214, 294, 98, CRYSTAL STRUCTURE OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE DETERMINED WITH AN ANAEROBICALLY MANIPULATED CRYSTAL 
741, 5n0kA, 0.6092, 2.94, 0.181, 1034, 105, RAT CERULOPLASMIN ORTHORHOMBIC FORM
742, 5ytnA, 0.6091, 2.29, 0.202, 298, 99, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH PEROXIDE 
743, 4ystA, 0.6091, 2.05, 0.214, 294, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 24.9 MGY
744, 4ysuA, 0.6090, 2.06, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 25.0 MGY
745, 3g5wC, 0.6090, 2.45, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
746, 4ysrA, 0.6089, 2.06, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.6 MGY
747, 3x1fA, 0.6089, 2.06, 0.214, 296, 98, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
748, 3wkpA, 0.6089, 2.07, 0.204, 295, 98, C135A MUTANT OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE IN COMPLEX WITH NITRITE
749, 3g5wB, 0.6089, 2.45, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
750, 4yssA, 0.6088, 2.08, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.7 MGY
751, 3g5wD, 0.6087, 2.45, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
752, 5ytmA, 0.6086, 2.07, 0.204, 298, 98, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS DETERMINED BY IN-OUSE SOURCE 
753, 4zk8A, 0.6086, 2.06, 0.214, 294, 98, COPPER-CONTAINING NITRITE REDUCTASE FROM THERMOPHILIC BACTERIUM GEOBACILLUS THERMODENITRIFICANS (RE-REFINED)
754, 3g5wF, 0.6086, 2.46, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
755, 4ysqA, 0.6085, 2.06, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.38 MGY
756, 4yspA, 0.6085, 2.06, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.32 MGY
757, 4e9xC, 0.6085, 2.46, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA3)
758, 4e9yC, 0.6083, 2.44, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA4)
759, 4e9wC, 0.6083, 2.43, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA2)
760, 4e9vC, 0.6083, 2.45, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA1)
761, 3wniA, 0.6082, 2.07, 0.214, 298, 98, 1.50 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
762, 3x1eA, 0.6081, 2.07, 0.214, 295, 98, STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS WITHOUT CHLORIDE
763, 4ysoA, 0.6079, 2.07, 0.214, 295, 98, COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 0.064 MGY
764, 3wnjA, 0.6077, 2.07, 0.214, 298, 98, 1.20 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
765, 2zwnC, 0.6076, 2.47, 0.202, 316, 99, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
766, 2zwnA, 0.6073, 2.49, 0.202, 317, 99, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
767, 4e9xA, 0.6071, 2.49, 0.202, 317, 99, MULTICOPPER OXIDASE MGLAC (DATA3)
768, 1aozB, 0.6070, 2.19, 0.173, 552, 98, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
769, 4e9wA, 0.6069, 2.49, 0.202, 317, 99, MULTICOPPER OXIDASE MGLAC (DATA2)
770, 4e9yA, 0.6068, 2.47, 0.202, 317, 99, MULTICOPPER OXIDASE MGLAC (DATA4)
771, 4e9vA, 0.6068, 2.49, 0.202, 317, 99, MULTICOPPER OXIDASE MGLAC (DATA1)
772, 2uxtA, 0.6066, 2.72, 0.098, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
773, 2zwnB, 0.6060, 2.52, 0.202, 316, 99, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
774, 1aspB, 0.6056, 2.21, 0.173, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
775, 1asoB, 0.6056, 2.17, 0.173, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
776, 4e9xB, 0.6055, 2.52, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA3)
777, 1aspA, 0.6054, 2.22, 0.173, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
778, 4e9yB, 0.6053, 2.52, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA4)
779, 1asoA, 0.6053, 2.22, 0.173, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
780, 1asqA, 0.6052, 2.21, 0.173, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
781, 4e9wB, 0.6050, 2.52, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA2)
782, 4e9vB, 0.6050, 2.52, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA1)
783, 1asqB, 0.6050, 2.18, 0.173, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
784, 1aozA, 0.6047, 2.22, 0.173, 552, 98, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
785, 3tasA, 0.6045, 2.38, 0.120, 300, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
786, 2uxtB, 0.6045, 2.84, 0.098, 420, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
787, 3kw8A, 0.6043, 2.05, 0.143, 273, 98, TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR AT 2.3 A RESOLUTION
788, 3tasB, 0.6039, 2.39, 0.120, 301, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
789, 3cg8C, 0.6035, 2.06, 0.143, 272, 98, LACCASE FROM STREPTOMYCES COELICOLOR
790, 5o4iL, 0.6034, 2.09, 0.143, 280, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
791, 6s0oF, 0.6033, 2.09, 0.143, 275, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
792, 5mkmC, 0.6033, 2.09, 0.143, 275, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
793, 6fdjF, 0.6032, 2.09, 0.143, 275, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
794, 3cg8B, 0.6031, 2.07, 0.143, 272, 98, LACCASE FROM STREPTOMYCES COELICOLOR
795, 6s0oB, 0.6030, 2.09, 0.143, 280, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
796, 5lhlC, 0.6030, 2.09, 0.143, 275, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
797, 6im9A, 0.6029, 2.23, 0.122, 490, 98, MDM2 BOUND CUEO-PM2 SENSOR 
798, 5o4qA, 0.6028, 2.10, 0.143, 281, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
799, 5mkmD, 0.6028, 2.10, 0.143, 277, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
800, 4gybA, 0.6028, 2.09, 0.143, 279, 98, TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AT 2.4 A RESOLUTION AC1709
801, 3cg8A, 0.6028, 2.09, 0.143, 270, 98, LACCASE FROM STREPTOMYCES COELICOLOR
802, 2uxvB, 0.6027, 2.77, 0.098, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
803, 5o4qJ, 0.6026, 2.10, 0.143, 280, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
804, 5o4iG, 0.6025, 2.10, 0.143, 278, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
805, 4uahB, 0.6025, 2.18, 0.121, 271, 99, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
806, 3tasC, 0.6025, 2.17, 0.121, 300, 99, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
807, 5o4iK, 0.6024, 2.10, 0.143, 278, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
808, 5lhlD, 0.6023, 2.10, 0.143, 278, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
809, 6fc7C, 0.6022, 2.14, 0.133, 277, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
810, 5o4iH, 0.6022, 2.10, 0.143, 277, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
811, 4wtqB, 0.6022, 2.19, 0.121, 269, 99, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
812, 4w1tB, 0.6021, 2.18, 0.121, 269, 99, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
813, 5o4iF, 0.6020, 2.21, 0.141, 277, 99, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
814, 3pauA, 0.6020, 2.89, 0.118, 464, 102, CUEO IN THE RESTING OXIDIZED STATE
815, 6fdjG, 0.6019, 2.09, 0.143, 278, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
816, 5o4iD, 0.6019, 2.11, 0.143, 278, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
817, 5o3kF, 0.6019, 2.12, 0.143, 276, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
818, 5mkmA, 0.6019, 2.10, 0.143, 278, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
819, 2fqgA, 0.6019, 2.90, 0.118, 464, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
820, 5o4qH, 0.6018, 2.11, 0.143, 278, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
821, 4wtqC, 0.6018, 2.18, 0.121, 269, 99, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
822, 4bdvA, 0.6018, 2.91, 0.133, 612, 105, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
823, 2fqdA, 0.6018, 2.90, 0.118, 464, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
824, 6s0oD, 0.6017, 2.10, 0.143, 278, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
825, 6fc7J, 0.6017, 2.10, 0.143, 281, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
826, 3tbcB, 0.6017, 2.19, 0.131, 278, 99, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
827, 5mkmF, 0.6016, 2.11, 0.143, 275, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
828, 4wtqA, 0.6016, 2.19, 0.121, 270, 99, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
829, 6fdjJ, 0.6013, 2.20, 0.141, 277, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
830, 6fc7F, 0.6013, 2.20, 0.131, 277, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
831, 5o3kC, 0.6013, 2.11, 0.143, 277, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
832, 3tbbA, 0.6013, 2.10, 0.133, 279, 98, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
833, 6s0oC, 0.6012, 2.20, 0.141, 277, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
834, 5b7eA, 0.6012, 2.94, 0.108, 477, 102, STRUCTURE OF PERDEUTERATED CUEO
835, 4w1tA, 0.6012, 2.19, 0.121, 272, 99, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
836, 6rh9J, 0.6011, 2.21, 0.152, 278, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
837, 5o4qF, 0.6011, 2.11, 0.143, 275, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
838, 4uanC, 0.6011, 2.20, 0.121, 272, 99, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
839, 5o4qL, 0.6010, 2.12, 0.143, 275, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
840, 3nt0A, 0.6010, 2.94, 0.127, 468, 102, C500S (T1D) MUTANT OF CUEO SOAKED IN AND BOUND TO CU(I)
841, 5o4iC, 0.6009, 2.12, 0.143, 277, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
842, 4gxfB, 0.6009, 2.10, 0.143, 279, 98, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
843, 4w1tC, 0.6008, 2.19, 0.121, 276, 99, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
844, 4uahA, 0.6008, 2.20, 0.121, 272, 99, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
845, 2fqfA, 0.6008, 2.90, 0.118, 465, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
846, 2fqeA, 0.6007, 2.92, 0.127, 463, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
847, 1n68A, 0.6007, 2.93, 0.118, 464, 102, COPPER BOUND TO THE MULTICOPPER OXIDASE CUEO
848, 5o4iB, 0.6004, 2.22, 0.141, 281, 99, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
849, 3tbbC, 0.6004, 2.21, 0.131, 277, 99, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
850, 6rhqC, 0.6002, 2.12, 0.143, 275, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
851, 6fdjC, 0.6002, 2.44, 0.140, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
852, 4uanA, 0.6002, 2.20, 0.121, 276, 99, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
853, 4uahC, 0.6002, 2.20, 0.121, 276, 99, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
854, 4m3hC, 0.6002, 2.43, 0.130, 270, 100, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
855, 3pavA, 0.6002, 2.97, 0.127, 466, 102, THE REDUCED FORM OF CUEO
856, 3nscA, 0.6002, 2.94, 0.118, 470, 102, C500S MUTANT OF CUEO BOUND TO CU(II)
857, 6rh9C, 0.6000, 2.21, 0.152, 277, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
858, 5o4qG, 0.6000, 2.12, 0.153, 278, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
859, 5b7mB, 0.6000, 2.93, 0.118, 464, 102, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
860, 3nsfA, 0.6000, 2.94, 0.127, 480, 102, APO FORM OF THE MULTICOPPER OXIDASE CUEO
861, 5o3kA, 0.5999, 2.22, 0.141, 281, 99, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
862, 3zx1A, 0.5999, 2.59, 0.178, 471, 101, MULTICOPPER OXIDASE FROM CAMPYLOBACTER JEJUNI: A METALLO-OXIDASE
863, 3tbcC, 0.5999, 2.21, 0.131, 277, 99, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
864, 5o4iJ, 0.5998, 2.12, 0.143, 279, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
865, 5mkmE, 0.5998, 2.12, 0.143, 277, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
866, 1v10A, 0.5998, 2.86, 0.149, 487, 101, STRUCTURE OF RIGIDOPORUS LIGNOSUS LACCASE FROM HEMIHEDRALLY TWINNED CRYSTALS
867, 1pf3A, 0.5998, 2.94, 0.118, 463, 102, CRYSTAL STRUCTURE OF THE M441L MUTANT OF THE MULTICOPPER OXIDASE CUEO
868, 6fc7K, 0.5997, 2.12, 0.143, 282, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
869, 5o4qC, 0.5997, 2.13, 0.153, 275, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
870, 5o4qI, 0.5996, 2.13, 0.143, 275, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
871, 5b7mC, 0.5996, 2.94, 0.118, 462, 102, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
872, 4m3hB, 0.5996, 2.21, 0.131, 269, 99, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
873, 4hakA, 0.5996, 2.93, 0.118, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT E506A
874, 3nsyA, 0.5996, 2.94, 0.118, 465, 102, THE MULTI-COPPER OXIDASE CUEO WITH SIX MET TO SER MUTATIONS (M358S M361SM362SM364SM366SM368S)
875, 5lhlF, 0.5995, 2.13, 0.143, 275, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
876, 4nerA, 0.5995, 2.94, 0.118, 476, 102, MULTICOPPER OXIDASE CUEO (DATA1)
877, 4e9tA, 0.5995, 2.93, 0.118, 476, 102, MULTICOPPER OXIDASE CUEO (DATA6)
878, 3tbcA, 0.5995, 2.12, 0.133, 279, 98, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
879, 6evgA, 0.5994, 2.75, 0.099, 444, 101, STRUCTURAL AND FUNCTIONAL CHARACTERISATION OF A BACTERIAL LACCASE-LIKE MULTI-COPPER OXIDASE CUEO FROM LIGNIN-DEGRADING BACTERIUM OCHROBACTRUM SP. WITH OXIDASE ACTIVITY TOWARDS LIGNIN MODEL COMPOUNDS AND LIGNOSULFONATE 
880, 4e9sA, 0.5994, 2.93, 0.118, 476, 102, MULTICOPPER OXIDASE CUEO (DATA5)
881, 4e9rA, 0.5994, 2.93, 0.118, 476, 102, MULTICOPPER OXIDASE CUEO (DATA4)
882, 4e9qA, 0.5994, 2.93, 0.118, 476, 102, MULTICOPPER OXIDASE CUEO (DATA2)
883, 3uaeA, 0.5993, 2.93, 0.118, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA6)
884, 3uadA, 0.5993, 2.94, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA5)
885, 3uacA, 0.5993, 2.93, 0.118, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA4)
886, 3qqxA, 0.5993, 2.95, 0.118, 474, 102, REDUCED NATIVE INTERMEDIATE OF THE MULTICOPPER OXIDASE CUEO
887, 6fc7I, 0.5992, 2.14, 0.143, 281, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
888, 6fc7B, 0.5992, 2.23, 0.131, 281, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
889, 3od3A, 0.5992, 2.94, 0.118, 488, 102, CUEO AT 1.1 A RESOLUTION INCLUDING RESIDUES IN PREVIOUSLY DISORDERED REGION
890, 1kv7A, 0.5992, 2.94, 0.118, 463, 102, CRYSTAL STRUCTURE OF CUEO A MULTI-COPPER OXIDASE FROM E. COLI INVOLVED IN COPPER HOMEOSTASIS
891, 6s0oE, 0.5991, 2.12, 0.143, 278, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
892, 6iqzA, 0.5991, 2.72, 0.076, 535, 105, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
893, 6iqxA, 0.5991, 2.72, 0.076, 535, 105, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
894, 5zd6A, 0.5991, 2.72, 0.076, 535, 105, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
895, 5o4iI, 0.5991, 2.23, 0.141, 275, 99, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
896, 5o3kL, 0.5991, 2.23, 0.152, 276, 99, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
897, 4najA, 0.5991, 2.22, 0.152, 279, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 90 MIN SOAKING
898, 4n8uC, 0.5991, 2.23, 0.141, 275, 99, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
899, 4halA, 0.5991, 2.94, 0.118, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT E506I
900, 3uabA, 0.5991, 2.93, 0.118, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA2)
901, 6iqyB, 0.5990, 2.72, 0.076, 536, 105, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
902, 5zd7B, 0.5990, 2.72, 0.076, 536, 105, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
903, 2uxvA, 0.5990, 2.89, 0.098, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
904, 5ys5A, 0.5989, 2.82, 0.119, 457, 101, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT WITH SEVEN COPPER IONS 
905, 4m3hA, 0.5989, 2.22, 0.121, 269, 99, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
906, 3uaaA, 0.5989, 2.93, 0.118, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA1)
907, 2yxwB, 0.5989, 2.92, 0.118, 444, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
908, 5ys1A, 0.5988, 2.81, 0.119, 461, 101, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT 
909, 6iqxB, 0.5986, 2.73, 0.076, 535, 105, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
910, 5n4lA, 0.5986, 2.34, 0.192, 1034, 99, RAT CERULOPLASMIN TRIGONAL FORM
911, 5mkmB, 0.5986, 2.14, 0.143, 278, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
912, 5migA, 0.5986, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 16-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 453 MIN. THE CRYSTAL WAS QUICK REFREEZING BEFORE THIS DATA COLLECTION.
913, 5midA, 0.5986, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 14-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 393 MIN.
914, 6rikA, 0.5985, 2.65, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRTEENTH STRUCTURE OF THE SERIES WITH 5200 KGY DOSE. 
915, 6iqyA, 0.5985, 2.72, 0.076, 536, 105, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
916, 5zd7A, 0.5985, 2.72, 0.076, 536, 105, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
917, 5mieA, 0.5985, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 15-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 423 MIN.
918, 5micA, 0.5985, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 13-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 363 MIN.
919, 5mibA, 0.5985, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 12-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 333 MIN.
920, 5mhyA, 0.5985, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SEVENTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 183 MIN.
921, 5mhxA, 0.5985, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SIXTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 153 MIN.
922, 4n8uA, 0.5985, 2.24, 0.141, 275, 99, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
923, 2yxwA, 0.5985, 2.94, 0.118, 440, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
924, 6rhoA, 0.5984, 2.65, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
925, 5miaA, 0.5984, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 11-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 303 MIN.
926, 5mi2A, 0.5984, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 10-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 273 MIN.
927, 5mi1A, 0.5984, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 9-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 243 MIN.
928, 5mhzA, 0.5984, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 8-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 213 MIN.
929, 5mejA, 0.5984, 2.64, 0.160, 499, 100, STRUCTURAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. FIRST STRUCTURE OF THE SERIES WITH 3 MIN TOTAL X-RAY EXPOSITION TIME.
930, 6ri2A, 0.5983, 2.65, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
931, 5o3kI, 0.5983, 2.15, 0.143, 275, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
932, 5mhwA, 0.5983, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FIFTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 123 MIN.
933, 5mhvA, 0.5983, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FOURTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 93 MIN.
934, 5mhuA, 0.5983, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE THIRD STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 63 MIN.
935, 5mewA, 0.5983, 2.64, 0.160, 499, 100, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. SECOND STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 33 MIN.
936, 5k8dB, 0.5983, 2.19, 0.155, 619, 97, CRYSTAL STRUCTURE OF RFVIIIFC
937, 3kw7A, 0.5983, 2.65, 0.160, 502, 100, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
938, 6rilA, 0.5982, 2.64, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTEENTH STRUCTURE OF THE SERIES WITH 5600 KGY DOSE (DATA WAS COLLECTED AFTER REFREEZING). 
939, 3t6zA, 0.5982, 2.66, 0.140, 495, 100, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
940, 3nsdA, 0.5982, 2.95, 0.118, 462, 102, SILVER BOUND TO THE MULTICOPPER OXIDASE CUEO (UNTAGGED)
941, 6rhpA, 0.5981, 2.64, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTY FIRST STRUCTURE OF THE SERIES WITH 4415 KGY DOSE (COLLECTED AFTER REFREEZING). 
942, 6rhiA, 0.5981, 2.65, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
943, 6riiA, 0.5980, 2.65, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTH STRUCTURE OF THE SERIES WITH 1200 KGY DOSE. 
944, 6ri0A, 0.5980, 2.65, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
945, 6rhhA, 0.5980, 2.64, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
946, 3ta4D, 0.5980, 2.14, 0.163, 273, 98, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
947, 3t71A, 0.5980, 2.67, 0.140, 495, 100, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
948, 3j2qA, 0.5980, 2.92, 0.133, 630, 105, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
949, 3cdzA, 0.5980, 2.92, 0.133, 630, 105, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
950, 6ri8A, 0.5979, 2.65, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 800 KGY DOSE. 
951, 6ri6A, 0.5979, 2.65, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 400 KGY DOSE. 
952, 6ri4A, 0.5979, 2.64, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 13 KGY DOSE. 
953, 6rgpA, 0.5979, 2.64, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
954, 6fdjL, 0.5979, 2.46, 0.140, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
955, 3t9wA, 0.5979, 2.14, 0.153, 270, 98, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116
956, 3t6vA, 0.5979, 2.66, 0.140, 495, 100, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
957, 2xllD, 0.5979, 2.74, 0.076, 533, 105, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
958, 6rhxA, 0.5978, 2.65, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
959, 6rhuA, 0.5978, 2.64, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
960, 6rhrA, 0.5978, 2.64, 0.160, 497, 100, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
961, 6rghA, 0.5978, 2.64, 0.160, 499, 100, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
962, 6im8A, 0.5978, 2.98, 0.127, 469, 102, CUEO-PM2 MULTICOPPER OXIDASE 
963, 3t6vB, 0.5978, 2.69, 0.140, 495, 100, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
964, 5gnoA, 0.5977, 2.99, 0.127, 463, 102, STRUCTURE OF MULTICOPPER OXIDASE CUEO - SIGNAL PEPTIDE-FREE
965, 5b7fA, 0.5977, 2.99, 0.127, 463, 102, STRUCTURE OF CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
966, 3t6xA, 0.5977, 2.66, 0.140, 495, 100, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
967, 2yxvB, 0.5977, 2.93, 0.118, 440, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
968, 4enzA, 0.5975, 2.12, 0.124, 1029, 97, STRUCTURE OF HUMAN CERULOPLASMIN AT 2.6 A RESOLUTION
969, 3kw7B, 0.5975, 2.66, 0.160, 502, 100, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
970, 6fdjI, 0.5974, 2.24, 0.141, 276, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
971, 5lhlE, 0.5973, 2.24, 0.141, 275, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
972, 3t6zC, 0.5973, 2.67, 0.140, 495, 100, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
973, 3t6xC, 0.5973, 2.68, 0.140, 495, 100, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
974, 3t6wA, 0.5973, 2.66, 0.140, 495, 100, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
975, 5b7mA, 0.5972, 2.82, 0.129, 463, 101, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
976, 4ejxA, 0.5972, 2.39, 0.182, 1034, 99, STRUCTURE OF CERULOPLASMIN-MYELOPEROXIDASE COMPLEX
977, 3t6zB, 0.5972, 2.70, 0.140, 495, 100, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
978, 1kyaA, 0.5972, 2.65, 0.140, 499, 100, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
979, 3t6wC, 0.5971, 2.68, 0.140, 495, 100, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
980, 3t6wB, 0.5971, 2.69, 0.140, 495, 100, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
981, 6s0oA, 0.5970, 2.25, 0.141, 278, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
982, 5z22A, 0.5970, 2.66, 0.170, 494, 100, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
983, 4ef3A, 0.5970, 2.82, 0.129, 466, 101, MULTICOPPER OXIDASE CUEO (CITRATE BUFFER)
984, 3x1bB, 0.5970, 2.67, 0.120, 500, 100, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
985, 3x1bA, 0.5970, 2.67, 0.120, 500, 100, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
986, 3t6vC, 0.5970, 2.68, 0.140, 495, 100, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
987, 1kyaC, 0.5970, 2.65, 0.140, 499, 100, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
988, 1kyaB, 0.5970, 2.65, 0.140, 499, 100, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
989, 6rh9L, 0.5969, 2.16, 0.153, 275, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
990, 1kyaD, 0.5969, 2.65, 0.140, 499, 100, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
991, 5z1xA, 0.5968, 2.66, 0.170, 495, 100, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
992, 5afaA, 0.5967, 2.89, 0.167, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH AG CRYSTAL OF THE HOLOENZYME SOAKED FOR 30 M IN 5 MM AGNO3 AT 278 K.
993, 3t71C, 0.5967, 2.69, 0.140, 495, 100, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
994, 3t6xB, 0.5967, 2.70, 0.140, 495, 100, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
995, 5z1xB, 0.5966, 2.67, 0.170, 495, 100, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
996, 3v9eA, 0.5966, 2.47, 0.155, 539, 97, STRUCTURE OF THE L499M MUTANT OF THE LACCASE FROM B.ACLADA
997, 3t71B, 0.5966, 2.70, 0.140, 495, 100, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
998, 6rh9I, 0.5964, 2.26, 0.152, 275, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
999, 5jrrA, 0.5962, 2.88, 0.167, 439, 102, CRYSTAL STRUCTURE OF NATIVE LACCASE FROM THERMUS THERMOPHILUS HB27
1000, 5e9nA, 0.5962, 2.66, 0.160, 495, 100, STECCHERINUM MURASHKINSKYI LACCASE AT 0.95 RESOLUTION
1001, 3cdzB, 0.5962, 2.15, 0.144, 631, 97, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
1002, 6rh9E, 0.5960, 2.47, 0.160, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1003, 5lduA, 0.5960, 2.67, 0.120, 499, 100, RECOMBINANT HIGH-REDOX POTENTIAL LACCASE FROM BASIDIOMYCETE TRAMETES HIRSUTA
1004, 4x4kA, 0.5960, 2.30, 0.156, 525, 96, STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA WITH FULL COPPER CONTENT
1005, 2yarA, 0.5960, 2.90, 0.167, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (87.5-100.0 PERCENT DOSE)
1006, 2yaeA, 0.5960, 2.89, 0.167, 438, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27(0.0-12.5 PERCENT DOSE)
1007, 1kcwA, 0.5959, 2.39, 0.182, 1017, 99, X-RAY CRYSTAL STRUCTURE OF HUMAN CERULOPLASMIN AT 3.0 ANGSTROMS
1008, 3v9cA, 0.5958, 2.67, 0.120, 499, 100, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA AT LOW DOSE OF IONIZATION RADIATION
1009, 3pxlA, 0.5958, 2.67, 0.120, 499, 100, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA
1010, 2yapA, 0.5958, 2.90, 0.167, 437, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (62.5-75.0 PERCENT DOSE)
1011, 2yaoA, 0.5958, 2.90, 0.167, 437, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (50.0-62.5 PERCENT DOSE)
1012, 2yafA, 0.5958, 2.90, 0.167, 438, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (12.5-25.0 PERCENT DOSE)
1013, 2xu9A, 0.5958, 2.90, 0.167, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27
1014, 5k5kA, 0.5957, 2.90, 0.167, 439, 102, CRYSTAL STRUCTURE OF LACCASSE FROM THERMUS THERMOPHILUS HB27 (ASCORBIC ACID 10 MIN)
1015, 2yamA, 0.5957, 2.90, 0.167, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (37.5-50.0 PERCENT DOSE)
1016, 5k84A, 0.5956, 2.90, 0.167, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 10 MIN)
1017, 5k0dA, 0.5956, 2.90, 0.167, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 3 MIN)
1018, 5jx9A, 0.5956, 2.90, 0.167, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 5 MIN)
1019, 5ehfA, 0.5956, 2.67, 0.140, 497, 100, LACCASE FROM ANTRODIELLA FAGINEA
1020, 2yaqA, 0.5956, 2.90, 0.167, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (75.0-87.5 PERCENT DOSE)
1021, 2qt6A, 0.5956, 2.68, 0.150, 498, 100, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
1022, 2h5uA, 0.5956, 2.68, 0.140, 497, 100, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.9A RESOLUTION
1023, 5k7aA, 0.5955, 2.90, 0.167, 439, 102, CRYSTAL STRUCTURE OF LACCASE FRON THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 1.5 MIN)
1024, 5k15A, 0.5955, 2.90, 0.167, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU2PO 8 MIN)
1025, 3divA, 0.5955, 2.68, 0.130, 497, 100, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.76A RESOLUTION
1026, 5k3kA, 0.5954, 2.90, 0.167, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CUSO4 20 MIN)
1027, 4bdvB, 0.5954, 2.17, 0.144, 606, 97, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
1028, 3fpxA, 0.5954, 2.69, 0.120, 499, 100, NATIVE FUNGUS LACCASE FROM TRAMETES HIRSUTA
1029, 2yahA, 0.5954, 2.90, 0.167, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (25.0-37.5 PERCENT DOSE)
1030, 2xuwA, 0.5954, 2.90, 0.167, 437, 102, CRYSTAL STRUCTURE OF APOLACCASE FROM THERMUS THERMOPHILUS HB27
1031, 3j2qB, 0.5953, 2.27, 0.144, 631, 97, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
1032, 2hzhA, 0.5953, 2.68, 0.150, 499, 100, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLUS ZONATUS AT 2.6 A RESOLUTION
1033, 6rh9B, 0.5952, 2.27, 0.152, 278, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1034, 5k8dA, 0.5952, 2.82, 0.135, 611, 104, CRYSTAL STRUCTURE OF RFVIIIFC
1035, 2xllC, 0.5952, 2.66, 0.077, 533, 104, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
1036, 2xllB, 0.5952, 2.66, 0.077, 533, 104, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
1037, 2xllA, 0.5952, 2.66, 0.077, 533, 104, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
1038, 5g3eA, 0.5951, 2.90, 0.167, 437, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1039, 5g3dA, 0.5951, 2.90, 0.167, 438, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CCASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1040, 5g3cA, 0.5951, 2.90, 0.167, 435, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS TERMOPHILUS MULTICOPPER OXIDASE
1041, 3sqrA, 0.5951, 2.43, 0.155, 539, 97, CRYSTAL STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA AT 1.67 A RESOLUTION
1042, 2qt6B, 0.5950, 2.68, 0.150, 498, 100, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
1043, 2xybA, 0.5949, 2.69, 0.150, 497, 100, CRYSTAL STRUCTURE OF A FULLY FUNCTIONAL LACCASE FROM THE LIGNINOLYTIC FUNGUS PYCNOPORUS CINNABARINUS
1044, 5n4lB, 0.5948, 2.38, 0.192, 1034, 99, RAT CERULOPLASMIN TRIGONAL FORM
1045, 2yxvA, 0.5948, 2.81, 0.119, 444, 101, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
1046, 4n8uB, 0.5947, 2.26, 0.141, 276, 99, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1047, 1gycA, 0.5947, 2.69, 0.150, 499, 100, CRYSTAL STRUCTURE DETERMINATION AT ROOM TEMPERATURE OF A LACCASE FROM TRAMETES VERSICOLOR IN ITS OXIDISED FORM CONTAINING A FULL COMPLEMENT OF COPPER IONS
1048, 3j2sB, 0.5946, 2.30, 0.144, 631, 97, MEMBRANE-BOUND FACTOR VIII LIGHT CHAIN
1049, 4jhvA, 0.5943, 2.70, 0.150, 496, 100, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA
1050, 5g3hA, 0.5942, 2.86, 0.176, 438, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1051, 4a2hA, 0.5940, 2.71, 0.150, 495, 100, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLOPSIS GALLICA PH 7.0
1052, 3ta4E, 0.5939, 2.18, 0.163, 267, 98, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
1053, 2j5wA, 0.5939, 2.41, 0.182, 1029, 99, CERULOPLASMIN REVISITED: STRUCTURAL AND FUNCTIONAL ROLES OF VARIOUS METAL CATION BINDING SITES
1054, 4a2fA, 0.5936, 2.73, 0.150, 495, 100, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 12.65 KEV
1055, 4a2eA, 0.5935, 2.71, 0.150, 495, 100, CRYSTAL STRUCTURE OF A CORIOLOPSIS GALLICA LACCASE AT 1.7 A RESOLUTION PH 5.5
1056, 4a2dA, 0.5935, 2.71, 0.150, 495, 100, CORIOLOPSIS GALLICA LACCASE T2 COPPER DEPLETED AT PH  4.5
1057, 5nq8A, 0.5930, 2.72, 0.140, 497, 100, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II
1058, 5lwwA, 0.5930, 2.41, 0.155, 550, 97, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM ASPERGILLUS NIGER BOUND TO ZINC
1059, 4ai7A, 0.5929, 2.93, 0.167, 437, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 2 H IN 5 MM HGCL2 AT 278 K.
1060, 4a2gA, 0.5928, 2.72, 0.150, 495, 100, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 8.98 KEV
1061, 5nq9A, 0.5927, 2.72, 0.140, 497, 100, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
1062, 4jhuA, 0.5927, 2.74, 0.150, 496, 100, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA SOAKED WITH CUCL
1063, 2hrgA, 0.5927, 2.72, 0.160, 496, 100, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII COMPLEXED WITH P-METHYLBENZOATE
1064, 2hrhA, 0.5926, 2.71, 0.160, 496, 100, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII
1065, 5nq9C, 0.5922, 2.73, 0.140, 497, 100, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
1066, 2xvbA, 0.5921, 2.94, 0.167, 438, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 5 MIN. IN 5 MM HGCL2 AT 278 K.
1067, 5anhC, 0.5919, 2.78, 0.160, 496, 100, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1068, 5a7eA, 0.5918, 3.28, 0.135, 495, 104, CRYSTALLOGRAPHIC STRUCTURAL DETERMINATION OF A TRIGONAL LACCASE FROM CORIOLOPSIS GALLICA (CGL) TO 1.5 A RESOLUTION
1069, 6im7A, 0.5917, 2.60, 0.121, 461, 99, CUEO-12.1 MULTICOPPER OXIDASE 
1070, 5nq7A, 0.5917, 2.73, 0.140, 497, 100, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM I
1071, 3ta4F, 0.5913, 2.24, 0.227, 282, 97, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
1072, 5anhA, 0.5911, 2.76, 0.160, 496, 100, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1073, 5anhB, 0.5908, 2.78, 0.160, 496, 100, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1074, 6rhqF, 0.5896, 2.29, 0.175, 276, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1075, 6rh9F, 0.5891, 2.30, 0.175, 276, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1076, 5o4iA, 0.5890, 2.31, 0.175, 278, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1077, 6fc7D, 0.5887, 2.29, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1078, 5o3kB, 0.5886, 2.30, 0.175, 278, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1079, 6rh9A, 0.5884, 2.30, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1080, 6fdjB, 0.5884, 2.33, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1081, 6fc7L, 0.5884, 2.30, 0.175, 276, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1082, 5g3gA, 0.5884, 3.15, 0.155, 437, 103, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1083, 5g3fA, 0.5884, 3.15, 0.155, 437, 103, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1084, 5g3bA, 0.5884, 3.15, 0.155, 437, 103, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE: THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1085, 2r7eA, 0.5884, 2.41, 0.102, 693, 98, CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII
1086, 2vmjA, 0.5882, 2.26, 0.250, 326, 96, TYPE 1 COPPER-BINDING LOOP OF NITRITE REDUCTASE MUTANT: 130- CAPEGMVPWHVVSGM-144 TO 130-CTPHPFM-136
1087, 5lhlA, 0.5881, 2.30, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1088, 6rhqA, 0.5880, 2.30, 0.175, 282, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1089, 5o4qD, 0.5880, 2.30, 0.175, 278, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1090, 6rhqD, 0.5878, 2.30, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1091, 6rh9H, 0.5878, 2.31, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1092, 6fc7G, 0.5877, 2.30, 0.175, 281, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1093, 5o3kD, 0.5877, 2.34, 0.175, 281, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1094, 6fdjA, 0.5875, 2.30, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1095, 6rh9G, 0.5874, 2.31, 0.175, 279, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1096, 6rh9D, 0.5874, 2.31, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1097, 6rh9K, 0.5873, 2.30, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1098, 6fc7H, 0.5873, 2.31, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1099, 5o4qE, 0.5873, 2.33, 0.175, 278, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1100, 5o3kG, 0.5873, 2.33, 0.175, 281, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1101, 4ysdA, 0.5873, 2.41, 0.196, 299, 97, ROOM TEMPERATURE STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
1102, 5o4qB, 0.5870, 2.34, 0.175, 278, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1103, 5o3kJ, 0.5870, 2.33, 0.175, 281, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1104, 1hfuA, 0.5869, 2.71, 0.131, 500, 99, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS AT 1.68 A RESOLUTION
1105, 6rhqE, 0.5868, 2.34, 0.175, 282, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1106, 5o3kK, 0.5868, 2.33, 0.175, 278, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1107, 5o4iE, 0.5867, 2.36, 0.175, 278, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1108, 6rhqB, 0.5866, 2.33, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1109, 6fc7A, 0.5864, 2.31, 0.175, 281, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1110, 6fdjE, 0.5862, 2.37, 0.175, 277, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1111, 6fdjD, 0.5862, 2.36, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1112, 6fc7E, 0.5862, 2.32, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1113, 5o4qK, 0.5862, 2.35, 0.175, 278, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1114, 1sddB, 0.5862, 2.10, 0.147, 601, 95, CRYSTAL STRUCTURE OF BOVINE FACTOR VAI
1115, 5o3kE, 0.5861, 2.35, 0.175, 278, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1116, 5lhlB, 0.5860, 2.33, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1117, 4nb7A, 0.5858, 2.34, 0.175, 280, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 180 MIN SOAKING
1118, 3abgB, 0.5855, 2.76, 0.076, 518, 105, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
1119, 4uanB, 0.5854, 2.33, 0.175, 270, 97, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
1120, 4gxfC, 0.5854, 2.34, 0.175, 279, 97, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1121, 4gxfA, 0.5854, 2.34, 0.175, 279, 97, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1122, 5o3kH, 0.5853, 2.38, 0.175, 278, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1123, 1a65A, 0.5853, 2.92, 0.130, 504, 100, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS
1124, 4gy4C, 0.5852, 2.36, 0.175, 278, 97, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1125, 4gy4B, 0.5851, 2.33, 0.175, 278, 97, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1126, 4gy4A, 0.5851, 2.36, 0.175, 276, 97, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1127, 3aw5A, 0.5851, 2.73, 0.172, 438, 99, STRUCTURE OF A MULTICOPPER OXIDASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROBACULUM AEROPHILUM
1128, 3abgA, 0.5851, 2.73, 0.100, 508, 100, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
1129, 6fdjK, 0.5850, 2.36, 0.175, 276, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1130, 6fdjH, 0.5850, 2.37, 0.175, 277, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1131, 3wkqA, 0.5840, 2.43, 0.196, 299, 97, COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH FORMATE
1132, 3tbbB, 0.5829, 2.35, 0.175, 278, 97, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
1133, 3wi9A, 0.5812, 2.35, 0.198, 303, 96, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS KAUSTOPHILUS
1134, 1zpuB, 0.5807, 2.75, 0.162, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1135, 1zpuA, 0.5805, 2.75, 0.162, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1136, 1zpuF, 0.5804, 2.75, 0.162, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1137, 1zpuC, 0.5803, 2.75, 0.162, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1138, 1zpuD, 0.5802, 2.75, 0.162, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1139, 1zpuE, 0.5801, 2.75, 0.162, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1140, 3wiaI, 0.5772, 2.32, 0.200, 272, 95, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
1141, 5lwxA, 0.5743, 2.46, 0.146, 554, 96, CRYSTAL STRUCTURE OF THE H253D MUTANT OF MCOG FROM ASPERGILLUS NIGER
1142, 5lm8A, 0.5729, 2.47, 0.146, 549, 96, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM FROM ASPERGILLUS NIGER
1143, 3pnrB, 0.5727, 3.98, 0.042, 129, 118, STRUCTURE OF PBICP-C IN COMPLEX WITH FALCIPAIN-2
1144, 4m4rF, 0.5693, 3.18, 0.036, 138, 110, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1145, 4bxsV, 0.5688, 2.62, 0.102, 1262, 98, CRYSTAL STRUCTURE OF THE PROTHROMBINASE COMPLEX FROM THE VENOM OF PSEUDONAJA TEXTILIS
1146, 4m4rD, 0.5678, 3.21, 0.036, 140, 110, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1147, 4l0pB, 0.5675, 3.24, 0.036, 139, 110, STRUCTURE OF THE HUMAN EPHA3 RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH EPHRIN-A5
1148, 4m4rB, 0.5665, 3.24, 0.036, 141, 110, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1149, 2wo3B, 0.5658, 3.36, 0.054, 142, 111, CRYSTAL STRUCTURE OF THE EPHA4-EPHRINA2 COMPLEX
1150, 1ibzA, 0.5615, 1.81, 0.236, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1151, 1ic0E, 0.5612, 1.83, 0.236, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1152, 1ic0C, 0.5611, 1.82, 0.236, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1153, 1ikoP, 0.5597, 3.10, 0.055, 141, 109, CRYSTAL STRUCTURE OF THE MURINE EPHRIN-B2 ECTODOMAIN
1154, 1ibyA, 0.5595, 2.00, 0.233, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1155, 3dkhB, 0.5592, 3.00, 0.153, 558, 98, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
1156, 1ibzB, 0.5592, 2.10, 0.233, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1157, 1ic0D, 0.5590, 1.92, 0.236, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1158, 3fu9A, 0.5584, 2.72, 0.146, 559, 96, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
1159, 1gw0B, 0.5582, 3.11, 0.153, 559, 98, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1160, 6f5kA, 0.5577, 3.27, 0.121, 557, 99, CRYSTAL STRUCTURE OF LACCASE FROM MYCELIOPHTHORA THERMOPHILA 
1161, 3ppsA, 0.5577, 3.29, 0.141, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1162, 3ppsD, 0.5575, 3.29, 0.141, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1163, 1gw0A, 0.5574, 3.11, 0.153, 559, 98, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1164, 3dkhA, 0.5573, 3.26, 0.152, 558, 99, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
1165, 1ic0B, 0.5573, 1.91, 0.236, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1166, 1ibyC, 0.5573, 2.09, 0.233, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1167, 2ih9A, 0.5572, 3.12, 0.153, 559, 98, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1168, 3fu8B, 0.5571, 3.09, 0.153, 558, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
1169, 2q9oB, 0.5571, 3.05, 0.153, 558, 98, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
1170, 3fu8A, 0.5569, 3.08, 0.153, 558, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
1171, 2q9oA, 0.5569, 3.07, 0.153, 558, 98, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
1172, 2ih9B, 0.5569, 3.11, 0.153, 559, 98, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1173, 2ih8A, 0.5569, 3.12, 0.153, 559, 98, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
1174, 4m4rH, 0.5568, 3.42, 0.027, 138, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1175, 1ibyB, 0.5568, 2.09, 0.233, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1176, 3fu9B, 0.5567, 3.12, 0.153, 559, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
1177, 3fu7B, 0.5567, 3.14, 0.153, 559, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
1178, 3fu7A, 0.5567, 3.08, 0.153, 558, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
1179, 2ih8B, 0.5564, 3.13, 0.153, 559, 98, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
1180, 1ic0F, 0.5564, 1.80, 0.216, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1181, 1ibzC, 0.5563, 1.80, 0.227, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1182, 2wo2B, 0.5561, 3.21, 0.073, 136, 109, CRYSTAL STRUCTURE OF THE EPHA4-EPHRINB2 COMPLEX
1183, 3ehbB, 0.5558, 2.36, 0.161, 252, 93, A D-PATHWAY MUTATION DECOUPLES THE PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE BY ALTERING THE SIDE CHAIN ORIENTATION OF A DISTANT CONSERVED GLUTAMATE
1184, 3qpkB, 0.5557, 3.14, 0.153, 559, 98, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1185, 3mx0D, 0.5557, 3.46, 0.036, 138, 110, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1186, 1ar1B, 0.5557, 2.39, 0.161, 252, 93, STRUCTURE AT 2.7 ANGSTROM RESOLUTION OF THE PARACOCCUS DENITRIFICANS TWO-SUBUNIT CYTOCHROME C OXIDASE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1187, 3qpkA, 0.5555, 3.14, 0.153, 559, 98, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1188, 1ibzD, 0.5554, 1.96, 0.236, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1189, 3mx0B, 0.5552, 3.40, 0.036, 138, 110, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1190, 3hb3B, 0.5551, 2.38, 0.161, 252, 93, HIGH RESOLUTION CRYSTAL STRUCTURE OF PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE
1191, 3d12E, 0.5551, 3.08, 0.075, 141, 106, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
1192, 1shxA, 0.5546, 3.59, 0.018, 138, 111, EPHRIN A5 LIGAND STRUCTURE
1193, 3ppsC, 0.5544, 3.28, 0.141, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1194, 3ppsB, 0.5543, 3.29, 0.141, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1195, 6ci0D, 0.5541, 2.42, 0.118, 257, 93, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION 
1196, 5wehB, 0.5541, 2.46, 0.118, 254, 93, CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1197, 2x11B, 0.5540, 3.64, 0.018, 138, 111, CRYSTAL STRUCTURE OF THE COMPLETE EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN A5 RECEPTOR BINDING DOMAIN
1198, 4bkfD, 0.5539, 3.10, 0.075, 141, 106, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
1199, 4bkfC, 0.5539, 3.10, 0.075, 141, 106, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
1200, 3d12B, 0.5539, 3.10, 0.075, 141, 106, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
1201, 1m56B, 0.5538, 2.55, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE)
1202, 3om3D, 0.5537, 2.43, 0.118, 256, 93, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE
1203, 2gsmB, 0.5537, 2.56, 0.117, 256, 94, CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES
1204, 1m57B, 0.5537, 2.43, 0.118, 260, 93, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES (EQ(I-286) MUTANT))
1205, 1ibyD, 0.5537, 1.96, 0.236, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1206, 3omnD, 0.5536, 2.55, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE
1207, 1qleB, 0.5536, 2.37, 0.161, 252, 93, CRYO-STRUCTURE OF THE PARACOCCUS DENITRIFICANS FOUR-SUBUNIT CYTOCHROME C OXIDASE IN THE COMPLETELY OXIDIZED STATE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1208, 3omaD, 0.5535, 2.56, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION
1209, 1shxB, 0.5535, 3.62, 0.018, 138, 111, EPHRIN A5 LIGAND STRUCTURE
1210, 1m56H, 0.5534, 2.56, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE)
1211, 3omiB, 0.5533, 2.56, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION
1212, 3omaB, 0.5532, 2.56, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION
1213, 1ic0A, 0.5530, 1.89, 0.239, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1214, 3omnB, 0.5528, 2.57, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE
1215, 3fyiD, 0.5527, 2.43, 0.118, 256, 93, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE
1216, 1m57H, 0.5527, 2.57, 0.117, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES (EQ(I-286) MUTANT))
1217, 3fyeB, 0.5526, 2.57, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1218, 6ci0B, 0.5525, 2.44, 0.118, 256, 93, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION 
1219, 3fyiB, 0.5525, 2.57, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE
1220, 5wehH, 0.5524, 2.48, 0.118, 253, 93, CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1221, 1shwA, 0.5524, 3.46, 0.036, 138, 110, EPHB2 / EPHRINA5 COMPLEX STRUCTURE
1222, 2gsmD, 0.5522, 2.56, 0.117, 256, 94, CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES
1223, 3omiD, 0.5521, 2.56, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION
1224, 3om3B, 0.5520, 2.57, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE
1225, 3fyeD, 0.5518, 2.56, 0.117, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1226, 1kgyE, 0.5518, 3.15, 0.056, 138, 108, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1227, 3dtuB, 0.5515, 2.58, 0.117, 259, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID
1228, 4uf7C, 0.5512, 3.15, 0.065, 138, 108, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
1229, 3dtuD, 0.5510, 2.57, 0.117, 258, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID
1230, 4uf7E, 0.5508, 3.18, 0.065, 139, 108, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
1231, 3heiB, 0.5506, 3.38, 0.055, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1232, 5z62B, 0.5500, 2.56, 0.138, 227, 94, STRUCTURE OF HUMAN CYTOCHROME C OXIDASE 
1233, 1kgyG, 0.5498, 3.13, 0.084, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1234, 2vsmB, 0.5491, 3.24, 0.073, 137, 109, NIPAH VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1235, 3gxuB, 0.5480, 3.34, 0.065, 138, 108, CRYSTAL STRUCTURE OF EPH RECEPTOR AND EPHRIN COMPLEX
1236, 1kgyH, 0.5480, 3.12, 0.075, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1237, 3heiL, 0.5478, 3.43, 0.055, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1238, 3heiJ, 0.5478, 3.40, 0.055, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1239, 6hu9b, 0.5475, 2.60, 0.149, 236, 94, III2-IV2 MITOCHONDRIAL RESPIRATORY SUPERCOMPLEX FROM S. CEREVISIAE 
1240, 3czuB, 0.5471, 3.44, 0.064, 130, 109, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2- EPHRIN A1 COMPLEX
1241, 3heiN, 0.5470, 3.44, 0.055, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1242, 5x1bO, 0.5469, 2.46, 0.118, 226, 93, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1243, 6hu9n, 0.5466, 2.60, 0.149, 236, 94, III2-IV2 MITOCHONDRIAL RESPIRATORY SUPERCOMPLEX FROM S. CEREVISIAE 
1244, 3heiP, 0.5463, 3.44, 0.055, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1245, 4f2fA, 0.5462, 1.94, 0.149, 100, 87, CRYSTAL STRUCTURE OF THE METAL BINDING DOMAIN (MBD) OF THE STREPTOCOCCUS PNEUMONIAE D39 CU(I) EXPORTING P-TYPE ATPASE COPA WITH CU(I)
1246, 4w9zA, 0.5461, 2.48, 0.129, 138, 93, CRYSTAL STRUCTURE OF THE PERIPLASMIC DOMAIN OF SUBUNIT II OF CYTOCHROME OXIDASE (COXB) OF BRADYRHIZOBIUM JAPONICUM
1247, 3heiH, 0.5461, 3.48, 0.064, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1248, 2vskD, 0.5449, 2.97, 0.038, 131, 104, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1249, 1kgyF, 0.5444, 3.17, 0.084, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1250, 5b1bO, 0.5441, 2.48, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
1251, 5b3sO, 0.5440, 2.51, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
1252, 5zcpO, 0.5439, 2.52, 0.118, 226, 93, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1253, 5x19O, 0.5439, 2.49, 0.118, 226, 93, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1254, 5b1aO, 0.5439, 2.52, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
1255, 3ag3O, 0.5439, 2.49, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1256, 3ag2O, 0.5439, 2.49, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
1257, 5z86O, 0.5438, 2.51, 0.118, 226, 93, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
1258, 6nmfO, 0.5437, 2.51, 0.118, 226, 93, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1259, 6j8mO, 0.5437, 2.51, 0.118, 226, 93, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
1260, 5zcqO, 0.5437, 2.52, 0.118, 226, 93, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
1261, 5z85O, 0.5436, 2.52, 0.118, 226, 93, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1262, 3wg7O, 0.5436, 2.52, 0.118, 226, 93, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
1263, 2y69O, 0.5436, 2.52, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
1264, 5zcoO, 0.5435, 2.52, 0.118, 226, 93, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
1265, 3ag4O, 0.5435, 2.50, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
1266, 4bkaC, 0.5434, 3.53, 0.036, 136, 110, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5
1267, 3abmO, 0.5434, 2.52, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
1268, 5z84O, 0.5433, 2.52, 0.118, 226, 93, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
1269, 2einB, 0.5432, 2.53, 0.118, 226, 93, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1270, 5xdqO, 0.5431, 2.52, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
1271, 5x1bB, 0.5431, 2.50, 0.118, 226, 93, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1272, 4bk5C, 0.5431, 3.53, 0.036, 136, 110, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5 (AMINE-METHYLATED SAMPLE)
1273, 3x2qO, 0.5431, 2.52, 0.118, 226, 93, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
1274, 3asoO, 0.5431, 2.53, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
1275, 5xdxO, 0.5429, 2.50, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
1276, 3ag1O, 0.5429, 2.50, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
1277, 5waub, 0.5428, 2.50, 0.118, 226, 93, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
1278, 3abkO, 0.5428, 2.62, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1279, 2einO, 0.5428, 2.53, 0.118, 226, 93, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1280, 6nmpO, 0.5427, 2.52, 0.118, 226, 93, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1281, 5x1fO, 0.5427, 2.62, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
1282, 3ag3B, 0.5427, 2.52, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1283, 2eikO, 0.5427, 2.51, 0.118, 226, 93, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1284, 5w97b, 0.5426, 2.50, 0.118, 226, 93, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
1285, 3asnO, 0.5426, 2.53, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
1286, 2vskB, 0.5426, 3.05, 0.067, 131, 105, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1287, 5wauB, 0.5425, 2.52, 0.118, 226, 93, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
1288, 5sydB, 0.5425, 2.27, 0.180, 131, 89, CIRCULARLY PERMUTATED AZURIN (CPAZ) BASED ON P. AERUGINOSA AZURIN SEQUENCE
1289, 2eijO, 0.5424, 2.51, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1290, 2dyrO, 0.5423, 2.54, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1291, 5x1fB, 0.5422, 2.52, 0.118, 226, 93, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
1292, 5iy5O, 0.5422, 2.53, 0.118, 226, 93, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
1293, 6nknO, 0.5421, 2.54, 0.118, 226, 93, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1294, 5z86B, 0.5421, 2.55, 0.118, 226, 93, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
1295, 3abkB, 0.5421, 2.53, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1296, 5zcpB, 0.5420, 2.55, 0.118, 226, 93, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1297, 2eijB, 0.5420, 2.52, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1298, 3abmB, 0.5419, 2.55, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
1299, 3ablO, 0.5419, 2.54, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
1300, 2zxwO, 0.5419, 2.54, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
1301, 2dyrB, 0.5419, 2.54, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1302, 5z84B, 0.5417, 2.56, 0.118, 226, 93, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
1303, 5xtiWD, 0.5417, 2.55, 0.118, 227, 93, struct.pdbx_descriptor              
1304, 5xtiUA, 0.5417, 2.55, 0.118, 227, 93, struct.pdbx_descriptor              
1305, 5xthUA, 0.5417, 2.55, 0.118, 227, 93, struct.pdbx_descriptor              
1306, 5lufy, 0.5417, 2.55, 0.118, 227, 93, CRYO-EM OF BOVINE RESPIRASOME
1307, 5gupVB, 0.5417, 2.55, 0.118, 227, 93, 
1308, 5gpnIB, 0.5417, 2.55, 0.118, 227, 93, 
1309, 2ybbM, 0.5417, 2.55, 0.118, 227, 93, FITTED MODEL FOR BOVINE  MITOCHONDRIAL SUPERCOMPLEX I1III2IV1 BY SINGLE PARTICLE CRYO-EM (EMD-1876)
1310, 2eimB, 0.5417, 2.52, 0.118, 226, 93, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1311, 2dysO, 0.5417, 2.54, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
1312, 1occO, 0.5417, 2.55, 0.118, 227, 93, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1313, 1occB, 0.5417, 2.55, 0.118, 227, 93, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1314, 3ag4B, 0.5415, 2.53, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
1315, 5zcoB, 0.5414, 2.56, 0.118, 226, 93, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
1316, 1v54O, 0.5414, 2.65, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1317, 5zcqB, 0.5413, 2.56, 0.118, 226, 93, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
1318, 1v55O, 0.5413, 2.64, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1319, 5b1aB, 0.5412, 2.56, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
1320, 5b3sB, 0.5411, 2.56, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
1321, 3wg7B, 0.5411, 2.67, 0.117, 226, 94, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
1322, 2occO, 0.5411, 2.56, 0.118, 227, 93, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1323, 3ag1B, 0.5410, 2.65, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
1324, 3heiD, 0.5409, 3.52, 0.055, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1325, 2eikB, 0.5409, 2.65, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1326, 1oczO, 0.5409, 2.57, 0.118, 227, 93, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
1327, 2occB, 0.5408, 2.56, 0.118, 227, 93, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1328, 1v54B, 0.5408, 2.66, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1329, 1oczB, 0.5408, 2.57, 0.118, 227, 93, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
1330, 5iy5B, 0.5407, 2.57, 0.118, 226, 93, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
1331, 2eilO, 0.5407, 2.66, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1332, 1v55B, 0.5407, 2.64, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1333, 1ocrO, 0.5406, 2.66, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1334, 5sydA, 0.5405, 2.46, 0.180, 130, 89, CIRCULARLY PERMUTATED AZURIN (CPAZ) BASED ON P. AERUGINOSA AZURIN SEQUENCE
1335, 5z85B, 0.5404, 2.68, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1336, 5x19B, 0.5404, 2.66, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1337, 3asnB, 0.5404, 2.56, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
1338, 2y69B, 0.5404, 2.67, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
1339, 2eilB, 0.5404, 2.67, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1340, 6nmfB, 0.5402, 2.67, 0.117, 226, 94, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1341, 3ag2B, 0.5402, 2.66, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
1342, 1ocrB, 0.5402, 2.66, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1343, 6j8mB, 0.5401, 2.68, 0.117, 226, 94, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
1344, 3mbwB, 0.5401, 3.35, 0.057, 127, 106, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2 LBD AND CRD DOMAINS IN COMPLEX WITH EPHRIN A1
1345, 3ablB, 0.5401, 2.58, 0.118, 226, 93, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
1346, 2eimO, 0.5401, 2.66, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1347, 3x2qB, 0.5400, 2.68, 0.117, 226, 94, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
1348, 2dysB, 0.5399, 2.67, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
1349, 5xdqB, 0.5398, 2.68, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
1350, 6nmpB, 0.5397, 2.58, 0.118, 226, 93, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1351, 5b1bB, 0.5396, 2.67, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
1352, 2zxwB, 0.5396, 2.68, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
1353, 6nknB, 0.5395, 2.68, 0.117, 226, 94, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1354, 1ocoO, 0.5394, 2.68, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
1355, 5xdxB, 0.5393, 2.66, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
1356, 3asoB, 0.5393, 2.68, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
1357, 1ocoB, 0.5392, 2.68, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
1358, 6giqb, 0.5383, 2.70, 0.160, 235, 94, SACCHAROMYCES CEREVISIAE RESPIRATORY SUPERCOMPLEX III2IV 
1359, 5w97B, 0.5383, 2.68, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
1360, 4txvB, 0.5379, 2.72, 0.128, 142, 94, CRYSTAL STRUCTURE OF THE MIXED DISULFIDE INTERMEDIATE BETWEEN THIOREDOXIN-LIKE TLPAS(C110S) AND SUBUNIT II OF CYTOCHROME C OXIDASE COXBPD (C233S)
1361, 2hleB, 0.5376, 3.07, 0.058, 133, 104, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE EPHB4-EPHRINB2 PROTEIN PROTEIN INTERACTION AND RECEPTOR SPECIFICITY.
1362, 3heiF, 0.5375, 3.52, 0.055, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1363, 4txvD, 0.5371, 2.62, 0.140, 133, 93, CRYSTAL STRUCTURE OF THE MIXED DISULFIDE INTERMEDIATE BETWEEN THIOREDOXIN-LIKE TLPAS(C110S) AND SUBUNIT II OF CYTOCHROME C OXIDASE COXBPD (C233S)
1364, 4f2eA, 0.5309, 2.06, 0.151, 98, 86, CRYSTAL STRUCTURE OF THE STREPTOCOCCUS PNEUMONIAE D39 COPPER CHAPERONE CUPA WITH CU(I)
1365, 2mryA, 0.5301, 2.12, 0.151, 98, 86, NMR SOLUTION STRUCTURE OF COPPER BINDING PROTEIN IN THE APO FORM
1366, 1ayrC, 0.5300, 3.77, 0.028, 368, 106, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1367, 1ayrA, 0.5300, 3.76, 0.028, 368, 106, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1368, 1cd3F, 0.5274, 4.35, 0.079, 426, 114, PROCAPSID OF BACTERIOPHAGE PHIX174
1369, 1al0F, 0.5273, 4.34, 0.079, 418, 114, PROCAPSID OF BACTERIOPHAGE PHIX174
1370, 3ugxA, 0.5266, 3.78, 0.047, 369, 106, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1371, 2bpa1, 0.5246, 4.30, 0.088, 426, 113, ATOMIC STRUCTURE OF SINGLE-STRANDED DNA BACTERIOPHAGE PHIX174 AND ITS FUNCTIONAL IMPLICATIONS
1372, 1kvpA, 0.5246, 4.30, 0.088, 497, 113, STRUCTURAL ANALYSIS OF THE SPIROPLASMA VIRUS SPV4 IMPLICATIONS FOR EVOLUTIONARY VARIATION TO OBTAIN HOST DIVERSITY AMONG THE MICROVIRIDAE ELECTRON MICROSCOPY ALPHA CARBONS ONLY
1373, 3p2dA, 0.5234, 3.80, 0.066, 354, 106, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1374, 1zshA, 0.5230, 3.72, 0.075, 354, 106, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE (IP6)
1375, 3p2dB, 0.5227, 3.70, 0.057, 352, 105, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1376, 1jsyA, 0.5225, 3.66, 0.076, 358, 105, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2
1377, 4jqiA, 0.5224, 3.86, 0.075, 353, 106, STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE
1378, 3m2lE, 0.5223, 4.15, 0.064, 293, 110, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1379, 3m4dC, 0.5222, 4.14, 0.064, 293, 110, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1380, 3m4dF, 0.5213, 4.18, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1381, 3m3rG, 0.5212, 4.18, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1382, 3m4eA, 0.5211, 4.17, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1383, 3m4eE, 0.5210, 4.18, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1384, 3m3rE, 0.5210, 4.18, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1385, 3m4dE, 0.5209, 4.15, 0.064, 293, 110, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1386, 1gff1, 0.5208, 4.26, 0.107, 417, 112, THE ATOMIC STRUCTURE OF THE DEGRADED PROCAPSID PARTICLE OF THE BACTERIOPHAGE G4: INDUCED STRUCTURAL CHANGES IN THE PRESENCE OF CALCIUM IONS AND FUNCTIONAL IMPLICATIONS
1387, 3m4eB, 0.5207, 4.18, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1388, 3m4dG, 0.5207, 4.19, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1389, 3m4dA, 0.5206, 4.18, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1390, 3m2lD, 0.5205, 4.21, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1391, 1rb8F, 0.5204, 4.48, 0.078, 422, 115, THE PHIX174 DNA BINDING PROTEIN J IN TWO DIFFERENT CAPSID ENVIRONMENTS.
1392, 1m06F, 0.5204, 4.40, 0.079, 422, 114, STRUCTURAL STUDIES OF BACTERIOPHAGE ALPHA3 ASSEMBLY X-RAY CRYSTALLOGRAPHY
1393, 3m4eG, 0.5203, 4.15, 0.072, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1394, 3m4dD, 0.5202, 4.20, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1395, 3m2lB, 0.5202, 4.21, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1396, 3m3rF, 0.5199, 4.20, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1397, 4p24A, 0.5198, 4.20, 0.063, 292, 111, PORE FORMING TOXIN
1398, 3m4eD, 0.5198, 4.12, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1399, 5j7yZB, 0.5196, 2.76, 0.140, 227, 93, 
1400, 5j4zZB, 0.5196, 2.76, 0.140, 227, 93, 
1401, 3m3rC, 0.5196, 4.16, 0.072, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1402, 3m4eC, 0.5195, 4.11, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1403, 7ahlE, 0.5193, 4.19, 0.063, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1404, 7ahlB, 0.5191, 4.17, 0.072, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1405, 3m2lA, 0.5191, 4.02, 0.082, 293, 110, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1406, 3m3rD, 0.5189, 4.14, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1407, 3m3rB, 0.5186, 4.14, 0.090, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1408, 3anzG, 0.5186, 4.17, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1409, 3m4eF, 0.5185, 4.12, 0.090, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1410, 3m2lG, 0.5185, 4.14, 0.090, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1411, 1rmfH, 0.5184, 4.09, 0.079, 216, 114, STRUCTURES OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FRAGMENT AT 2.8 ANGSTROMS RESOLUTION
1412, 4yhdG, 0.5182, 4.19, 0.063, 281, 111, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1413, 4p24B, 0.5182, 4.13, 0.090, 291, 111, PORE FORMING TOXIN
1414, 3m2lC, 0.5182, 4.13, 0.090, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1415, 4p24D, 0.5181, 4.14, 0.090, 292, 111, PORE FORMING TOXIN
1416, 3m4dB, 0.5181, 4.13, 0.090, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1417, 2j7lA, 0.5181, 3.02, 0.115, 210, 96, E.COLI P PILUS CHAPERONE PAPD IN COMPLEX WITH A PILUS BIOGENESIS INHIBITOR PILICIDE 2C
1418, 3m3rA, 0.5180, 4.13, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1419, 7ahlA, 0.5178, 4.13, 0.090, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1420, 7ahlF, 0.5177, 4.14, 0.090, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1421, 4yhdA, 0.5177, 4.14, 0.082, 281, 110, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1422, 4p24F, 0.5177, 4.03, 0.091, 290, 110, PORE FORMING TOXIN
1423, 3m2lF, 0.5177, 4.04, 0.082, 293, 110, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1424, 7ahlD, 0.5176, 4.13, 0.090, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1425, 3gd1C, 0.5176, 3.96, 0.085, 345, 106, STRUCTURE OF AN ARRESTIN/CLATHRIN COMPLEX REVEALS A NOVEL CLATHRIN BINDING DOMAIN THAT MODULATES RECEPTOR TRAFFICKING
1426, 3anzY, 0.5176, 4.22, 0.063, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1427, 3anzD, 0.5176, 4.18, 0.064, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1428, 1g4mA, 0.5176, 3.79, 0.085, 356, 106, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1429, 3ugxC, 0.5175, 4.13, 0.028, 358, 106, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1430, 3f83A, 0.5175, 3.92, 0.071, 508, 112, STRUCTURE OF FUSION COMPLEX OF THE MINOR PILIN CFAE AND MAJOR PILIN CFAB OF CFA/I PILI FROM ETEC E. COLI
1431, 1ayrD, 0.5175, 4.10, 0.028, 363, 106, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1432, 4p24E, 0.5174, 4.13, 0.090, 291, 111, PORE FORMING TOXIN
1433, 3anzK, 0.5174, 4.22, 0.063, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1434, 3anzI, 0.5173, 4.19, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1435, 3anzT, 0.5172, 4.19, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1436, 3anza, 0.5171, 4.19, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1437, 3anzJ, 0.5171, 4.19, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1438, 3anzH, 0.5170, 4.19, 0.064, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1439, 7ahlG, 0.5169, 4.18, 0.081, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1440, 2wtrB, 0.5169, 3.89, 0.086, 367, 105, FULL LENGTH ARRESTIN2
1441, 1jerA, 0.5168, 3.14, 0.153, 110, 98, CUCUMBER STELLACYANIN CU2+ PH 7.0
1442, 3anzU, 0.5167, 4.23, 0.063, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1443, 3anzb, 0.5166, 4.23, 0.063, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1444, 3anzN, 0.5166, 4.23, 0.063, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1445, 1g4mB, 0.5166, 3.84, 0.086, 357, 105, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1446, 3anzZ, 0.5165, 4.23, 0.063, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1447, 3anzA, 0.5165, 4.23, 0.063, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1448, 1ayrB, 0.5165, 4.02, 0.029, 363, 105, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1449, 3anzV, 0.5164, 4.23, 0.063, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1450, 3anzB, 0.5164, 4.23, 0.063, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1451, 2ckbC, 0.5164, 4.03, 0.128, 202, 109, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1452, 4zrgA, 0.5163, 3.97, 0.029, 343, 105, VISUAL ARRESTIN MUTANT - R175E
1453, 3uguA, 0.5163, 4.08, 0.038, 345, 106, CRYSTAL STRUCTURE OF P44 (SPLICE VARIANT OF VISUAL ARRESTIN)
1454, 3anzX, 0.5163, 4.23, 0.063, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1455, 3anzR, 0.5163, 4.22, 0.063, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1456, 3anzO, 0.5163, 4.15, 0.082, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1457, 2ckbA, 0.5163, 4.02, 0.119, 202, 109, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1458, 7ahlC, 0.5162, 4.15, 0.090, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1459, 5w0pA, 0.5162, 3.94, 0.019, 847, 106, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1460, 3anzL, 0.5161, 4.16, 0.073, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1461, 3anzF, 0.5161, 4.15, 0.082, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1462, 4n0cG, 0.5160, 4.06, 0.092, 197, 109, 42F3 TCR PCPE3/H-2LD COMPLEX
1463, 4p24C, 0.5159, 4.14, 0.090, 291, 111, PORE FORMING TOXIN
1464, 4j2qB, 0.5159, 4.06, 0.038, 346, 106, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1465, 3anzM, 0.5159, 4.16, 0.073, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1466, 4p24G, 0.5158, 4.04, 0.082, 292, 110, PORE FORMING TOXIN
1467, 3tpuA, 0.5157, 4.03, 0.092, 205, 109, 42F3 P5E8/H2-LD COMPLEX
1468, 6f2sB, 0.5156, 4.60, 0.079, 195, 114, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1469, 3anzQ, 0.5155, 4.16, 0.082, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1470, 6f2sJ, 0.5154, 4.62, 0.070, 195, 114, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1471, 3d34A, 0.5150, 3.51, 0.087, 211, 103, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
1472, 5w0pB, 0.5149, 3.81, 0.019, 802, 104, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1473, 4v4mC, 0.5145, 4.68, 0.051, 184, 117, 
1474, 3anzW, 0.5144, 4.63, 0.052, 184, 116, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1475, 1cf1A, 0.5144, 4.62, 0.052, 184, 116, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1476, 1kiuO, 0.5142, 4.16, 0.090, 294, 111, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1477, 1kiuM, 0.5142, 4.08, 0.028, 373, 106, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1478, 1kiuK, 0.5142, 2.94, 0.095, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1479, 1kiuI, 0.5142, 2.94, 0.095, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1480, 5dgyD, 0.5141, 2.94, 0.095, 205, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1481, 4zwjD, 0.5141, 2.94, 0.095, 205, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1482, 5w0pD, 0.5140, 3.88, 0.029, 833, 105, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1483, 4j2qA, 0.5140, 3.88, 0.029, 833, 105, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1484, 1g4rA, 0.5140, 3.95, 0.019, 773, 106, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1485, 6f2sF, 0.5138, 4.02, 0.029, 340, 105, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1486, 3anzS, 0.5138, 3.82, 0.066, 353, 106, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1487, 3anzP, 0.5138, 4.64, 0.070, 195, 114, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1488, 3anzE, 0.5138, 4.17, 0.090, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1489, 3anzC, 0.5138, 4.17, 0.090, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1490, 1sujA, 0.5138, 4.18, 0.090, 295, 111, X-RAY CRYSTAL STRUCTURE OF AMBYSTOMA TIGRINUM CONE ARRESTIN
1491, 6f2sH, 0.5137, 4.06, 0.082, 294, 110, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1492, 4v4mBA, 0.5137, 4.02, 0.047, 363, 106, 
1493, 4idjA, 0.5137, 4.62, 0.070, 218, 114, S.AUREUS A-HEMOLYSIN MONOMER IN COMPLEX WITH FAB
1494, 6f2sI, 0.5136, 4.69, 0.051, 184, 117, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1495, 3tpuM, 0.5136, 4.03, 0.083, 276, 109, 42F3 P5E8/H2-LD COMPLEX
1496, 3tpuC, 0.5136, 4.67, 0.061, 203, 115, 42F3 P5E8/H2-LD COMPLEX
1497, 1cf1B, 0.5136, 4.08, 0.092, 204, 109, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1498, 4v4mRA, 0.5135, 4.04, 0.101, 204, 109, 
1499, 4v4mL, 0.5135, 4.09, 0.029, 360, 105, 
1500, 4v4mJ, 0.5135, 4.62, 0.052, 184, 116, 
1501, 4v4mGB, 0.5135, 4.63, 0.043, 184, 116, 
1502, 5fc9A, 0.5134, 4.62, 0.043, 184, 116, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1503, 5dgyB, 0.5134, 4.62, 0.052, 184, 116, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1504, 4zwjB, 0.5134, 4.63, 0.043, 184, 116, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1505, 6f2sK, 0.5133, 4.62, 0.043, 184, 116, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1506, 5tv1A, 0.5133, 2.33, 0.148, 95, 88, ACTIVE ARRESTIN-3 WITH INOSITOL HEXAKISPHOSPHATE
1507, 4v4mT, 0.5133, 3.87, 0.029, 673, 105, 
1508, 4v4mJA, 0.5133, 3.87, 0.029, 673, 105, 
1509, 4v4mH, 0.5133, 4.54, 0.071, 195, 113, 
1510, 3tpuG, 0.5133, 3.93, 0.086, 337, 105, 42F3 P5E8/H2-LD COMPLEX
1511, 4v4mSA, 0.5132, 4.62, 0.043, 184, 116, 
1512, 4v4mS, 0.5132, 4.63, 0.043, 184, 116, 
1513, 4v4mMA, 0.5132, 4.63, 0.043, 184, 116, 
1514, 4bcuA, 0.5132, 4.63, 0.043, 184, 116, SATELLITE TOBACCO NECROSIS VIRUS (STNV) VIRUS LIKE PARTICLE IN COMPLEX WITH THE B3 APTAMER
1515, 3ugxB, 0.5132, 4.62, 0.052, 184, 116, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1516, 3s4gA, 0.5132, 4.63, 0.052, 184, 116, LOW RESOLUTION STRUCTURE OF STNV COMPLEXED WITH RNA
1517, 3q13A, 0.5132, 4.05, 0.101, 202, 109, THE STRUCTURE OF THE CA2+-BINDING GLYCOSYLATED F-SPONDIN DOMAIN OF F- SPONDIN A C2-DOMAIN VARIANT FROM EXTRACELLULAR MATRIX
1518, 4yhdB, 0.5131, 4.62, 0.043, 184, 116, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1519, 4v4mZA, 0.5131, 4.62, 0.043, 184, 116, 
1520, 4v4mVA, 0.5131, 4.62, 0.052, 184, 116, 
1521, 4v4mR, 0.5131, 4.62, 0.052, 184, 116, 
1522, 4v4mP, 0.5131, 4.62, 0.052, 188, 116, 
1523, 4v4mX, 0.5130, 3.97, 0.029, 352, 104, 
1524, 4v4mW, 0.5130, 4.62, 0.052, 184, 116, 
1525, 4v4mTA, 0.5130, 3.73, 0.086, 235, 105, 
1526, 4v4mHA, 0.5130, 4.15, 0.091, 283, 110, 
1527, 4v4mGA, 0.5130, 4.63, 0.043, 184, 116, 
1528, 4v4mF, 0.5130, 4.63, 0.043, 184, 116, 
1529, 4v4mDA, 0.5130, 4.62, 0.052, 184, 116, 
1530, 4yhdC, 0.5129, 4.63, 0.043, 184, 116, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1531, 4v4mWA, 0.5129, 4.62, 0.043, 184, 116, 
1532, 4v4mV, 0.5129, 4.63, 0.043, 184, 116, 
1533, 4v4mPA, 0.5129, 4.62, 0.043, 184, 116, 
1534, 4v4mLA, 0.5129, 4.63, 0.043, 184, 116, 
1535, 4v4mG, 0.5129, 4.62, 0.052, 184, 116, 
1536, 4v4mD, 0.5129, 4.63, 0.043, 184, 116, 
1537, 4v4mAA, 0.5129, 4.63, 0.043, 184, 116, 
1538, 4v4mA, 0.5129, 4.62, 0.052, 184, 116, 
1539, 4nhuA, 0.5129, 4.62, 0.052, 184, 116, THE M33 TCR P3M33L/H-2 LD COMPLEX
1540, 3d34B, 0.5129, 4.63, 0.052, 184, 116, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
1541, 6f2sD, 0.5128, 4.63, 0.043, 184, 116, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1542, 4v4mYA, 0.5128, 4.56, 0.043, 184, 115, 
1543, 4v4mKA, 0.5128, 4.63, 0.043, 184, 116, 
1544, 4v4mHB, 0.5128, 3.94, 0.093, 279, 108, 
1545, 4v4mEB, 0.5128, 4.63, 0.043, 184, 116, 
1546, 4v4mE, 0.5128, 4.63, 0.043, 184, 116, 
1547, 4v4mBB, 0.5128, 4.63, 0.043, 184, 116, 
1548, 4v4mB, 0.5128, 4.63, 0.043, 184, 116, 
1549, 4v4mUA, 0.5127, 4.62, 0.043, 184, 116, 
1550, 4v4mNA, 0.5127, 4.62, 0.043, 184, 116, 
1551, 4v4mI, 0.5127, 4.62, 0.052, 184, 116, 
1552, 4v4mEA, 0.5127, 4.62, 0.052, 184, 116, 
1553, 4v4mDB, 0.5127, 4.63, 0.043, 184, 116, 
1554, 4mbrA, 0.5127, 4.62, 0.052, 184, 116, 3.65 ANGSTROM CRYSTAL STRUCTURE OF SERINE-RICH REPEAT PROTEIN (SRR2) FROM STREPTOCOCCUS AGALACTIAE
1555, 5dgyC, 0.5126, 4.63, 0.043, 184, 116, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1556, 4zwjC, 0.5126, 4.63, 0.043, 184, 116, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1557, 4v4mY, 0.5126, 4.63, 0.043, 184, 116, 
1558, 4v4mU, 0.5126, 4.62, 0.052, 184, 116, 
1559, 4v4mN, 0.5126, 4.65, 0.052, 184, 116, 
1560, 4v4mIA, 0.5126, 3.99, 0.120, 197, 108, 
1561, 4v4mFA, 0.5126, 3.54, 0.097, 215, 103, 
1562, 3lh9B, 0.5126, 4.65, 0.070, 195, 114, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
1563, 4v4mXA, 0.5125, 4.63, 0.043, 184, 116, 
1564, 4v4mCB, 0.5125, 4.63, 0.043, 184, 116, 
1565, 3lh9A, 0.5125, 4.63, 0.052, 184, 116, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
1566, 1hxmC, 0.5125, 4.62, 0.043, 184, 116, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1567, 6f2sG, 0.5124, 4.62, 0.043, 184, 116, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1568, 3tfkC, 0.5124, 4.63, 0.043, 184, 116, 42F3-P4B10/H2-LD
1569, 2bukA, 0.5124, 4.63, 0.043, 184, 116, SATELLITE TOBACCO NECROSIS VIRUS
1570, 1mwaA, 0.5123, 4.63, 0.043, 184, 116, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1571, 4v4mQA, 0.5122, 4.69, 0.051, 184, 117, 
1572, 4v4mM, 0.5122, 4.63, 0.043, 184, 116, 
1573, 4v4mFB, 0.5122, 4.62, 0.052, 184, 116, 
1574, 4v4mCA, 0.5122, 4.62, 0.052, 184, 116, 
1575, 4yhdD, 0.5121, 4.62, 0.052, 184, 116, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1576, 4v4mZ, 0.5121, 4.63, 0.043, 184, 116, 
1577, 4v4mQ, 0.5121, 4.62, 0.052, 184, 116, 
1578, 4v4mOA, 0.5121, 4.63, 0.043, 184, 116, 
1579, 4v4mO, 0.5121, 4.63, 0.043, 184, 116, 
1580, 4m6nH, 0.5120, 3.99, 0.063, 316, 111, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5
1581, 3vacB, 0.5120, 3.79, 0.019, 789, 104, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
1582, 6f2sC, 0.5118, 3.79, 0.019, 789, 104, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1583, 6f2sA, 0.5118, 4.63, 0.043, 184, 116, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1584, 4v4mK, 0.5118, 4.62, 0.052, 184, 116, 
1585, 6f2sE, 0.5117, 4.62, 0.052, 184, 116, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
1586, 4v4mAB, 0.5117, 4.62, 0.052, 184, 116, 
1587, 4mvbC, 0.5112, 4.62, 0.052, 184, 116, 42F3 PCPB7/H-2LD COMPLEX
1588, 1qppA, 0.5111, 4.63, 0.043, 184, 116, CRYSTAL STRUCTURES OF SELF CAPPING PAPD CHAPERONE HOMODIMERS
1589, 5k93A, 0.5110, 4.62, 0.052, 184, 116, PAPD WILD-TYPE CHAPERONE
1590, 3vacA, 0.5110, 4.63, 0.043, 184, 116, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
1591, 4nhuC, 0.5109, 3.72, 0.099, 288, 101, THE M33 TCR P3M33L/H-2 LD COMPLEX
1592, 5dgyA, 0.5108, 4.63, 0.043, 184, 116, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1593, 4zwjA, 0.5108, 4.63, 0.052, 184, 116, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1594, 1g6rA, 0.5107, 3.66, 0.090, 286, 100, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1595, 4m6mH, 0.5106, 3.85, 0.056, 206, 107, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
1596, 4ms8C, 0.5105, 4.56, 0.071, 195, 113, 42F3 TCR PCPB9/H-2LD COMPLEX
1597, 7pcyA, 0.5104, 4.09, 0.101, 201, 109, THE CRYSTAL STRUCTURE OF PLASTOCYANIN FROM A GREEN ALGA ENTEROMORPHA PROLIFERA
1598, 1hxmE, 0.5104, 4.57, 0.043, 184, 115, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1599, 6mi2A, 0.5101, 4.09, 0.128, 202, 109, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
1600, 4rqqD, 0.5101, 4.63, 0.052, 184, 116, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1601, 1ylbB, 0.5101, 4.62, 0.052, 184, 116, NMR SOLUTION STRUCTURE OF THE REDUCED SPINACH PLASTOCYANIN
1602, 5k93B, 0.5100, 4.63, 0.043, 184, 116, PAPD WILD-TYPE CHAPERONE
1603, 4ydjH, 0.5099, 4.56, 0.043, 184, 115, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1604, 3ujjH, 0.5099, 4.62, 0.052, 184, 116, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE
1605, 1hxmA, 0.5099, 4.15, 0.091, 282, 110, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1606, 6ey0F, 0.5098, 4.63, 0.043, 184, 116, N-TERMINAL PART (RESIDUES 30-212) OF PORM WITH THE LLAMA NANOBODY NB01
1607, 4z7wG, 0.5098, 4.63, 0.043, 184, 116, T316 COMPLEX
1608, 4rqqB, 0.5098, 4.63, 0.052, 184, 116, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1609, 4jzjH, 0.5098, 4.63, 0.052, 184, 116, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
1610, 1ws7A, 0.5098, 4.62, 0.052, 184, 116, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1611, 6ey0G, 0.5097, 4.62, 0.052, 184, 116, N-TERMINAL PART (RESIDUES 30-212) OF PORM WITH THE LLAMA NANOBODY NB01
1612, 1ypzH, 0.5097, 4.55, 0.043, 184, 115, IMMUNE RECEPTOR
1613, 1g6rC, 0.5097, 4.23, 0.063, 213, 111, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1614, 5fc9D, 0.5096, 4.23, 0.061, 356, 115, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1615, 4jzjA, 0.5096, 4.48, 0.071, 195, 113, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
1616, 1hxmG, 0.5096, 4.72, 0.070, 195, 115, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1617, 6ea5Q, 0.5095, 4.63, 0.043, 184, 116, STRUCTURE OF BDBV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
1618, 5zv3H, 0.5094, 4.63, 0.052, 184, 116, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-28.1 IN COMPLEX WITH ITS TAU PEPTIDE 
1619, 2xwtA, 0.5093, 4.69, 0.061, 195, 115, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY
1620, 6mi2D, 0.5091, 4.65, 0.052, 184, 116, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
1621, 6mamA, 0.5091, 4.02, 0.130, 199, 108, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
1622, 2w07A, 0.5091, 3.22, 0.104, 207, 96, STRUCTURAL DETERMINANTS OF POLYMERIZATION REACTIVITY OF THE P PILUS ADAPTOR SUBUNIT PAPF
1623, 1ws7D, 0.5091, 3.21, 0.134, 210, 97, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1624, 4z7wE, 0.5090, 4.24, 0.061, 356, 115, T316 COMPLEX
1625, 2wtrA, 0.5089, 4.02, 0.120, 199, 108, FULL LENGTH ARRESTIN2
1626, 5e8eB, 0.5088, 3.82, 0.019, 833, 104, CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB
1627, 3qpqJ, 0.5088, 3.82, 0.019, 833, 104, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1628, 2uy6A, 0.5088, 4.12, 0.119, 202, 109, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1629, 2h32H, 0.5088, 4.24, 0.063, 215, 111, CRYSTAL STRUCTURE OF THE PRE-B CELL RECEPTOR
1630, 6b5pH, 0.5087, 4.03, 0.120, 196, 108, STRUCTURE OF PFCSP PEPTIDE 20 WITH HUMAN ANTIBODY CIS42
1631, 4rirH, 0.5086, 2.83, 0.154, 98, 91, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
1632, 1pdkA, 0.5086, 3.87, 0.056, 206, 107, PAPD-PAPK CHAPERONE-PILUS SUBUNIT COMPLEX FROM E.COLI P PILUS
1633, 1oarJ, 0.5086, 4.31, 0.062, 209, 112, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
1634, 1oarH, 0.5086, 4.16, 0.054, 237, 111, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
1635, 6b5tH, 0.5084, 2.69, 0.135, 99, 89, STRUCTURE OF PFCSP PEPTIDE 29 WITH HUMAN ANTIBODY CIS42
1636, 2xg4A, 0.5084, 3.21, 0.134, 210, 97, E. COLI P PILUS CHAPERONE-SUBUNIT COMPLEX PAPD-PAPH BOUND TO PILUS BIOGENESIS INHIBITOR PILICIDE 2C
1637, 6gk8H, 0.5083, 4.17, 0.089, 238, 112, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-28.1; DOUBLE MUTANT (S32R; E35K) OF CBTAU-28.1; IN COMPLEX WITH TAU PEPTIDE A7731 (RESIDUES 52-71) 
1638, 6fumA, 0.5083, 4.39, 0.053, 230, 113, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1639, 6e47G, 0.5083, 3.87, 0.056, 206, 107, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND GLYCOCHENODEOXYCHOLIC ACID 
1640, 5wk3U, 0.5083, 3.96, 0.092, 131, 109, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
1641, 2hb0B, 0.5083, 4.20, 0.119, 191, 109, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
1642, 5kzpG, 0.5082, 4.16, 0.045, 239, 112, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
1643, 3jabQ, 0.5082, 4.34, 0.062, 215, 112, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
1644, 3jabH, 0.5082, 3.17, 0.103, 107, 97, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
1645, 2hb0A, 0.5082, 3.95, 0.092, 129, 109, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
1646, 1ws8A, 0.5082, 4.22, 0.064, 230, 110, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1647, 12e8H, 0.5082, 4.13, 0.128, 202, 109, 2E8 FAB FRAGMENT
1648, 4a6yH, 0.5081, 2.37, 0.136, 95, 88, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
1649, 6dznH, 0.5080, 4.24, 0.054, 214, 111, PAN-EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB 
1650, 6cd2A, 0.5080, 3.87, 0.056, 206, 107, CRYSTAL STRUCTURE OF THE PAPC USHER BOUND TO THE CHAPERONE-ADHESIN PAPD-PAPG 
1651, 6b5sH, 0.5080, 4.15, 0.090, 222, 111, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN ANTIBODY CIS42
1652, 3na9H, 0.5080, 4.30, 0.071, 219, 112, CRYSTAL STRUCTURE OF FAB15
1653, 2xg5A, 0.5080, 4.34, 0.071, 215, 112, E. COLI P PILUS CHAPERONE-SUBUNIT COMPLEX PAPD-PAPH BOUND TO PILUS BIOGENESIS INHIBITOR PILICIDE 5D
1654, 2j2zA, 0.5080, 4.39, 0.062, 210, 112, X-RAY STRUCTURE OF THE CHAPERONE PAPD IN COMPLEX WITH THE PILUS TERMINATOR SUBUNIT PAPH AT 2.3 ANGSTROM RESOLUTION
1655, 1qpxA, 0.5080, 4.16, 0.099, 226, 111, CRYSTAL STRUCTURES OF SELF-CAPPING PAPD CHAPERONE HOMODIMERS
1656, 1qppB, 0.5080, 3.16, 0.115, 215, 96, CRYSTAL STRUCTURES OF SELF CAPPING PAPD CHAPERONE HOMODIMERS
1657, 4risH, 0.5079, 3.07, 0.104, 105, 96, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
1658, 3mugH, 0.5079, 4.20, 0.110, 199, 109, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1659, 1oazH, 0.5079, 3.69, 0.076, 356, 105, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
1660, 1a4jH, 0.5079, 4.21, 0.071, 228, 112, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
1661, 5w0pC, 0.5078, 4.10, 0.091, 216, 110, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1662, 1afvK, 0.5078, 3.22, 0.115, 216, 96, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
1663, 4a6yB, 0.5077, 4.45, 0.062, 211, 113, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
1664, 3s62H, 0.5077, 4.16, 0.090, 212, 111, STRUCTURE OF FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8 AGAINST P. VIVAX P25 PROTEIN
1665, 3mugB, 0.5077, 4.42, 0.071, 219, 112, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1666, 2qadH, 0.5077, 3.19, 0.124, 215, 97, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
1667, 1jxgB, 0.5077, 4.41, 0.080, 122, 113, THE 1.6 A RESOLUTION CRYSTAL STRUCTURE OF A MUTANT POPLAR PLASTOCYANIN BEARING A 21-25 ENGENEERED DISULFIDE BRIDGE
1668, 6fr9A, 0.5076, 4.41, 0.080, 122, 113, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1669, 5ibuH, 0.5076, 4.17, 0.081, 211, 111, FAB (UNBOUND)
1670, 2qadD, 0.5076, 3.27, 0.144, 216, 97, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
1671, 1zeaH, 0.5076, 4.28, 0.081, 222, 111, STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE
1672, 1gafH, 0.5076, 4.08, 0.128, 202, 109, 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA- NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
1673, 6r7tA, 0.5075, 3.65, 0.059, 112, 102, CRYSTAL STRUCTURE OF HUMAN MELANOMA-ASSOCIATED ANTIGEN B1 (MAGEB1) IN COMPLEX WITH NANOBODY 
1674, 4n0cC, 0.5075, 4.37, 0.071, 221, 112, 42F3 TCR PCPE3/H-2LD COMPLEX
1675, 4c2iH, 0.5075, 4.13, 0.053, 355, 114, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 1 COMPLEXED WITH FAB FRAGMENTS OF HUMAN ANTIBODY 1F4
1676, 3dpaA, 0.5075, 4.16, 0.099, 226, 111, CRYSTAL STRUCTURE OF CHAPERONE PROTEIN PAPD REVEALS AN IMMUNOGLOBULIN FOLD
1677, 1kemH, 0.5075, 4.14, 0.063, 221, 111, CATALYTIC ANTIBODY 28B4 FAB FRAGMENT
1678, 1iuzA, 0.5075, 4.14, 0.063, 221, 111, PLASTOCYANIN
1679, 6funA, 0.5074, 4.14, 0.053, 356, 114, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1680, 5wk2H, 0.5074, 3.00, 0.105, 104, 95, CRYSTAL STRUCTURE OF ANTI-CCL17 ANTIBODY M116
1681, 4oiiI, 0.5074, 4.14, 0.063, 221, 111, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1682, 3lh8A, 0.5074, 4.25, 0.088, 215, 113, CRYSTAL STRUCTURE OF MOUSE VPS26B IN SPACEGROUP P41 21 2
1683, 6frcA, 0.5073, 4.18, 0.090, 226, 111, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1684, 6eh7A, 0.5073, 3.17, 0.125, 215, 96, F11 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS HAAEMAGGLUTININ EPITOPE PKYVKQNTLKLAT CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1685, 5wk3Q, 0.5073, 4.17, 0.081, 215, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
1686, 5jo4C, 0.5073, 4.22, 0.064, 225, 110, ANTIBODY FAB FRAGMENT COMPLEX
1687, 4oiiH, 0.5073, 3.27, 0.134, 216, 97, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1688, 2uy7E, 0.5073, 3.27, 0.144, 216, 97, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1689, 2uy7A, 0.5073, 3.27, 0.134, 206, 97, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1690, 6eh6A, 0.5072, 3.25, 0.083, 212, 96, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1691, 6dzrL, 0.5072, 4.26, 0.081, 228, 111, CRYSTAL STRUCTURE OF H38C2 K99R MUTATION 
1692, 6furA, 0.5071, 4.11, 0.073, 237, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1693, 6frbA, 0.5071, 4.27, 0.081, 122, 111, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1694, 5fcsL, 0.5071, 4.22, 0.080, 217, 112, DIABODY
1695, 4dgvH, 0.5071, 3.73, 0.029, 849, 104, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1 P2(1) FORM
1696, 3nabH, 0.5071, 4.38, 0.080, 220, 113, CRYSTAL STRUCTURE OF FAB15 MUT6
1697, 3mugF, 0.5071, 4.20, 0.089, 214, 112, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1698, 3i9gH, 0.5071, 4.18, 0.073, 215, 110, CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
1699, 2wmpA, 0.5071, 4.11, 0.073, 237, 110, STRUCTURE OF THE E. COLI CHAPERONE PAPD IN COMPLEX WITH THE PILIN DOMAIN OF THE PAPGII ADHESIN
1700, 1oayH, 0.5071, 4.20, 0.070, 229, 114, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
1701, 6fuqA, 0.5070, 2.71, 0.133, 100, 90, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1702, 4dgyH, 0.5070, 4.09, 0.138, 202, 109, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1 C2 FORM
1703, 1ws8D, 0.5070, 4.32, 0.054, 219, 112, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1704, 6c6qF, 0.5069, 4.20, 0.070, 229, 114, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR 
1705, 5o6vH, 0.5069, 4.21, 0.071, 209, 112, THE CRYO-EM STRUCTURE OF TICK-BORNE ENCEPHALITIS VIRUS COMPLEXED WITH FAB FRAGMENT OF NEUTRALIZING ANTIBODY 19/1786
1706, 3nacH, 0.5069, 4.24, 0.080, 217, 113, CRYSTAL STRUCTURE OF FAB15 MUT7
1707, 1hxmF, 0.5069, 4.22, 0.081, 123, 111, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1708, 1dbjH, 0.5069, 4.04, 0.093, 195, 108, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1709, 6rcuB, 0.5068, 4.19, 0.082, 228, 110, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.004 AND R5.016 
1710, 1oauJ, 0.5068, 3.26, 0.134, 218, 97, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
1711, 1oauH, 0.5068, 4.16, 0.081, 218, 111, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
1712, 6furC, 0.5067, 2.70, 0.144, 98, 90, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1713, 3mugD, 0.5067, 4.09, 0.138, 202, 109, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1714, 3g04B, 0.5067, 4.31, 0.071, 217, 112, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID- STIMULATING AUTOANTIBODY
1715, 5npjA, 0.5066, 4.14, 0.089, 217, 112, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
1716, 2pltA, 0.5066, 3.73, 0.090, 283, 100, STRUCTURE DETERMINATION OF PLASTOCYANIN FROM A CRYSTAL SPECIMEN WITH HEMIHEDRAL TWINNING FRACTION OF ONE-HALF
1717, 2d7tL, 0.5066, 4.09, 0.138, 202, 109, CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV
1718, 1klfO, 0.5066, 4.09, 0.138, 202, 109, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1719, 1klfM, 0.5066, 4.33, 0.062, 221, 112, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1720, 1klfK, 0.5066, 4.05, 0.074, 221, 108, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1721, 1dbkH, 0.5066, 4.15, 0.089, 217, 112, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1722, 6ea7H, 0.5065, 3.28, 0.134, 216, 97, STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
1723, 4yo0A, 0.5065, 3.29, 0.134, 216, 97, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE
1724, 4xzuE, 0.5065, 4.08, 0.138, 202, 109, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
1725, 1oayJ, 0.5065, 4.12, 0.111, 218, 108, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
1726, 1klfI, 0.5065, 4.09, 0.138, 202, 109, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1727, 1hxmB, 0.5065, 4.10, 0.128, 202, 109, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1728, 1afvH, 0.5065, 4.44, 0.079, 240, 114, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
1729, 4wuuE, 0.5064, 4.21, 0.089, 226, 112, STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1
1730, 4m1dH, 0.5064, 4.41, 0.062, 217, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
1731, 3g6jE, 0.5064, 4.15, 0.073, 236, 110, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
1732, 2uy7C, 0.5064, 4.35, 0.054, 222, 112, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1733, 5o6vI, 0.5063, 3.19, 0.115, 215, 96, THE CRYO-EM STRUCTURE OF TICK-BORNE ENCEPHALITIS VIRUS COMPLEXED WITH FAB FRAGMENT OF NEUTRALIZING ANTIBODY 19/1786
1734, 4rirA, 0.5063, 4.19, 0.072, 121, 111, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
1735, 4dp1X, 0.5063, 4.09, 0.138, 202, 109, THE 1.35 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 4.0
1736, 4dp0X, 0.5063, 4.17, 0.099, 226, 111, THE 1.5 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 4.0
1737, 3naaH, 0.5063, 2.95, 0.096, 103, 94, CRYSTAL STRUCTURE OF FAB15 MUT5
1738, 3mmeC, 0.5063, 3.78, 0.066, 113, 106, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
1739, 3iyoB, 0.5063, 4.25, 0.080, 212, 112, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
1740, 3iyoA, 0.5063, 4.35, 0.071, 225, 112, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
1741, 1ngqH, 0.5063, 4.28, 0.143, 230, 112, N1G9 (IGG1-LAMBDA) FAB FRAGMENT
1742, 6fy2X, 0.5062, 4.26, 0.071, 219, 113, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
1743, 6fy1H, 0.5062, 4.22, 0.063, 222, 111, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A SCAFFOLDED AUTOLOGOUS V1V2 
1744, 5vnwD, 0.5062, 4.27, 0.081, 122, 111, CRYSTAL STRUCTURE OF NB.B201 BOUND TO HUMAN SERUM ALBUMIN
1745, 1cf1D, 0.5062, 4.27, 0.081, 122, 111, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1746, 5ibuG, 0.5060, 4.09, 0.138, 202, 109, FAB (UNBOUND)
1747, 4ye4H, 0.5060, 4.12, 0.073, 237, 110, CRYSTAL STRUCTURE OF NEUTRALIZING ANTIBODY HJ16 IN COMPLEX WITH HIV-1 GP120
1748, 3iyoD, 0.5060, 4.29, 0.063, 215, 111, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
1749, 2uy7G, 0.5060, 4.32, 0.045, 232, 112, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
1750, 1tetH, 0.5060, 2.75, 0.144, 98, 90, CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
1751, 6fuoA, 0.5059, 3.88, 0.105, 110, 105, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1752, 6c9uH, 0.5059, 2.99, 0.095, 205, 95, CRYSTAL STRUCTURE OF [KS3][AT3] DIDOMAIN FROM MODULE 3 OF 6- DEOXYERTHRONOLIDE B SYNTHASE IN COMPLEX WITH ANTIBODY FRAGMENT (FAB) 
1753, 5k59A, 0.5059, 2.99, 0.095, 205, 95, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
1754, 4ydjA, 0.5059, 2.99, 0.095, 205, 95, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1755, 3mugL, 0.5059, 4.30, 0.062, 219, 113, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1756, 3mugJ, 0.5059, 4.10, 0.091, 213, 110, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1757, 2zpkI, 0.5059, 4.20, 0.090, 209, 111, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
1758, 6mwxK, 0.5058, 4.28, 0.080, 208, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
1759, 6mwvC, 0.5058, 4.19, 0.081, 121, 111, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
1760, 6mwcK, 0.5058, 2.99, 0.095, 205, 95, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
1761, 6mwcG, 0.5058, 4.31, 0.143, 230, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
1762, 6mwcC, 0.5058, 4.39, 0.080, 220, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
1763, 6mw9K, 0.5058, 4.10, 0.064, 223, 109, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
1764, 6mw9G, 0.5058, 4.17, 0.072, 231, 111, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
1765, 6muiO, 0.5058, 4.12, 0.112, 214, 107, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
1766, 6marM, 0.5058, 3.28, 0.134, 216, 97, HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151 
1767, 6fupA, 0.5058, 4.14, 0.082, 212, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1768, 6e48F, 0.5058, 4.31, 0.063, 219, 111, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND LITHOCHOLIC ACID 
1769, 5kzpF, 0.5058, 2.63, 0.135, 99, 89, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
1770, 5anyK, 0.5058, 2.65, 0.135, 99, 89, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
1771, 4zd3H, 0.5058, 4.32, 0.071, 225, 112, STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY FAB FRAGMENT
1772, 6marH, 0.5057, 4.29, 0.071, 222, 112, HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151 
1773, 6higH, 0.5057, 4.16, 0.045, 468, 110, HPD-1/NBO1A FAB COMPLEX 
1774, 5vicH, 0.5057, 4.16, 0.045, 468, 110, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z004 BOUND TO DENV-1 ENVELOPE PROTEIN DIII
1775, 4zs6C, 0.5057, 4.25, 0.088, 215, 113, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
1776, 3hg1E, 0.5057, 4.30, 0.072, 219, 111, GERMLINE-GOVERNED RECOGNITION OF A CANCER EPITOPE BY AN IMMUNODOMINANT HUMAN T CELL RECEPTOR
1777, 5tz2H, 0.5056, 4.27, 0.080, 226, 112, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B222
1778, 5kzpE, 0.5056, 4.05, 0.083, 120, 108, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
1779, 5iblC, 0.5056, 3.76, 0.057, 368, 106, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
1780, 5cusH, 0.5056, 4.28, 0.054, 225, 111, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
1781, 5bq7A, 0.5056, 4.12, 0.082, 227, 110, CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS-HUMAN FAB 5F-10 FRAGMENT
1782, 4tnwH, 0.5056, 4.15, 0.055, 461, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1783, 4rqqH, 0.5056, 3.29, 0.134, 216, 97, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1784, 2oslH, 0.5056, 4.27, 0.080, 209, 112, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
1785, 2jelH, 0.5056, 4.11, 0.138, 202, 109, JEL42 FAB/HPR COMPLEX
1786, 1kdjA, 0.5056, 4.20, 0.081, 205, 111, OXIDIZED FORM OF PLASTOCYANIN FROM DRYOPTERIS CRASSIRHIZOMA
1787, 1hxmH, 0.5056, 4.06, 0.083, 292, 109, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1788, 6c08B, 0.5055, 4.31, 0.079, 238, 114, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
1789, 5yhlH, 0.5055, 4.16, 0.073, 236, 110, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
1790, 5i1kH, 0.5055, 4.13, 0.073, 237, 110, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-20
1791, 4s1sH, 0.5055, 4.17, 0.072, 207, 111, CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY 45-VRC01.H5.F-185917 IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE
1792, 4qokE, 0.5055, 4.35, 0.080, 218, 113, STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES
1793, 4hqqH, 0.5055, 4.35, 0.080, 218, 113, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
1794, 3gkwL, 0.5055, 4.35, 0.080, 218, 113, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI- EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
1795, 5ywyH, 0.5054, 4.35, 0.080, 218, 113, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
1796, 5yslG, 0.5054, 4.35, 0.080, 218, 113, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1797, 4dp2X, 0.5054, 4.35, 0.080, 218, 113, THE 1.8 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 6.0
1798, 3ubxH, 0.5054, 4.35, 0.080, 218, 113, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
1799, 3ubxG, 0.5054, 4.35, 0.080, 218, 113, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
1800, 3tf7C, 0.5054, 4.05, 0.083, 135, 109, 42F3 QL9/H2-LD COMPLEX
1801, 1v7mH, 0.5054, 4.09, 0.128, 202, 109, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
1802, 1oaxJ, 0.5054, 3.74, 0.066, 113, 106, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
1803, 1oaxH, 0.5054, 4.19, 0.099, 226, 111, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
1804, 1kelH, 0.5054, 4.35, 0.080, 218, 113, CATALYTIC ANTIBODY 28B4 FAB FRAGMENT COMPLEXED WITH HAPTEN (1-[N-4 -NITROBENZYL-N-4 -CARBOXYBUTYLAMINO] METHYLPHOSPHONIC ACID)
1805, 5yslC, 0.5053, 4.29, 0.063, 199, 111, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1806, 5w06H, 0.5053, 3.99, 0.083, 135, 108, HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587
1807, 4nobA, 0.5053, 4.24, 0.080, 209, 112, CRYSTAL STRUCTURE OF THE 1ST IG DOMAIN FROM MOUSE POLYMERIC IMMUNOGLOBULIN RECEPTOR [PSI-NYSGRC-006220]
1808, 4dwhA, 0.5053, 4.14, 0.091, 219, 110, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC (2.5 A RESOLUTION)
1809, 1ypzF, 0.5053, 4.18, 0.100, 221, 110, IMMUNE RECEPTOR
1810, 1oazJ, 0.5053, 4.16, 0.118, 244, 110, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
1811, 5yfiH, 0.5052, 4.25, 0.081, 213, 111, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY 
1812, 5t5fH, 0.5052, 4.20, 0.099, 226, 111, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
1813, 5o2uB, 0.5052, 4.22, 0.091, 216, 110, LLAMA VHH IN COMPLEX WITH P24
1814, 5o14H, 0.5052, 4.32, 0.089, 182, 112, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
1815, 5it2H, 0.5052, 4.27, 0.080, 220, 112, STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY 693-10-B06 FAB FRAGMENT
1816, 3sqbC, 0.5052, 4.09, 0.091, 223, 110, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC CHAPERONE
1817, 3sqbA, 0.5052, 4.20, 0.045, 240, 112, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC CHAPERONE
1818, 3ncjH, 0.5052, 4.26, 0.080, 224, 112, CRYSTAL STRUCTURE OF FAB15 MUT8
1819, 6dcqM, 0.5051, 4.22, 0.071, 218, 112, ECTODOMAIN OF FULL LENGTH; WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB 
1820, 5truh, 0.5051, 2.88, 0.156, 102, 90, STRUCTURE OF THE FIRST-IN-CLASS CHECKPOINT INHIBITOR IPILIMUMAB BOUND TO HUMAN CTLA-4
1821, 4dp5X, 0.5051, 4.19, 0.144, 230, 111, THE 1.88 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 8.0
1822, 4dp4X, 0.5051, 4.08, 0.103, 215, 107, THE 1.54 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 6.0
1823, 3g6jG, 0.5051, 4.23, 0.079, 223, 114, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
1824, 2ivfC, 0.5051, 4.42, 0.062, 211, 112, ETHYLBENZENE DEHYDROGENASE FROM AROMATOLEUM AROMATICUM
1825, 1kdiA, 0.5051, 4.28, 0.089, 228, 112, REDUCED FORM OF PLASTOCYANIN FROM DRYOPTERIS CRASSIRHIZOMA
1826, 1i7zA, 0.5051, 4.15, 0.100, 244, 110, ANTIBODY GNC92H2 BOUND TO LIGAND
1827, 6mwxO, 0.5050, 4.31, 0.062, 215, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
1828, 6mwxG, 0.5050, 4.21, 0.120, 199, 108, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
1829, 6mwxC, 0.5050, 4.24, 0.079, 223, 114, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
1830, 6mwvO, 0.5050, 4.17, 0.072, 210, 111, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
1831, 6mwvK, 0.5050, 2.64, 0.135, 99, 89, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
1832, 6mwvG, 0.5050, 4.31, 0.071, 221, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
1833, 6mwcO, 0.5050, 4.31, 0.071, 221, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
1834, 6mw9O, 0.5050, 4.07, 0.121, 232, 107, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
1835, 6mw9C, 0.5050, 4.09, 0.082, 217, 110, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
1836, 6muiK, 0.5050, 4.29, 0.071, 122, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
1837, 6muiG, 0.5050, 4.29, 0.071, 122, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
1838, 6muiC, 0.5050, 4.20, 0.081, 218, 111, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
1839, 6fy0H, 0.5050, 4.10, 0.083, 210, 109, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
1840, 5vk2D, 0.5050, 4.28, 0.072, 216, 111, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
1841, 5anyL, 0.5050, 3.56, 0.078, 112, 102, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
1842, 5anyJ, 0.5050, 2.89, 0.129, 197, 93, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
1843, 5anyI, 0.5050, 4.44, 0.062, 230, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
1844, 4tnvJ, 0.5050, 4.29, 0.080, 122, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1845, 4jfyB, 0.5050, 4.12, 0.062, 221, 113, APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD
1846, 4amkH, 0.5050, 4.35, 0.089, 212, 112, FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10
1847, 3ve0A, 0.5050, 4.07, 0.101, 115, 109, CRYSTAL STRUCTURE OF SUDAN EBOLAVIRUS GLYCOPROTEIN (STRAIN BONIFACE) BOUND TO 16F6
1848, 3qpqH, 0.5050, 4.29, 0.063, 221, 111, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1849, 3mlrH, 0.5050, 4.34, 0.081, 218, 111, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE
1850, 1tcrA, 0.5050, 2.99, 0.128, 200, 94, MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE
1851, 1rzgC, 0.5050, 3.01, 0.128, 191, 94, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
1852, 5zwoD, 0.5049, 4.16, 0.091, 225, 110, CRYO-EM STRUCTURE OF THE YEAST B COMPLEX AT AVERAGE RESOLUTION OF 3.9 ANGSTROM 
1853, 5zwmAA, 0.5049, 4.14, 0.092, 135, 109, Cryo-EM structure of the yeast pre-B complex at an average resolution of 3.4~4.6 angstrom (tri-snRNP and U2 snRNP Part)  
1854, 5xcqA, 0.5049, 4.25, 0.090, 212, 111, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
1855, 5eszA, 0.5049, 2.66, 0.135, 99, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244
1856, 4tnvV, 0.5049, 2.65, 0.135, 99, 89, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1857, 3jwnI, 0.5049, 4.13, 0.103, 214, 107, COMPLEX OF FIMC FIMF FIMG AND FIMH
1858, 1hxmD, 0.5049, 4.42, 0.084, 214, 119, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1859, 1ag6A, 0.5049, 2.87, 0.156, 102, 90, PLASTOCYANIN FROM SPINACH
1860, 5yslE, 0.5048, 4.24, 0.110, 219, 109, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1861, 5vk2F, 0.5048, 4.25, 0.090, 218, 111, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
1862, 5kg9H, 0.5048, 4.25, 0.090, 218, 111, CRYSTAL STRUCTURE OF THE GP120 V2 ANTIBODY RE505-22 FAB FROM IGH- AND IGK-HUMANIZED MOUSE
1863, 4od2B, 0.5048, 4.25, 0.090, 218, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-DR5 ANTIBODY BOUND TO DR5
1864, 4m1dI, 0.5048, 4.25, 0.090, 218, 111, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
1865, 2gcyA, 0.5048, 4.25, 0.090, 218, 111, HUMANIZED ANTIBODY C25 FAB FRAGMENT
1866, 5yslA, 0.5047, 4.25, 0.090, 218, 111, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1867, 4tnvF, 0.5047, 4.25, 0.090, 218, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1868, 4kmtH, 0.5047, 4.25, 0.090, 218, 111, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12
1869, 4dp6X, 0.5047, 4.25, 0.090, 218, 111, THE 1.67 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 8.0
1870, 1s3kL, 0.5047, 4.25, 0.090, 218, 111, CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE
1871, 1ngpH, 0.5047, 4.25, 0.090, 218, 111, N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3- NITROPHENYL) ACETATE
1872, 6ea5M, 0.5046, 4.25, 0.090, 218, 111, STRUCTURE OF BDBV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
1873, 6c08E, 0.5046, 4.22, 0.090, 226, 111, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
1874, 5w05H, 0.5046, 4.22, 0.099, 218, 111, ANTI-TISSUE FACTOR ANTIBODY M59 A HUMANIZED VERSION OF 10H10
1875, 4tnvI, 0.5046, 4.25, 0.090, 218, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1876, 4tnvH, 0.5046, 4.25, 0.090, 218, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1877, 4nrzA, 0.5046, 4.25, 0.090, 218, 111, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
1878, 1v7nJ, 0.5046, 4.15, 0.090, 223, 111, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
1879, 1jxgA, 0.5046, 4.28, 0.081, 214, 111, THE 1.6 A RESOLUTION CRYSTAL STRUCTURE OF A MUTANT POPLAR PLASTOCYANIN BEARING A 21-25 ENGENEERED DISULFIDE BRIDGE
1880, 6mamE, 0.5045, 4.22, 0.090, 215, 111, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
1881, 6fr7A, 0.5045, 4.35, 0.107, 220, 112, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1882, 6dc9L, 0.5045, 4.12, 0.100, 215, 110, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
1883, 5a3iG, 0.5045, 4.28, 0.062, 226, 112, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
1884, 4s1rH, 0.5045, 4.19, 0.092, 202, 109, CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY 45-VRC01.H08.F-117225 IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE
1885, 3bwuC, 0.5045, 4.27, 0.071, 213, 112, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF FIMD (N-TERMINAL DOMAIN FIMDN) WITH FIMC AND THE N-TERMINALLY TRUNCATED PILUS SUBUNIT FIMF (FIMFT)
1886, 1ob1B, 0.5045, 3.28, 0.117, 1699, 94, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
1887, 12e8P, 0.5045, 3.28, 0.117, 1699, 94, 2E8 FAB FRAGMENT
1888, 6qnoH, 0.5044, 4.25, 0.054, 166, 111, RHODOPSIN-GI PROTEIN COMPLEX 
1889, 5jhdD, 0.5044, 4.19, 0.081, 212, 111, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
1890, 5ifhH, 0.5044, 4.11, 0.091, 224, 110, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  2 CASE P11475
1891, 4p3dL, 0.5044, 3.04, 0.105, 198, 95, MT1-MMP:FAB COMPLEX (FORM II)
1892, 4nrzH, 0.5044, 4.31, 0.143, 230, 112, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
1893, 3mlvN, 0.5044, 2.65, 0.124, 99, 89, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
1894, 6fraA, 0.5043, 4.18, 0.072, 210, 111, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1895, 4dwhC, 0.5043, 4.31, 0.098, 217, 112, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC (2.5 A RESOLUTION)
1896, 3jwnC, 0.5043, 4.27, 0.099, 211, 111, COMPLEX OF FIMC FIMF FIMG AND FIMH
1897, 3fo2A, 0.5043, 4.13, 0.091, 214, 110, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
1898, 3c2aH, 0.5043, 4.11, 0.073, 231, 110, ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE
1899, 1c1eH, 0.5043, 4.26, 0.092, 216, 109, CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN
1900, 6fy2H, 0.5042, 4.21, 0.071, 211, 112, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
1901, 4zs6H, 0.5042, 4.16, 0.090, 222, 111, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
1902, 4ki5C, 0.5042, 4.45, 0.071, 218, 112, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
1903, 6eh9A, 0.5041, 2.66, 0.135, 99, 89, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1904, 5kzpH, 0.5041, 4.20, 0.120, 216, 108, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
1905, 5jhdI, 0.5041, 4.28, 0.088, 215, 113, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
1906, 4tnvG, 0.5041, 4.13, 0.091, 217, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1907, 4p3dB, 0.5041, 4.28, 0.110, 215, 109, MT1-MMP:FAB COMPLEX (FORM II)
1908, 4j1uC, 0.5041, 4.32, 0.045, 220, 111, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
1909, 3mlwH, 0.5041, 4.12, 0.091, 222, 110, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
1910, 3inuH, 0.5041, 4.16, 0.090, 223, 111, CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY.
1911, 6hjqK, 0.5040, 4.40, 0.071, 225, 112, STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT 
1912, 6hjqI, 0.5040, 4.21, 0.081, 217, 111, STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT 
1913, 6hjqG, 0.5040, 2.89, 0.122, 100, 90, STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT 
1914, 6hjpG, 0.5040, 4.11, 0.100, 235, 110, STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT 
1915, 5lxaH, 0.5040, 4.12, 0.128, 203, 109, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 3.0 ANGSTROM RESOLUTION
1916, 4tnwG, 0.5040, 4.11, 0.103, 215, 107, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1917, 4tnvU, 0.5040, 4.24, 0.063, 226, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1918, 6fy3X, 0.5039, 4.31, 0.090, 235, 111, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-3D; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
1919, 6fxnD, 0.5039, 2.91, 0.129, 200, 93, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1920, 6apcH, 0.5039, 4.26, 0.080, 219, 112, CRYSTAL STRUCTURE OF INFANT ANTIBODY ADI-19425
1921, 5i1jH, 0.5039, 4.27, 0.071, 221, 112, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-11
1922, 4rbpM, 0.5039, 4.20, 0.081, 221, 111, CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE
1923, 4hwbH, 0.5039, 4.07, 0.083, 201, 109, CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA 1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
1924, 4bz2H, 0.5039, 4.15, 0.082, 178, 110, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 2D73
1925, 3rfzC, 0.5039, 4.30, 0.147, 218, 109, CRYSTAL STRUCTURE OF THE FIMD USHER BOUND TO ITS COGNATE FIMC:FIMH SUBSTRATE
1926, 3fo0L, 0.5039, 4.24, 0.081, 226, 111, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)
1927, 2bz7A, 0.5039, 4.29, 0.062, 221, 112, OXIDIZED AND REDUCED STRUCTURES OF A MUTANT PLASTOCYANIN OF FERN
1928, 1ncaH, 0.5039, 4.15, 0.147, 201, 109, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
1929, 1faiH, 0.5039, 2.95, 0.106, 201, 94, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
1930, 1a4kB, 0.5039, 3.05, 0.105, 199, 95, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
1931, 6idgL, 0.5038, 4.31, 0.128, 216, 109, ANTIBODY 64M-5 FAB IN COMPLEX WITH DT(6-4)T 
1932, 6fr6A, 0.5038, 4.24, 0.072, 231, 111, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1933, 6bzuH, 0.5038, 4.13, 0.081, 219, 111, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
1934, 5truH, 0.5038, 4.18, 0.073, 219, 110, STRUCTURE OF THE FIRST-IN-CLASS CHECKPOINT INHIBITOR IPILIMUMAB BOUND TO HUMAN CTLA-4
1935, 5mvzH, 0.5038, 4.18, 0.091, 221, 110, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
1936, 5ganB, 0.5038, 4.19, 0.082, 218, 110, THE OVERALL STRUCTURE OF THE YEAST SPLICEOSOMAL U4/U6.U5 TRI-SNRNP AT 3.7 ANGSTROM
1937, 5cusK, 0.5038, 4.13, 0.119, 202, 109, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
1938, 4tnwF, 0.5038, 4.21, 0.099, 226, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1939, 4tnvY, 0.5038, 4.14, 0.082, 203, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1940, 1qunO, 0.5038, 4.16, 0.090, 224, 111, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
1941, 1qunK, 0.5038, 4.30, 0.138, 218, 109, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
1942, 6hjpK, 0.5037, 4.25, 0.110, 213, 109, STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT 
1943, 6hjpI, 0.5037, 4.14, 0.046, 228, 109, STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT 
1944, 5wk3S, 0.5037, 4.25, 0.090, 226, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
1945, 5i1lH, 0.5037, 4.21, 0.072, 216, 111, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
1946, 5d7sH, 0.5037, 4.21, 0.072, 216, 111, CRYSTAL STRUCTURE OF MOR04357 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT
1947, 4yo0C, 0.5037, 4.21, 0.072, 216, 111, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE
1948, 4hiiB, 0.5037, 4.12, 0.073, 216, 110, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- GALACTOSE
1949, 2dblH, 0.5037, 4.31, 0.062, 238, 112, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1950, 2b1hH, 0.5037, 4.17, 0.090, 222, 111, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE
1951, 1x9rA, 0.5037, 4.12, 0.091, 221, 110, UMECYANIN FROM HORSE RADDISH- CRYSTAL STRUCTURE OF THE OXIDISED FORM
1952, 1qunM, 0.5037, 4.48, 0.044, 178, 113, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
1953, 1qunI, 0.5037, 4.44, 0.053, 215, 113, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
1954, 1ncbH, 0.5037, 4.18, 0.091, 223, 110, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
1955, 6mxsL, 0.5036, 4.40, 0.062, 213, 112, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
1956, 6fy0I, 0.5036, 4.27, 0.072, 224, 111, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
1957, 6d01C, 0.5036, 4.39, 0.062, 216, 112, CRYSTAL STRUCTURE OF 1210 FAB IN COMPLEX WITH CIRCUMSPOROZOITE PROTEIN NANP5 
1958, 5a3iC, 0.5036, 4.32, 0.089, 213, 112, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
1959, 4gkzA, 0.5036, 2.95, 0.106, 201, 94, HA1.7 A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
1960, 3vxqA, 0.5036, 4.33, 0.128, 216, 109, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
1961, 3mlvH, 0.5036, 2.89, 0.156, 102, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
1962, 3fo2L, 0.5036, 4.36, 0.053, 221, 113, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
1963, 2ocwA, 0.5036, 4.11, 0.082, 221, 110, SOLUTION STRUCTURE OF HUMAN SECRETORY COMPONENT
1964, 2gsiC, 0.5036, 4.33, 0.080, 219, 113, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
1965, 1n7mL, 0.5036, 4.27, 0.128, 217, 109, GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN
1966, 1mwaC, 0.5036, 4.18, 0.119, 202, 109, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1967, 4tnwV, 0.5035, 4.00, 0.123, 215, 106, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1968, 4qf1H, 0.5035, 4.23, 0.090, 215, 111, CRYSTAL STRUCTURE OF UNLIGANDED CH59UA THE INFERRED UNMUTATED ANCESTOR OF THE RV144 ANTI-HIV ANTIBODY LINEAGE PRODUCING CH59
1969, 4m43H, 0.5035, 4.44, 0.062, 221, 112, CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11
1970, 4hs6L, 0.5035, 3.29, 0.117, 1781, 94, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
1971, 3ivkH, 0.5035, 4.25, 0.090, 180, 111, CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
1972, 3ivkA, 0.5035, 4.18, 0.090, 221, 111, CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
1973, 2vxvH, 0.5035, 4.12, 0.091, 221, 110, CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
1974, 2nz9E, 0.5035, 3.00, 0.105, 198, 95, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
1975, 6d01G, 0.5034, 3.00, 0.105, 198, 95, CRYSTAL STRUCTURE OF 1210 FAB IN COMPLEX WITH CIRCUMSPOROZOITE PROTEIN NANP5 
1976, 5w23M, 0.5034, 4.12, 0.073, 216, 110, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
1977, 5ibtH, 0.5034, 4.13, 0.073, 216, 110, UCA FAB (UNBOUND) FROM 6515 LINEAGE
1978, 4tnwI, 0.5034, 4.20, 0.082, 221, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1979, 4jr9H, 0.5034, 4.35, 0.089, 225, 112, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK
1980, 3mlsK, 0.5034, 4.27, 0.081, 218, 111, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
1981, 3fo1A, 0.5034, 4.16, 0.082, 198, 110, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
1982, 2bzcA, 0.5034, 4.27, 0.081, 203, 111, OXIDIZED AND REDUCED STRUCTURES OF A MUTANT PLASTOCYANIN OF FERN
1983, 6f2gB, 0.5033, 4.28, 0.062, 219, 113, struct.pdbx_descriptor               Putative amino acid/polyamine transport protein; Nanobody 74  
1984, 6dwcA, 0.5033, 4.26, 0.072, 226, 111, STRUCTURE OF THE APO 4497 ANTIBODY FAB FRAGMENT 
1985, 5y11A, 0.5033, 2.97, 0.149, 105, 94, SFTSV GN WITH NEUTRALIZING ANTIBODY MAB4-5
1986, 5i1lB, 0.5033, 3.00, 0.105, 198, 95, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
1987, 5cusI, 0.5033, 3.00, 0.105, 198, 95, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
1988, 5c7kE, 0.5033, 4.35, 0.071, 221, 113, CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195
1989, 4z8fL, 0.5033, 4.11, 0.093, 218, 108, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -P5(DT)P- 3 
1990, 4tnwW, 0.5033, 4.21, 0.081, 216, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1991, 4rauE, 0.5033, 4.28, 0.099, 220, 111, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
1992, 4ocwH, 0.5033, 4.38, 0.062, 226, 112, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.06 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
1993, 4hzlA, 0.5033, 4.15, 0.119, 202, 109, NEUTRALIZING ANTIBODY MAB 8 IN COMPLEX WITH THE EPITOPE II OF HCV E2 ENVELOPE PROTEIN
1994, 4dqoH, 0.5033, 4.05, 0.103, 204, 107, CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
1995, 3mltB, 0.5033, 4.33, 0.062, 221, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
1996, 3kymP, 0.5033, 4.33, 0.128, 216, 109, CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
1997, 3cm9S, 0.5033, 3.77, 0.085, 585, 106, SOLUTION STRUCTURE OF HUMAN SIGA2
1998, 2e7lA, 0.5033, 4.13, 0.111, 215, 108, STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1999, 1v7mI, 0.5033, 4.29, 0.062, 216, 113, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
2000, 1i9iH, 0.5033, 4.17, 0.128, 202, 109, NATIVE CRYSTAL STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
2001, 6q3sD, 0.5032, 4.17, 0.090, 224, 111, ENGINEERED HUMAN HLA_A2 MHC CLASS I MOLECULE IN COMPLEX WITH TCR AND SV9 PEPTIDE 
2002, 6nb8H, 0.5032, 4.26, 0.099, 212, 111, CRYSTAL STRUCTURE OF ANTI- SARS-COV HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT 
2003, 6flcB, 0.5032, 4.33, 0.062, 219, 113, 2C8 FAB BOUND TO EDIII OF DENV 2 
2004, 6dwaA, 0.5032, 4.01, 0.094, 218, 106, STRUCTURE OF THE 4497 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
2005, 6dcvB, 0.5032, 4.23, 0.081, 224, 111, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2006, 5d6cA, 0.5032, 4.23, 0.081, 224, 111, STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT
2007, 4tnwU, 0.5032, 4.34, 0.054, 222, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2008, 3mlwI, 0.5032, 4.19, 0.083, 216, 108, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
2009, 3l1oH, 0.5032, 4.25, 0.099, 219, 111, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE CRYSTALLIZED IN THE PRESENCE OF ZINC
2010, 3ghbH, 0.5032, 4.28, 0.119, 215, 109, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020
2011, 2zpkH, 0.5032, 4.34, 0.081, 218, 111, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
2012, 2w65A, 0.5032, 4.18, 0.090, 222, 111, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE
2013, 1i9eA, 0.5032, 4.27, 0.080, 213, 112, TCR DOMAIN
2014, 1i7zC, 0.5032, 4.35, 0.062, 224, 112, ANTIBODY GNC92H2 BOUND TO LIGAND
2015, 5dqjH, 0.5031, 4.33, 0.128, 216, 109, STRUCTURE OF UNLIGANDED S55-5 FAB
2016, 4r9yN, 0.5031, 2.90, 0.156, 102, 90, CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4
2017, 4ffzL, 0.5031, 4.27, 0.090, 131, 111, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
2018, 3njhD, 0.5031, 4.27, 0.119, 217, 109, D37A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
2019, 3mltI, 0.5031, 4.41, 0.071, 219, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
2020, 3cvhH, 0.5031, 4.28, 0.072, 213, 111, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
2021, 2ygtA, 0.5031, 4.26, 0.090, 198, 111, CLOSTRIDIUM PERFRINGENS DELTA-TOXIN
2022, 2ntfB, 0.5031, 4.15, 0.071, 224, 112, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
2023, 8fabD, 0.5030, 4.15, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE HUMAN MYELOMA IMMUNOGLOBULIN IGG HIL AT 1.8 ANGSTROMS RESOLUTION
2024, 6ddvB, 0.5030, 4.18, 0.090, 224, 111, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
2025, 6bzuB, 0.5030, 4.36, 0.125, 219, 112, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
2026, 6apdK, 0.5030, 4.31, 0.090, 251, 111, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
2027, 5yxuF, 0.5030, 4.20, 0.100, 217, 110, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
2028, 5vk2H, 0.5030, 4.16, 0.073, 238, 110, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
2029, 5uz7N, 0.5030, 4.27, 0.062, 219, 112, VOLTA PHASE PLATE CRYO-ELECTRON MICROSCOPY STRUCTURE OF A CALCITONIN RECEPTOR-HETEROTRIMERIC GS PROTEIN COMPLEX
2030, 5menE, 0.5030, 4.33, 0.089, 219, 112, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHWL IN COMPLEX WITH COGNATE T-CELL RECEPTOR
2031, 5lfuA, 0.5030, 3.91, 0.073, 585, 110, MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) GLYCOSYLATED AND LYSINE- METHYLATED FULL EXTRACELLULAR DOMAIN
2032, 4z95L, 0.5030, 4.12, 0.102, 112, 108, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -5(DT)-P- 3 
2033, 4np4H, 0.5030, 4.10, 0.082, 217, 110, CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB
2034, 4jamH, 0.5030, 4.26, 0.108, 220, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
2035, 4bz1H, 0.5030, 4.21, 0.111, 203, 108, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
2036, 3mlsI, 0.5030, 4.13, 0.100, 230, 110, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
2037, 3kymL, 0.5030, 4.32, 0.089, 216, 112, CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
2038, 3aazL, 0.5030, 4.25, 0.119, 217, 109, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
2039, 2vl5B, 0.5030, 4.26, 0.063, 226, 111, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2040, 1ws7B, 0.5030, 4.26, 0.119, 219, 109, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
2041, 1oowA, 0.5030, 4.18, 0.090, 221, 111, THE CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN DOUBLE MUTANT G8D/L12E GIVES INSIGHT INTO ITS LOW REACTIVITY TOWARDS PHOTOSYSTEM 1 AND CYTOCHROME F
2042, 1klfG, 0.5030, 4.28, 0.045, 228, 110, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
2043, 1klfE, 0.5030, 4.20, 0.081, 224, 111, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
2044, 1klfA, 0.5030, 4.16, 0.073, 235, 110, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
2045, 1dbaH, 0.5030, 4.22, 0.063, 207, 111, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
2046, 6icfH, 0.5029, 4.18, 0.063, 212, 111, THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 263 AND 266 
2047, 6eqaE, 0.5029, 4.21, 0.101, 115, 109, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN 
2048, 5whzH, 0.5029, 4.24, 0.110, 219, 109, PGDM1400-10E8V4 CODV FAB
2049, 5lspH, 0.5029, 4.35, 0.107, 222, 112, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
2050, 4x7tB, 0.5029, 4.22, 0.082, 218, 110, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
2051, 3uzqA, 0.5029, 4.28, 0.128, 216, 109, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 1 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
2052, 3u46H, 0.5029, 3.43, 0.102, 122, 98, CH04H/CH02L P212121
2053, 3mlsJ, 0.5029, 4.36, 0.062, 219, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
2054, 3c2aI, 0.5029, 4.18, 0.072, 213, 111, ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE
2055, 2y36H, 0.5029, 4.13, 0.103, 282, 107, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)- ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE DLWTTAIPTIPS
2056, 1lcsA, 0.5029, 4.29, 0.071, 222, 113, RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS
2057, 1klfC, 0.5029, 4.28, 0.090, 222, 111, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
2058, 1f4xH, 0.5029, 4.25, 0.081, 222, 111, CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
2059, 6aniI, 0.5028, 3.99, 0.123, 216, 106, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
2060, 5trpL, 0.5028, 4.26, 0.090, 223, 111, CRYSTAL STRUCTURE OF THE UNLIGANDED DH270 COOPERATING LINEAGE MEMBER DH272
2061, 5sv4B, 0.5028, 4.21, 0.100, 190, 110, ANTI-RICIN A-CHAIN SINGLE DOMAIN ANTIBODY A3C8
2062, 5cusJ, 0.5028, 4.26, 0.099, 217, 111, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
2063, 4xnyH, 0.5028, 4.17, 0.101, 128, 109, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08C IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120
2064, 3lh8B, 0.5028, 4.16, 0.064, 240, 109, CRYSTAL STRUCTURE OF MOUSE VPS26B IN SPACEGROUP P41 21 2
2065, 3ijyC, 0.5028, 4.01, 0.092, 487, 109, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
2066, 2i60R, 0.5028, 4.16, 0.093, 214, 107, CRYSTAL STRUCTURE OF [PHE23]M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2067, 2fjgH, 0.5028, 4.23, 0.081, 215, 111, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
2068, 1v7nK, 0.5028, 4.24, 0.063, 223, 111, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
2069, 1r24B, 0.5028, 4.32, 0.080, 212, 112, FAB FROM MURINE IGG3 KAPPA
2070, 1mhhD, 0.5028, 4.29, 0.071, 226, 112, ANTIBODY-ANTIGEN COMPLEX
2071, 6mxrB, 0.5027, 4.25, 0.081, 219, 111, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
2072, 6fg2F, 0.5027, 4.31, 0.128, 228, 109, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
2073, 6fg2D, 0.5027, 4.25, 0.128, 217, 109, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
2074, 5aumB, 0.5027, 3.01, 0.085, 103, 94, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
2075, 4uaoC, 0.5027, 2.66, 0.124, 99, 89, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI IN COMPLEX WITH AN INVASION INHIBITORY ANTIBODY
2076, 4qlrA, 0.5027, 3.01, 0.105, 205, 95, LLAMA NANOBODY N02 RAISED AGAINST EAEC T6SS TSSM
2077, 4ma7H, 0.5027, 3.01, 0.105, 205, 95, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE
2078, 4lu5L, 0.5027, 3.01, 0.105, 205, 95, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
2079, 6f2wB, 0.5026, 4.24, 0.090, 219, 111, BACTERIAL ASC TRANSPORTER CRYSTAL STRUCTURE IN OPEN TO IN CONFORMATION 
2080, 6d01E, 0.5026, 4.16, 0.091, 219, 110, CRYSTAL STRUCTURE OF 1210 FAB IN COMPLEX WITH CIRCUMSPOROZOITE PROTEIN NANP5 
2081, 6b0aH, 0.5026, 4.18, 0.100, 244, 110, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1269
2082, 5ywfD, 0.5026, 4.33, 0.043, 341, 115, CRYSTAL STRUCTURE OF 2H4 FAB
2083, 5udcB, 0.5026, 4.16, 0.064, 216, 109, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
2084, 5f6hK, 0.5026, 4.26, 0.110, 218, 109, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE
2085, 5cp3A, 0.5026, 4.48, 0.071, 234, 112, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES IN COMPLEX WITH SULFATHIAZOLE
2086, 5bk3F, 0.5026, 4.24, 0.081, 228, 111, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2087, 5aumA, 0.5026, 4.47, 0.062, 226, 113, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
2088, 4xx1E, 0.5026, 4.16, 0.073, 231, 110, LOW RESOLUTION STRUCTURE OF LCAT IN COMPLEX WITH FAB1
2089, 4odtL, 0.5026, 4.27, 0.088, 215, 113, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
2090, 4nrxD, 0.5026, 4.72, 0.067, 205, 120, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
2091, 4j3oC, 0.5026, 3.01, 0.105, 205, 95, CRYSTAL STRUCTURE OF THE FIMD USHER TRAVERSED BY THE PILUS TIP COMPLEX ASSEMBLY COMPOSED OF FIMC:FIMF:FIMG:FIMH
2092, 4hiiD, 0.5026, 4.39, 0.098, 216, 112, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- GALACTOSE
2093, 3t2nI, 0.5026, 4.28, 0.080, 214, 113, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
2094, 3t2nH, 0.5026, 4.28, 0.128, 217, 109, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
2095, 3njmA, 0.5026, 4.18, 0.091, 128, 110, P117A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
2096, 3gi9H, 0.5026, 4.36, 0.089, 175, 112, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
2097, 1xedF, 0.5026, 4.33, 0.080, 234, 112, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
2098, 1x9uA, 0.5026, 3.85, 0.079, 282, 101, UMECYANIN FROM HORSE RADDISH- CRYSTAL STRUCTURE OF THE REDUCED FORM
2099, 1hinH, 0.5026, 4.30, 0.138, 217, 109, STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY-ANTIGEN RECOGNITION
2100, 6dcvH, 0.5025, 4.28, 0.071, 222, 112, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2101, 5xbmE, 0.5025, 4.14, 0.081, 218, 111, STRUCTURE OF SCARB2-JL2 COMPLEX 
2102, 5gguH, 0.5025, 4.10, 0.082, 217, 110, CRYSTAL STRUCTURE OF TREMELIMUMAB FAB
2103, 5fuuM, 0.5025, 4.00, 0.093, 217, 108, ECTODOMAIN OF CLEAVED WILD TYPE JR-FL ENVDCT TRIMER IN COMPLEX WITH PGT151 FAB
2104, 5fc9C, 0.5025, 4.16, 0.081, 214, 111, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
2105, 5bk3C, 0.5025, 4.15, 0.093, 217, 108, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2106, 5b3jE, 0.5025, 4.17, 0.091, 225, 110, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
2107, 4ydlH, 0.5025, 4.15, 0.091, 225, 110, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
2108, 4ydlB, 0.5025, 4.30, 0.119, 216, 109, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
2109, 4p3cL, 0.5025, 4.26, 0.072, 223, 111, MT1-MMP:FAB COMPLEX (FORM I)
2110, 1ws7C, 0.5025, 4.16, 0.100, 130, 110, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
2111, 6qexC, 0.5024, 4.34, 0.062, 218, 112, NANODISC RECONSTITUTED HUMAN ABCB1 IN COMPLEX WITH UIC2 FAB AND TAXOL 
2112, 6cdoB, 0.5024, 4.32, 0.128, 219, 109, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
2113, 6cdmD, 0.5024, 4.29, 0.090, 128, 111, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
2114, 5j13C, 0.5024, 4.26, 0.099, 222, 111, STRUCTURAL BASIS FOR TSLP ANTAGONISM BY THE THERAPEUTIC ANTIBODY TEZEPELUMAB (MEDI9929 / AMG-157)
2115, 4rauH, 0.5024, 4.26, 0.090, 220, 111, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
2116, 4k7pH, 0.5024, 4.23, 0.054, 218, 112, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
2117, 3qpqF, 0.5024, 4.32, 0.062, 218, 112, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
2118, 1dbmH, 0.5024, 4.35, 0.071, 210, 112, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
2119, 1a5fH, 0.5024, 4.31, 0.147, 218, 109, FAB FRAGMENT OF A MONOCLONAL ANTI-E-SELECTIN ANTIBODY
2120, 6nb8L, 0.5023, 4.18, 0.120, 217, 108, CRYSTAL STRUCTURE OF ANTI- SARS-COV HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT 
2121, 6mxrL, 0.5023, 4.29, 0.081, 209, 111, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
2122, 6bzuF, 0.5023, 4.16, 0.100, 219, 110, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
2123, 5u6fA, 0.5023, 4.15, 0.093, 214, 107, BACTERIAL ADHESIN FROM MOBILUNCUS MULIERIS CONTAINING INTRAMOLECULAR DISULFIDE; ISOPEPTIDE; AND ESTER BOND CROSS-LINKS (SPACE GROUP P21) 
2124, 5dqjA, 0.5023, 4.48, 0.071, 228, 113, STRUCTURE OF UNLIGANDED S55-5 FAB
2125, 4xzuA, 0.5023, 3.02, 0.105, 199, 95, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
2126, 4odhH, 0.5023, 4.35, 0.071, 203, 112, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.UCA A POTENT V1V2- DIRECTED HIV-1 NEUTRALIZING ANTIBODY
2127, 4bz1L, 0.5023, 4.11, 0.064, 205, 109, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
2128, 3ghbI, 0.5023, 4.20, 0.073, 203, 110, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020
2129, 2v17H, 0.5023, 3.63, 0.112, 122, 98, STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT OF TAU PROTEIN
2130, 2ok0H, 0.5023, 4.22, 0.073, 217, 110, FAB ED10-DNA COMPLEX
2131, 2fl5H, 0.5023, 3.73, 0.096, 111, 104, COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
2132, 1xf5C, 0.5023, 2.99, 0.160, 105, 94, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
2133, 1rzgA, 0.5023, 4.40, 0.107, 220, 112, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
2134, 1ob1E, 0.5023, 4.26, 0.063, 226, 111, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
2135, 1kiuG, 0.5023, 4.34, 0.088, 221, 113, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2136, 1kiuE, 0.5023, 4.24, 0.099, 218, 111, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2137, 1kiuC, 0.5023, 4.12, 0.083, 135, 109, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2138, 1kiuA, 0.5023, 2.66, 0.157, 95, 89, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2139, 6jjcA, 0.5022, 4.27, 0.090, 218, 111, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) SEMI-EMPTY VLP 
2140, 6apdN, 0.5022, 4.04, 0.092, 215, 109, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
2141, 5w4lF, 0.5022, 4.22, 0.091, 223, 110, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING AND ADCC-POTENT C11-LIKE ANTIBODY N12-I3 IN COMPLEX WITH HIV-1 CLADE A/E GP120 THE CD4 MIMETIC M48U1 AND THE ANTIBODY N5-I5.
2142, 4xwgH, 0.5022, 4.22, 0.091, 223, 110, CRYSTAL STRUCTURE OF LCAT (C31Y) IN COMPLEX WITH FAB1
2143, 4rauW, 0.5022, 4.23, 0.148, 218, 108, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
2144, 4rauT, 0.5022, 3.00, 0.085, 103, 94, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
2145, 4buhA, 0.5022, 4.28, 0.088, 225, 113, HUMAN IGE AGAINST THE MAJOR ALLERGEN BET V 1 - CRYSTAL STRUCTURE OF CLONE M0418 SCFV
2146, 3mlsH, 0.5022, 4.34, 0.138, 219, 109, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
2147, 3mj9A, 0.5022, 4.28, 0.080, 218, 112, CRYSTAL STRUCTURE OF JAML IN COMPLEX WITH THE STIMULATORY ANTIBODY HL4E10
2148, 3lhaB, 0.5022, 4.27, 0.090, 209, 111, CRYSTAL STRUCTURE OF MOUSE VPS26B(R240S/G241A/E242S) IN SPACEGROUP P41 21 2
2149, 1igtB, 0.5022, 4.28, 0.126, 219, 111, STRUCTURE OF IMMUNOGLOBULIN
2150, 1dbbH, 0.5022, 4.39, 0.080, 213, 113, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
2151, 6fn1C, 0.5021, 4.15, 0.100, 220, 110, ZOSUQUIDAR AND UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
2152, 6ehgC, 0.5021, 4.37, 0.053, 219, 113, COMPLEMENT COMPONENT C3B IN COMPLEX WITH A NANOBODY
2153, 6apdJ, 0.5021, 4.32, 0.071, 212, 112, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
2154, 5yl1A, 0.5021, 4.30, 0.110, 219, 109, T=1 SUBVIRAL PARTICLE OF PENAEUS VANNAMEI NODAVIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-37  and 251-368) 
2155, 5fc9B, 0.5021, 4.12, 0.093, 218, 108, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
2156, 5d72H, 0.5021, 4.32, 0.138, 214, 109, CRYSTAL STRUCTURE OF MOR04252 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF
2157, 5c7xH, 0.5021, 3.60, 0.081, 288, 99, CRYSTAL STRUCTURE OF MOR04357 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF
2158, 4zsoD, 0.5021, 4.37, 0.107, 222, 112, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
2159, 4hihD, 0.5021, 4.19, 0.063, 213, 111, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE.
2160, 3uluH, 0.5021, 4.31, 0.090, 222, 111, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
2161, 3ikcD, 0.5021, 4.30, 0.147, 218, 109, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
2162, 3aazB, 0.5021, 4.17, 0.073, 235, 110, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
2163, 2qhrH, 0.5021, 4.25, 0.090, 222, 111, CRYSTAL STRUCTURE OF THE 13F6-1-2 FAB FRAGMENT BOUND TO ITS EBOLA VIRUS GLYCOPROTEIN PEPTIDE EPITOPE.
2164, 1ymhD, 0.5021, 4.33, 0.080, 216, 112, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
2165, 1uwxM, 0.5021, 4.28, 0.099, 220, 111, P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
2166, 1mhhB, 0.5021, 4.30, 0.119, 220, 109, ANTIBODY-ANTIGEN COMPLEX
2167, 6qnkD, 0.5020, 4.34, 0.062, 223, 112, ANTIBODY FAB FRAGMENT TARGETING GI PROTEIN HETEROTRIMER 
2168, 6dg2C, 0.5020, 4.28, 0.071, 219, 113, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
2169, 5ur8A, 0.5020, 3.03, 0.095, 205, 95, HUMAN ANTIBODY FRAGMENT (FAB) TO MENINGOCOCCAL FACTOR H BINDING PROTEIN
2170, 5t33H, 0.5020, 3.03, 0.095, 205, 95, CRYSTAL STRUCTURE OF STRAIN-SPECIFIC GLYCAN-DEPENDENT CD4 BINDING SITE-DIRECTED NEUTRALIZING ANTIBODY CAP257-RH1 IN COMPLEX WITH HIV-1 STRAIN RHPA GP120 CORE WITH AN OLIGOMANNOSE N276 GLYCAN.
2171, 5jsaE, 0.5020, 3.03, 0.095, 205, 95, UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128
2172, 5dr5L, 0.5020, 3.03, 0.095, 205, 95, CRYSTAL STRUCTURE OF THE SCLEROSTIN-NEUTRALIZING FAB ABD09097
2173, 4s2sH, 0.5020, 3.77, 0.077, 193, 104, CRYSTAL STRUCTURE OF FAB FRAGMENT OF MONOCLONAL ANTIBODY ROAB13
2174, 4nzuH, 0.5020, 4.18, 0.091, 223, 110, CRYSTAL STRUCTURE OF THE PRIMARY MONOCLONAL ANTIBODY 13PL FAB  FROM A MULTIPLE MYELOMA PATIENT
2175, 4jfdE, 0.5020, 4.26, 0.072, 212, 111, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2176, 3wihH, 0.5020, 4.10, 0.092, 221, 109, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
2177, 3hmwH, 0.5020, 4.28, 0.126, 219, 111, CRYSTAL STRUCTURE OF USTEKINUMAB FAB
2178, 3gi8L, 0.5020, 4.28, 0.126, 219, 111, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
2179, 3chnS, 0.5020, 4.29, 0.064, 236, 110, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
2180, 2y06H, 0.5020, 4.30, 0.071, 226, 112, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE GDPRPSYISHLL
2181, 2r6pF, 0.5020, 4.32, 0.052, 229, 115, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
2182, 2r6pD, 0.5020, 3.83, 0.089, 282, 101, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
2183, 2r29H, 0.5020, 4.40, 0.098, 444, 112, NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY
2184, 2oz4H, 0.5020, 4.21, 0.071, 219, 113, STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
2185, 2ntfH, 0.5020, 4.28, 0.088, 225, 113, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
2186, 2fl5B, 0.5020, 4.16, 0.101, 124, 109, COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
2187, 1uwxH, 0.5020, 4.25, 0.090, 223, 111, P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
2188, 1rjlB, 0.5020, 3.75, 0.077, 185, 104, STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
2189, 1mjjA, 0.5020, 2.69, 0.157, 95, 89, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
2190, 6okqE, 0.5019, 4.27, 0.081, 213, 111, CRYSTAL STRUCTURE OF THE SF12 FAB 
2191, 6mamC, 0.5019, 4.28, 0.081, 214, 111, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
2192, 6flbL, 0.5019, 4.32, 0.080, 219, 113, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 2 
2193, 6e64A, 0.5019, 4.28, 0.081, 203, 111, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
2194, 6dzrH, 0.5019, 4.27, 0.081, 225, 111, CRYSTAL STRUCTURE OF H38C2 K99R MUTATION 
2195, 6dc9M, 0.5019, 4.33, 0.080, 221, 112, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
2196, 5tpnH, 0.5019, 4.33, 0.128, 229, 109, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH HUMAN ANTIBODY HRSV90
2197, 5tkjJ, 0.5019, 4.38, 0.098, 222, 112, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2198, 4x7sL, 0.5019, 4.17, 0.082, 218, 110, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 1
2199, 4rauB, 0.5019, 4.26, 0.081, 218, 111, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
2200, 3vxsD, 0.5019, 4.29, 0.081, 215, 111, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE
2201, 3mj8B, 0.5019, 4.28, 0.081, 221, 111, CRYSTAL STRUCTURE OF HL4E10 FAB A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS
2202, 3j3oL, 0.5019, 4.33, 0.098, 211, 112, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 160S POLIOVIRUS AND C3-FAB COMPLEX
2203, 2r51A, 0.5019, 4.21, 0.063, 229, 111, CRYSTAL STRUCTURE OF MOUSE VPS26B
2204, 1riuL, 0.5019, 4.19, 0.118, 223, 110, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE
2205, 1l4iA, 0.5019, 4.16, 0.071, 224, 112, CRYSTAL STRUCTURE OF THE PERIPLASMIC CHAPERONE SFAE
2206, 6okqB, 0.5018, 4.08, 0.103, 215, 107, CRYSTAL STRUCTURE OF THE SF12 FAB 
2207, 6b5rH, 0.5018, 4.28, 0.117, 220, 111, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN ANTIBODY CIS42
2208, 6aynB, 0.5018, 4.28, 0.090, 223, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
2209, 6al1H, 0.5018, 4.14, 0.128, 245, 109, THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 181 AND 184 
2210, 5xqwH, 0.5018, 4.27, 0.089, 219, 112, CATALYTIC ANTIBODY 7B9 
2211, 5x2nL, 0.5018, 4.15, 0.082, 218, 110, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2212, 5tkjA, 0.5018, 4.28, 0.128, 220, 109, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2213, 5o2uD, 0.5018, 3.81, 0.075, 585, 106, LLAMA VHH IN COMPLEX WITH P24
2214, 5gguA, 0.5018, 4.28, 0.080, 215, 113, CRYSTAL STRUCTURE OF TREMELIMUMAB FAB
2215, 5bk3B, 0.5018, 4.32, 0.062, 216, 112, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2216, 4rauN, 0.5018, 4.32, 0.062, 216, 112, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
2217, 4m62M, 0.5018, 4.32, 0.062, 216, 112, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
2218, 4gw1B, 0.5018, 4.30, 0.071, 208, 112, CQFD MEDITOPE
2219, 4dp8X, 0.5018, 4.29, 0.071, 222, 113, THE 1.07 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 4.0
2220, 3wihI, 0.5018, 4.29, 0.099, 220, 111, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
2221, 3ikcC, 0.5018, 4.26, 0.081, 218, 111, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
2222, 3hagA, 0.5018, 4.22, 0.072, 221, 111, CRYSTAL STRUCTURE OF THE HEPATITIS E VIRUS-LIKE PARTICLE
2223, 3clfH, 0.5018, 4.30, 0.101, 218, 109, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
2224, 2zzqA, 0.5018, 4.08, 0.085, 210, 106, CRYSTAL STRUCTURE ANALYSIS OF THE HEV CAPSID PROTEIN PORF2
2225, 2oqjE, 0.5018, 4.17, 0.100, 233, 110, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
2226, 1zluH, 0.5018, 4.16, 0.130, 216, 108, FAB 2G12 + MAN5
2227, 1yuhH, 0.5018, 4.37, 0.089, 215, 112, FAB FRAGMENT
2228, 1clzL, 0.5018, 4.38, 0.080, 220, 112, IGG FAB (IGG3 KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
2229, 6qnkB, 0.5017, 4.17, 0.103, 215, 107, ANTIBODY FAB FRAGMENT TARGETING GI PROTEIN HETEROTRIMER 
2230, 6fxnH, 0.5017, 4.14, 0.083, 217, 109, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2231, 6eynL, 0.5017, 4.25, 0.097, 211, 113, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
2232, 6azlB, 0.5017, 4.24, 0.110, 218, 109, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
2233, 6azkD, 0.5017, 4.28, 0.126, 219, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
2234, 6azkB, 0.5017, 4.02, 0.113, 204, 106, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
2235, 4plkL, 0.5017, 4.28, 0.072, 211, 111, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
2236, 4j1uA, 0.5017, 4.33, 0.138, 219, 109, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
2237, 3rfzF, 0.5017, 3.94, 0.109, 283, 101, CRYSTAL STRUCTURE OF THE FIMD USHER BOUND TO ITS COGNATE FIMC:FIMH SUBSTRATE
2238, 2xa8L, 0.5017, 4.13, 0.120, 218, 108, CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A
2239, 2oqjH, 0.5017, 2.92, 0.097, 189, 93, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
2240, 2i5yR, 0.5017, 4.01, 0.085, 210, 106, CRYSTAL STRUCTURE OF CD4M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2241, 1gpoM, 0.5017, 4.18, 0.080, 211, 112, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
2242, 1g9mH, 0.5017, 4.19, 0.080, 220, 112, HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
2243, 6gk7H, 0.5016, 4.27, 0.090, 209, 111, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-27.1; DOUBLE MUTANT (S31Y; T100I) OF CBTAU-27.1; IN COMPLEX WITH TAU PEPTIDE A8119B (RESIDUES 299-318) 
2244, 6fr5A, 0.5016, 4.30, 0.089, 210, 112, HA1.7 TCR STUDY OF CDR LOOP FLEXIBILITY 
2245, 6foeH, 0.5016, 4.26, 0.119, 216, 109, BAXB01 FAB FRAGMENT
2246, 6au5D, 0.5016, 4.15, 0.089, 211, 112, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
2247, 5w23N, 0.5016, 4.18, 0.091, 116, 110, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2248, 5udcH, 0.5016, 4.26, 0.099, 218, 111, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
2249, 5mp5D, 0.5016, 4.20, 0.120, 217, 108, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2250, 5lz0B, 0.5016, 4.28, 0.126, 219, 111, LLAMA NANOBODY PORM_01
2251, 5ikcH, 0.5016, 3.96, 0.086, 113, 105, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
2252, 5f6hI, 0.5016, 4.18, 0.080, 221, 112, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE
2253, 5c7xM, 0.5016, 2.82, 0.124, 99, 89, CRYSTAL STRUCTURE OF MOR04357 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF
2254, 5brzD, 0.5016, 4.27, 0.089, 219, 112, MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1
2255, 4ydvB, 0.5016, 4.30, 0.128, 217, 109, STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS
2256, 4qhuB, 0.5016, 4.24, 0.073, 468, 110, CRYSTAL STRUCTURE OF IL-17A/FAB6785 COMPLEX
2257, 4nryH, 0.5016, 4.18, 0.100, 220, 110, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
2258, 4k3jL, 0.5016, 4.06, 0.056, 483, 108, CRYSTAL STRUCTURE OF ONARTUZUMAB FAB IN COMPLEX WITH MET AND HGF-BETA
2259, 3ulvF, 0.5016, 4.34, 0.072, 224, 111, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
2260, 3t65A, 0.5016, 4.28, 0.072, 221, 111, S25-2- A(2-8)KDO DISACCHARIDE COMPLEX
2261, 3t4yA, 0.5016, 4.33, 0.088, 218, 113, S25-2- KDO MONOSACCHARIDE COMPLEX
2262, 3qpqD, 0.5016, 4.24, 0.130, 219, 108, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
2263, 3pcyA, 0.5016, 4.28, 0.081, 221, 111, THE CRYSTAL STRUCTURE OF MERCURY-SUBSTITUTED POPLAR PLASTOCYANIN AT 1.9-ANGSTROMS RESOLUTION
2264, 3fo1L, 0.5016, 4.46, 0.054, 216, 112, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
2265, 3dggA, 0.5016, 4.30, 0.119, 217, 109, CRYSTAL STRUCTURE OF FABOX108
2266, 2op4H, 0.5016, 4.19, 0.080, 220, 112, CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9
2267, 1fgnH, 0.5016, 4.18, 0.080, 220, 112, MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
2268, 6h7wJ, 0.5015, 4.17, 0.080, 219, 112, MODEL OF RETROMER-VPS5 COMPLEX ASSEMBLED ON MEMBRANE. 
2269, 6ghgA, 0.5015, 4.08, 0.113, 208, 106, VARIABLE HEAVY - VARIABLE LIGHT DOMAIN AND FAB-ARM CROSSMABS WITH CHARGED RESIDUE EXCHANGES 
2270, 6aynD, 0.5015, 4.30, 0.101, 210, 109, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
2271, 5ucbH, 0.5015, 3.10, 0.105, 201, 95, STRUCTURE OF ANTIGEN-FAB COMPLEX WITH ENGINEERED SWITCH RESIDUE REGION.
2272, 5itfB, 0.5015, 4.25, 0.110, 218, 109, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
2273, 5fr2B, 0.5015, 4.33, 0.072, 224, 111, FARNESYLATED RHOA-GDP IN COMPLEX WITH RHOGDI-ALPHA LYSINE ACETYLATED AT K178
2274, 5bmfL, 0.5015, 4.28, 0.071, 223, 112, CRYSTAL STRUCTURE OF A THEOPHYLLINE BINDING ANTIBODY FAB FRAGMENT
2275, 4hijB, 0.5015, 4.09, 0.121, 218, 107, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND L-RHAMNOSE- (1-2)-ALPHA-D-GALACTOSE-(3-O)-PHOSPHATE-2-GLYCEROL
2276, 3ulvH, 0.5015, 4.18, 0.072, 229, 111, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
2277, 3s88H, 0.5015, 4.28, 0.081, 223, 111, CRYSTAL STRUCTURE OF SUDAN EBOLAVIRUS GLYCOPROTEIN (STRAIN GULU) BOUND TO 16F6
2278, 3oklA, 0.5015, 4.20, 0.111, 202, 108, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO
2279, 3kymJ, 0.5015, 4.29, 0.090, 225, 111, CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
2280, 3kr3H, 0.5015, 4.15, 0.081, 220, 111, CRYSTAL STRUCTURE OF IGF-II ANTIBODY COMPLEX
2281, 3f8uB, 0.5015, 4.30, 0.119, 215, 109, TAPASIN/ERP57 HETERODIMER
2282, 2zkhH, 0.5015, 4.25, 0.054, 217, 112, HUMAN THROMBOPOIETIN NEUTRALIZING ANTIBODY TN1 FAB
2283, 2y07H, 0.5015, 4.30, 0.138, 218, 109, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE PPYPAWHAPGNI
2284, 1zglT, 0.5015, 4.04, 0.093, 124, 107, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2285, 1x9rB, 0.5015, 4.22, 0.073, 214, 110, UMECYANIN FROM HORSE RADDISH- CRYSTAL STRUCTURE OF THE OXIDISED FORM
2286, 1q72L, 0.5015, 4.26, 0.072, 210, 111, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
2287, 1bypA, 0.5015, 4.29, 0.081, 213, 111, E43KD44K DOUBLE MUTANT PLASTOCYANIN FROM SILENE
2288, 6mxsB, 0.5014, 4.11, 0.112, 197, 107, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
2289, 6h7wC, 0.5014, 4.50, 0.080, 220, 113, MODEL OF RETROMER-VPS5 COMPLEX ASSEMBLED ON MEMBRANE. 
2290, 6eynC, 0.5014, 4.28, 0.108, 210, 111, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
2291, 6db8H, 0.5014, 4.39, 0.062, 214, 112, STRUCTURAL BASIS FOR PROMISCUOUS BINDING AND ACTIVATION OF FLUOROGENIC DYES BY DIR2S RNA APTAMER 
2292, 5uweH, 0.5014, 4.27, 0.101, 217, 109, CRYSTAL STRUCTURE OF THE ADCC-POTENT; WEAKLY NEUTRALIZING HIV ENV CO- RECEPTOR BINDING SITE ANTIBODY N12-I2 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1 
2293, 5tkjD, 0.5014, 4.34, 0.106, 217, 113, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2294, 5f88D, 0.5014, 4.29, 0.128, 219, 109, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
2295, 5d72M, 0.5014, 4.30, 0.128, 219, 109, CRYSTAL STRUCTURE OF MOR04252 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF
2296, 4f24A, 0.5014, 4.14, 0.108, 218, 111, CRYSTAL STRUCTURES REVEAL THE MULTI-LIGAND BINDING MECHANISM OF THE STAPHYLOCOCCUS AUREUS CLFB
2297, 3u4eH, 0.5014, 2.86, 0.124, 99, 89, CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45
2298, 3t77A, 0.5014, 4.34, 0.128, 216, 109, S25-2- A(2-4)KDO DISACCHARIDE COMPLEX
2299, 3so3C, 0.5014, 4.30, 0.110, 217, 109, STRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON- CANONICAL MECHANISM OF INHIBITION.
2300, 3ijyD, 0.5014, 4.29, 0.071, 217, 113, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
2301, 2v7nB, 0.5014, 4.34, 0.080, 214, 112, UNUSUAL TWINNING IN CRYSTALS OF THE CITS BINDING ANTIBODY FAB FRAGMENT F3P4
2302, 2r56H, 0.5014, 3.75, 0.090, 292, 100, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
2303, 2o5yL, 0.5014, 4.28, 0.090, 217, 111, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX
2304, 1rfdL, 0.5014, 4.19, 0.080, 220, 112, ANTI-COCAINE ANTIBODY M82G2
2305, 1fptL, 0.5014, 4.26, 0.063, 217, 111, THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
2306, 6ghgH, 0.5013, 4.18, 0.080, 217, 112, VARIABLE HEAVY - VARIABLE LIGHT DOMAIN AND FAB-ARM CROSSMABS WITH CHARGED RESIDUE EXCHANGES 
2307, 6fr4A, 0.5013, 3.54, 0.060, 177, 100, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
2308, 5yxnA, 0.5013, 4.31, 0.119, 216, 109, A T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HEPATITIS C VIRUS NS3 PEPTIDE (KLVALGINAV) 
2309, 5w5xH, 0.5013, 4.16, 0.073, 203, 110, CRYSTAL STRUCTURE OF BAXP168G IN COMPLEX WITH AN ACTIVATING ANTIBODY 
2310, 5odbA, 0.5013, 4.30, 0.063, 225, 111, CRYSTAL STRUCTURE OF THE RA-ASSOCIATED MAB D10 (CHIMERIC FAB FRAGMENT) 
2311, 5mp5F, 0.5013, 4.30, 0.099, 220, 111, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2312, 5jueH, 0.5013, 4.29, 0.128, 219, 109, CRYSTAL STRUCTURE OF UIC2 FAB
2313, 5bk3E, 0.5013, 4.26, 0.081, 219, 111, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2314, 4xbgH, 0.5013, 4.29, 0.081, 218, 111, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
2315, 4ocrH, 0.5013, 4.51, 0.077, 361, 117, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.01 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
2316, 4lciH, 0.5013, 4.13, 0.082, 209, 110, ANTI CANINE CD28 ANTIBODY 1C6
2317, 4jo3L, 0.5013, 4.29, 0.080, 215, 113, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
2318, 4gw1D, 0.5013, 4.26, 0.081, 226, 111, CQFD MEDITOPE
2319, 4dpbX, 0.5013, 2.93, 0.151, 104, 93, THE 1.00 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 8.0
2320, 3u4bH, 0.5013, 4.28, 0.119, 218, 109, CH04H/CH02L FAB P4
2321, 3phqA, 0.5013, 2.72, 0.135, 99, 89, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO
2322, 3phoA, 0.5013, 4.22, 0.092, 217, 109, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
2323, 3oazM, 0.5013, 3.75, 0.090, 292, 100, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
2324, 3njkA, 0.5013, 4.31, 0.119, 207, 109, D116A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS AT PH5.5
2325, 3kj6H, 0.5013, 4.23, 0.081, 224, 111, CRYSTAL STRUCTURE OF A METHYLATED BETA2 ADRENERGIC RECEPTOR- FAB COMPLEX
2326, 3jbf7, 0.5013, 4.23, 0.063, 224, 111, COMPLEX OF POLIOVIRUS WITH VHH PVSP19B
2327, 3dggD, 0.5013, 4.25, 0.097, 211, 113, CRYSTAL STRUCTURE OF FABOX108
2328, 2xraH, 0.5013, 4.18, 0.080, 214, 112, CRYSTAL STRUCTURE OF THE HK20 FAB IN COMPLEX WITH A GP41 MIMETIC 5-HELIX
2329, 2gkiB, 0.5013, 4.27, 0.081, 213, 111, HEAVY AND LIGHT CHAIN VARIABLE SINGLE DOMAINS OF AN ANTI-DNA BINDING ANTIBODY HYDROLYZE BOTH DOUBLE- AND SINGLE-STRANDED DNAS WITHOUT SEQUENCE SPECIFICITY
2330, 1zglP, 0.5013, 4.17, 0.083, 334, 109, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2331, 1za3A, 0.5013, 4.16, 0.092, 236, 109, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
2332, 1nd0C, 0.5013, 4.29, 0.128, 219, 109, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
2333, 1nd0A, 0.5013, 4.39, 0.089, 220, 112, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
2334, 1mjuL, 0.5013, 4.25, 0.090, 220, 111, 1.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12
2335, 1gpoL, 0.5013, 4.18, 0.091, 214, 110, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
2336, 1figL, 0.5013, 4.26, 0.090, 221, 111, ROUTES TO CATALYSIS: STRUCTURE OF A CATALYTIC ANTIBODY AND COMPARISON WITH ITS NATURAL COUNTERPART
2337, 1cicB, 0.5013, 4.32, 0.128, 218, 109, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
2338, 6d01A, 0.5012, 4.28, 0.110, 218, 109, CRYSTAL STRUCTURE OF 1210 FAB IN COMPLEX WITH CIRCUMSPOROZOITE PROTEIN NANP5 
2339, 5xf1H, 0.5012, 4.33, 0.128, 219, 109, STRUCTURE OF THE FULL-LENGTH GLUCAGON CLASS B G PROTEIN-COUPLED RECEPTOR
2340, 5xctA, 0.5012, 4.29, 0.090, 211, 111, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
2341, 5xajF, 0.5012, 4.21, 0.111, 202, 108, STRUCTURAL MIMICRY OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN REVEALED BY THE CRYSTALLOGRAPHIC STUDY OF AN IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX.
2342, 5x2nK, 0.5012, 4.22, 0.100, 192, 110, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2343, 5w23L, 0.5012, 4.09, 0.082, 211, 110, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2344, 5ur8B, 0.5012, 4.22, 0.082, 217, 110, HUMAN ANTIBODY FRAGMENT (FAB) TO MENINGOCOCCAL FACTOR H BINDING PROTEIN
2345, 5otjB, 0.5012, 4.30, 0.138, 216, 109, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
2346, 5mp5L, 0.5012, 4.30, 0.098, 225, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2347, 5ir1B, 0.5012, 4.16, 0.091, 218, 110, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
2348, 5i2iD, 0.5012, 4.45, 0.089, 230, 112, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
2349, 5hpmD, 0.5012, 4.19, 0.100, 233, 110, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
2350, 5fuzH, 0.5012, 4.33, 0.062, 120, 112, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
2351, 5eu6D, 0.5012, 4.18, 0.084, 214, 107, HLA CLASS I ANTIGEN
2352, 4uv4H, 0.5012, 4.18, 0.080, 220, 112, CRYSTAL STRUCTURE OF ANTI-FPR FPRO0165 FAB FRAGMENT
2353, 4qciH, 0.5012, 2.84, 0.124, 99, 89, PDGF-B BLOCKING ANTIBODY BOUND TO PDGF-BB
2354, 4oduB, 0.5012, 4.24, 0.081, 227, 111, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
2355, 4lu5M, 0.5012, 4.27, 0.110, 216, 109, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
2356, 4hxaH, 0.5012, 4.17, 0.120, 216, 108, CRYSTAL STRUCTURE OF 13D9 FAB
2357, 4hieB, 0.5012, 4.31, 0.072, 214, 111, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102
2358, 4ffzY, 0.5012, 3.65, 0.112, 122, 98, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
2359, 4alaH, 0.5012, 4.28, 0.090, 217, 111, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
2360, 3rifJ, 0.5012, 3.98, 0.083, 123, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2361, 3kymB, 0.5012, 4.35, 0.080, 215, 113, CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
2362, 3kj4B, 0.5012, 4.27, 0.072, 223, 111, STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY
2363, 3ikcB, 0.5012, 4.31, 0.119, 238, 109, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
2364, 3ijsC, 0.5012, 4.25, 0.081, 242, 111, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
2365, 2z4qA, 0.5012, 4.14, 0.103, 213, 107, CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
2366, 2xzqH, 0.5012, 4.38, 0.119, 219, 109, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE YQLRPNAETLRF
2367, 2oslA, 0.5012, 4.38, 0.119, 219, 109, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
2368, 2n80B, 0.5012, 4.12, 0.103, 219, 107, P75NTR DD:RHOGDI
2369, 2cdeD, 0.5012, 4.17, 0.130, 216, 108, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
2370, 1qygL, 0.5012, 3.97, 0.113, 215, 106, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
2371, 1ngwB, 0.5012, 4.31, 0.088, 217, 113, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
2372, 6pcyA, 0.5011, 4.30, 0.099, 220, 111, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
2373, 6okqC, 0.5011, 4.25, 0.090, 231, 111, CRYSTAL STRUCTURE OF THE SF12 FAB 
2374, 6jmqD, 0.5011, 4.26, 0.054, 167, 111, LAT1-CD98HC COMPLEX BOUND TO MEM-108 FAB 
2375, 6jjdA, 0.5011, 4.44, 0.071, 213, 112, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) FULL VLP 
2376, 6hkgC, 0.5011, 4.27, 0.119, 216, 109, STRUCTURE OF FISW84 FAB FRAGMENT 
2377, 6eh4D, 0.5011, 4.27, 0.119, 216, 109, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
2378, 6dl8H, 0.5011, 4.10, 0.112, 215, 107, CRYSTAL STRUCTURE OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB VARIANT CH67:1203D4 CHIMERA 
2379, 6cugD, 0.5011, 4.34, 0.089, 222, 112, CRYSTAL STRUCTURE OF BC8B TCR-CD1B-PC COMPLEX 
2380, 6azlD, 0.5011, 4.30, 0.138, 218, 109, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
2381, 6au5B, 0.5011, 4.18, 0.080, 220, 112, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
2382, 5y2kG, 0.5011, 4.18, 0.080, 216, 112, A HUMAN ANTIBODY AF4H1L1 
2383, 5xhvQ, 0.5011, 4.16, 0.080, 214, 112, CRYSTAL STRUCTURE OF FAB S40 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ HA1 SUBUNIT.
2384, 5tq2H, 0.5011, 4.27, 0.108, 222, 111, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN COMPLEX WITH ZINC AT GLUN1 AND GLUN2A
2385, 5tkjG, 0.5011, 4.21, 0.102, 204, 108, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2386, 5myxA, 0.5011, 4.25, 0.090, 229, 111, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 24 IN COMPLEX WITH HUMAN ABETA-PE3-18
2387, 5mvjF, 0.5011, 4.29, 0.099, 204, 111, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2388, 4ww2A, 0.5011, 4.14, 0.103, 212, 107, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 BETA CHAIN- TRBV7-8 ANTIGEN-PRESENTING GLYCOPROTEIN CD1D AND BETA-2- MICROGLOBULIN
2389, 4u6hC, 0.5011, 4.33, 0.128, 219, 109, VACCINIA L1/M12B9-FAB COMPLEX
2390, 4s2sA, 0.5011, 4.48, 0.088, 221, 113, CRYSTAL STRUCTURE OF FAB FRAGMENT OF MONOCLONAL ANTIBODY ROAB13
2391, 4qhmE, 0.5011, 4.25, 0.072, 206, 111, I3.1 (UNBOUND) FROM CH103 LINEAGE
2392, 4ffvH, 0.5011, 4.30, 0.119, 216, 109, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH 11A19 FAB
2393, 3vxqD, 0.5011, 4.31, 0.071, 208, 113, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
2394, 3rifG, 0.5011, 4.19, 0.090, 200, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2395, 3qumC, 0.5011, 4.29, 0.081, 220, 111, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
2396, 3o2dL, 0.5011, 4.36, 0.128, 219, 109, CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
2397, 3lqaH, 0.5011, 4.32, 0.080, 221, 112, CRYSTAL STRUCTURE OF CLADE C GP120 IN COMPLEX WITH SCD4 AND 21C FAB
2398, 3hr5L, 0.5011, 4.31, 0.128, 216, 109, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
2399, 3h42H, 0.5011, 4.32, 0.138, 219, 109, CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH FAB FROM LDLR COMPETITIVE ANTIBODY
2400, 3cviH, 0.5011, 4.28, 0.088, 215, 113, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
2401, 1f4wH, 0.5011, 4.30, 0.080, 221, 112, CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
2402, 6gk7L, 0.5010, 3.61, 0.110, 174, 100, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-27.1; DOUBLE MUTANT (S31Y; T100I) OF CBTAU-27.1; IN COMPLEX WITH TAU PEPTIDE A8119B (RESIDUES 299-318) 
2403, 6fn4C, 0.5010, 4.30, 0.073, 244, 110, APO FORM OF UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
2404, 6dcvA, 0.5010, 4.28, 0.110, 218, 109, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2405, 5uddK, 0.5010, 4.35, 0.062, 216, 112, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2406, 5occH, 0.5010, 2.87, 0.124, 99, 89, CRYSTAL STRUCTURE OF CD32B (FC GAMMA RECEPTOR IIB) IN COMPLEX WITH HUMAN IGG1 FAB FRAGMENT (6G08) 
2407, 5ocaH, 0.5010, 4.02, 0.094, 210, 106, PCSK9:FAB COMPLEX WITH DEXTRAN SULFATE
2408, 5mvjB, 0.5010, 4.26, 0.101, 219, 109, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2409, 5mp1K, 0.5010, 3.85, 0.067, 193, 105, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2410, 5mhrN, 0.5010, 4.26, 0.063, 194, 111, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2411, 4zffB, 0.5010, 4.21, 0.111, 204, 108, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
2412, 4zffA, 0.5010, 4.29, 0.045, 216, 111, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
2413, 4tnvX, 0.5010, 4.14, 0.102, 186, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2414, 4plkK, 0.5010, 4.18, 0.080, 215, 112, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
2415, 4mxvE, 0.5010, 4.18, 0.080, 220, 112, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
2416, 4lqfH, 0.5010, 4.29, 0.081, 220, 111, STRUCTURE OF MURINE IGG2B A2C7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.3 ANGSTROMS
2417, 4ioiB, 0.5010, 4.01, 0.104, 214, 106, MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC
2418, 3u36E, 0.5010, 4.30, 0.089, 205, 112, CRYSTAL STRUCTURE OF PG9 FAB
2419, 3oayM, 0.5010, 4.16, 0.089, 208, 112, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
2420, 3au0A, 0.5010, 4.19, 0.130, 219, 108, STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF CLFB:LIGAND INTERACTIONS
2421, 2r2bA, 0.5010, 4.30, 0.138, 218, 109, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2422, 2r1yA, 0.5010, 4.18, 0.102, 203, 108, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2423, 2nz9C, 0.5010, 4.07, 0.082, 217, 110, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
2424, 1rivL, 0.5010, 4.29, 0.117, 219, 111, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META- OXYBENZOYLECGONINE
2425, 1pncA, 0.5010, 4.21, 0.064, 217, 110, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: TWO INDEPENDENT REFINEMENTS OF THE STRUCTURE OF POPLAR PLASTOCYANIN AT 173K
2426, 1ngwH, 0.5010, 4.34, 0.071, 209, 112, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
2427, 8fabB, 0.5009, 4.07, 0.103, 204, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE HUMAN MYELOMA IMMUNOGLOBULIN IGG HIL AT 1.8 ANGSTROMS RESOLUTION
2428, 6dtkC, 0.5009, 4.19, 0.090, 214, 111, HETERODIMERS OF FALS MUTANT SOD ENZYME 
2429, 6dcwL, 0.5009, 4.31, 0.119, 218, 109, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 FAB IN COMPLEX WITH A HUMAN TAU PEPTIDE 
2430, 6axpB, 0.5009, 4.30, 0.128, 216, 109, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
2431, 5wuxH, 0.5009, 4.04, 0.072, 225, 111, TNFALPHA-CERTOLIZUMAB FAB
2432, 5swzT, 0.5009, 4.30, 0.110, 219, 109, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2433, 5mp5B, 0.5009, 4.26, 0.090, 221, 111, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2434, 5mp1L, 0.5009, 4.16, 0.073, 213, 110, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2435, 5drzL, 0.5009, 4.32, 0.099, 216, 111, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
2436, 5bk3H, 0.5009, 4.17, 0.102, 216, 108, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2437, 5bjzD, 0.5009, 4.32, 0.088, 225, 113, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ALLOSTERIC SYNTHETIC ANTIBODY
2438, 5aumH, 0.5009, 4.28, 0.110, 220, 109, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
2439, 4tnvW, 0.5009, 4.34, 0.053, 220, 113, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2440, 4r7nB, 0.5009, 4.27, 0.071, 222, 112, FAB C2E3
2441, 4n8cH, 0.5009, 4.25, 0.090, 219, 111, THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS
2442, 4hgwA, 0.5009, 4.31, 0.138, 218, 109, CRYSTAL STRUCTURE OF S25-2 IN COMPLEX WITH A 56-DEHYDRO-KDO DISACCHARIDE
2443, 3vfgL, 0.5009, 4.16, 0.139, 218, 108, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
2444, 3u36H, 0.5009, 4.27, 0.062, 214, 113, CRYSTAL STRUCTURE OF PG9 FAB
2445, 3u36C, 0.5009, 4.14, 0.103, 210, 107, CRYSTAL STRUCTURE OF PG9 FAB
2446, 3u36A, 0.5009, 4.19, 0.081, 206, 111, CRYSTAL STRUCTURE OF PG9 FAB
2447, 3sy0A, 0.5009, 4.20, 0.080, 224, 112, S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX
2448, 2r1xA, 0.5009, 4.07, 0.113, 208, 106, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2449, 2r1wA, 0.5009, 4.03, 0.113, 211, 106, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2450, 2jixL, 0.5009, 4.29, 0.099, 212, 111, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
2451, 2hrpN, 0.5009, 4.26, 0.072, 220, 111, ANTIGEN-ANTIBODY COMPLEX
2452, 2adiB, 0.5009, 4.18, 0.092, 215, 109, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM
2453, 1ztxH, 0.5009, 4.32, 0.072, 218, 111, WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB
2454, 1pndA, 0.5009, 4.26, 0.082, 339, 110, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: TWO INDEPENDENT REFINEMENTS OF THE STRUCTURE OF POPLAR PLASTOCYANIN AT 173K
2455, 1nsnH, 0.5009, 4.30, 0.128, 217, 109, THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION
2456, 1fl6A, 0.5009, 4.31, 0.128, 217, 109, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
2457, 6n4qL, 0.5008, 4.20, 0.083, 216, 108, CRYOEM STRUCTURE OF NAV1.7 VSD2 (ACTIVED STATE) IN COMPLEX WITH THE GATING MODIFIER TOXIN PROTX2 
2458, 6n4qJ, 0.5008, 4.28, 0.110, 218, 109, CRYOEM STRUCTURE OF NAV1.7 VSD2 (ACTIVED STATE) IN COMPLEX WITH THE GATING MODIFIER TOXIN PROTX2 
2459, 6fr3A, 0.5008, 2.84, 0.124, 99, 89, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
2460, 6flaB, 0.5008, 4.35, 0.062, 216, 112, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
2461, 5yxuA, 0.5008, 4.30, 0.080, 214, 112, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
2462, 5swzO, 0.5008, 4.69, 0.069, 311, 116, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2463, 5swzE, 0.5008, 4.29, 0.110, 219, 109, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2464, 5nb5M, 0.5008, 4.20, 0.080, 220, 112, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
2465, 5mp3B, 0.5008, 4.33, 0.062, 212, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
2466, 5h35A, 0.5008, 4.16, 0.120, 239, 108, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
2467, 5eukB, 0.5008, 4.30, 0.138, 217, 109, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
2468, 4z7uE, 0.5008, 4.32, 0.138, 218, 109, S13 COMPLEX
2469, 4xhjG, 0.5008, 4.32, 0.092, 216, 109, GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.
2470, 4q6iL, 0.5008, 4.38, 0.089, 219, 112, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2471, 4nkiH, 0.5008, 4.23, 0.072, 231, 111, CRYSTAL STRUCTURE OF A FAB
2472, 3vxrD, 0.5008, 4.21, 0.082, 208, 110, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE
2473, 3tt3L, 0.5008, 4.20, 0.080, 224, 112, CRYSTAL STRUCTURE OF LEUT IN THE INWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
2474, 3okmA, 0.5008, 4.06, 0.113, 211, 106, CRYSTAL STRUCTURE OF UNLIGANDED S25-39
2475, 3ma9H, 0.5008, 4.34, 0.080, 220, 112, CRYSTAL STRUCTURE OF GP41 DERIVED PROTEIN COMPLEXED WITH FAB 8066
2476, 3ijhC, 0.5008, 4.31, 0.128, 217, 109, STRUCTURE OF S67-27 IN COMPLEX WITH KO
2477, 2r0kH, 0.5008, 3.98, 0.114, 211, 105, PROTEASE DOMAIN OF HGFA WITH INHIBITOR FAB58
2478, 2nyyC, 0.5008, 4.18, 0.092, 216, 109, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
2479, 2fl5F, 0.5008, 4.18, 0.092, 216, 109, COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
2480, 1qblH, 0.5008, 4.18, 0.092, 216, 109, FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
2481, 1nl0H, 0.5008, 4.30, 0.128, 219, 109, CRYSTAL STRUCTURE OF HUMAN FACTOR IX GLA DOMAIN IN COMPLEX OF AN INHIBITORY ANTIBODY 10C12
2482, 1nccH, 0.5008, 4.30, 0.128, 219, 109, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
2483, 1fl6L, 0.5008, 4.31, 0.128, 216, 109, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
2484, 6flcH, 0.5007, 4.12, 0.103, 214, 107, 2C8 FAB BOUND TO EDIII OF DENV 2 
2485, 6flaL, 0.5007, 4.36, 0.080, 224, 112, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
2486, 6eleA, 0.5007, 4.14, 0.100, 214, 110, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
2487, 6eh5A, 0.5007, 4.39, 0.062, 219, 113, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
2488, 6dc7L, 0.5007, 2.84, 0.124, 99, 89, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
2489, 5vnwC, 0.5007, 4.18, 0.063, 210, 111, CRYSTAL STRUCTURE OF NB.B201 BOUND TO HUMAN SERUM ALBUMIN
2490, 5th2D, 0.5007, 4.24, 0.139, 217, 108, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
2491, 5mvjD, 0.5007, 4.40, 0.088, 228, 113, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2492, 5drzA, 0.5007, 4.40, 0.088, 228, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
2493, 4ydvH, 0.5007, 4.21, 0.111, 202, 108, STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS
2494, 4xpgH, 0.5007, 4.17, 0.120, 216, 108, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO BETA-CFT OR WIN35428
2495, 4n8cI, 0.5007, 4.28, 0.100, 191, 110, THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS
2496, 3ztjI, 0.5007, 4.14, 0.120, 241, 108, STRUCTURE OF INFLUENZA A NEUTRALIZING ANTIBODY SELECTED FROM CULTURES OF SINGLE HUMAN PLASMA CELLS IN COMPLEX WITH HUMAN H3 INFLUENZA HAEMAGGLUTININ.
2497, 3okkA, 0.5007, 4.16, 0.120, 240, 108, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO
2498, 3macH, 0.5007, 4.31, 0.119, 218, 109, CRYSTAL STRUCTURE OF GP41-DERIVED PROTEIN COMPLEXED WITH FAB 8062
2499, 3kykH, 0.5007, 4.30, 0.138, 218, 109, CRYSTAL STRUCTURE OF LI33 IGG1 FAB
2500, 3hr5Q, 0.5007, 4.26, 0.099, 219, 111, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
2501, 3hi6X, 0.5007, 4.20, 0.080, 220, 112, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
2502, 3gi8H, 0.5007, 3.89, 0.125, 198, 104, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
2503, 3bpcA, 0.5007, 4.19, 0.084, 196, 107, CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4- EPI-23-DEHYDRO KDO (4.8) KDO
2504, 2oqjB, 0.5007, 4.18, 0.139, 218, 108, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
2505, 1ws8B, 0.5007, 4.30, 0.081, 221, 111, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
2506, 1lcsB, 0.5007, 4.17, 0.102, 194, 108, RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS
2507, 1iqwH, 0.5007, 4.28, 0.119, 216, 109, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A
2508, 1gc1H, 0.5007, 4.31, 0.128, 215, 109, HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
2509, 6attL, 0.5006, 4.15, 0.073, 214, 109, 39S FAB BOUND TO HER2 ECD 
2510, 5x2mK, 0.5006, 4.31, 0.147, 217, 109, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
2511, 5mp1D, 0.5006, 4.23, 0.091, 213, 110, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2512, 5jo5H, 0.5006, 4.18, 0.093, 216, 108, CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.
2513, 5iczB, 0.5006, 4.30, 0.099, 220, 111, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
2514, 4zfgL, 0.5006, 4.38, 0.080, 219, 112, DUAL-SPECIFICITY FAB 5A12 IN COMPLEX WITH ANGIOPOIETIN 2
2515, 4xpaH, 0.5006, 4.27, 0.108, 216, 111, X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO 3 4DICHLOROPHENETHYLAMINE
2516, 4qhmG, 0.5006, 4.29, 0.054, 221, 112, I3.1 (UNBOUND) FROM CH103 LINEAGE
2517, 4m61A, 0.5006, 4.25, 0.130, 217, 108, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
2518, 4jreB, 0.5006, 4.30, 0.080, 216, 112, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
2519, 4isvB, 0.5006, 4.19, 0.120, 216, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2 A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE
2520, 3g6aH, 0.5006, 4.29, 0.090, 211, 111, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY CNTO607
2521, 2xraL, 0.5006, 4.21, 0.111, 202, 108, CRYSTAL STRUCTURE OF THE HK20 FAB IN COMPLEX WITH A GP41 MIMETIC 5-HELIX
2522, 2fl5D, 0.5006, 4.30, 0.147, 218, 109, COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
2523, 1tkwA, 0.5006, 4.18, 0.082, 120, 110, THE TRANSIENT COMPLEX OF POPLAR PLASTOCYANIN WITH TURNIP CYTOCHROME F DETERMINED WITH PARAMAGNETIC NMR
2524, 1plcA, 0.5006, 4.19, 0.080, 220, 112, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: RESTRAINED LEAST-SQUARES REFINEMENT OF THE CRYSTAL STRUCTURE OF POPLAR PLASTOCYANIN AT 1.33 ANGSTROMS RESOLUTION
2525, 1nd0E, 0.5006, 4.22, 0.139, 218, 108, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
2526, 1igjD, 0.5006, 4.32, 0.092, 218, 109, 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
2527, 6jjcB, 0.5005, 4.50, 0.080, 220, 113, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) SEMI-EMPTY VLP 
2528, 6eluH, 0.5005, 4.37, 0.107, 214, 112, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
2529, 6e0cM, 0.5005, 4.31, 0.080, 221, 112, CRYO-EM STRUCTURE OF THE CENP-A NUCLEOSOME (W601) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
2530, 6dtkE, 0.5005, 4.19, 0.100, 226, 110, HETERODIMERS OF FALS MUTANT SOD ENZYME 
2531, 6co3H, 0.5005, 4.30, 0.128, 220, 109, ADUCANUMAB ABETA COMPLEX 
2532, 5x2pL, 0.5005, 4.22, 0.063, 218, 111, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
2533, 5udcE, 0.5005, 4.24, 0.081, 220, 111, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
2534, 5t1mD, 0.5005, 4.31, 0.110, 219, 109, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
2535, 5mu2J, 0.5005, 4.32, 0.081, 217, 111, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2536, 5ivzD, 0.5005, 4.24, 0.072, 220, 111, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
2537, 5iv2D, 0.5005, 4.31, 0.128, 216, 109, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
2538, 5i2iB, 0.5005, 4.34, 0.072, 224, 111, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
2539, 5hpmB, 0.5005, 2.99, 0.096, 103, 94, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
2540, 5h35H, 0.5005, 4.70, 0.075, 205, 120, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
2541, 5dlmL, 0.5005, 4.32, 0.071, 221, 112, COMPLEX OF INFLUENZA M2E AND ANTIBODY
2542, 4u6hA, 0.5005, 4.21, 0.072, 229, 111, VACCINIA L1/M12B9-FAB COMPLEX
2543, 4tnwY, 0.5005, 4.30, 0.119, 220, 109, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2544, 4rgnD, 0.5005, 4.27, 0.119, 216, 109, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2545, 4r7nT, 0.5005, 4.19, 0.139, 218, 108, FAB C2E3
2546, 4r7nD, 0.5005, 4.22, 0.081, 221, 111, FAB C2E3
2547, 4pcyA, 0.5005, 4.19, 0.080, 216, 112, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
2548, 4kzeH, 0.5005, 4.05, 0.094, 213, 106, CRYSTAL STRUCTURE OF AN RNA APTAMER IN COMPLEX WITH FAB
2549, 4kuzL, 0.5005, 4.36, 0.107, 219, 112, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM
2550, 4k8rD, 0.5005, 4.20, 0.064, 217, 110, AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
2551, 4jo4M, 0.5005, 4.10, 0.131, 219, 107, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
2552, 4gw5B, 0.5005, 4.20, 0.081, 213, 111, CQYN MEDITOPE - CETUXIMAB FAB
2553, 4g5zH, 0.5005, 4.32, 0.090, 212, 111, CRYSTAL STRUCTURE OF THE THERAPEUTICAL ANTIBODY FRAGMENT OF CANAKINUMAB IN ITS UNBOUND STATE
2554, 3vrlE, 0.5005, 4.31, 0.090, 222, 111, CRYSTAL STRUCTURE OF BMJ4 P24 CAPSID PROTEIN IN COMPLEX WITH A10F9 FAB
2555, 3s37H, 0.5005, 4.19, 0.103, 215, 107, STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
2556, 3lrsA, 0.5005, 4.29, 0.099, 220, 111, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
2557, 3ijsD, 0.5005, 2.84, 0.124, 99, 89, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
2558, 2r23A, 0.5005, 2.88, 0.124, 99, 89, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
2559, 2ig2H, 0.5005, 4.39, 0.119, 219, 109, DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L- KETTE LAMBDA-TYP SUBGRUPPE I (GERMAN)
2560, 1q72H, 0.5005, 4.15, 0.055, 217, 110, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
2561, 1e4xH, 0.5005, 3.87, 0.067, 193, 104, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
2562, 6erxD, 0.5004, 4.33, 0.071, 222, 112, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2563, 5u5mB, 0.5004, 4.09, 0.083, 229, 109, CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO- MEDITOPE
2564, 5tlkD, 0.5004, 4.73, 0.069, 313, 116, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
2565, 5tlkA, 0.5004, 4.28, 0.108, 218, 111, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
2566, 5t1lB, 0.5004, 4.27, 0.128, 217, 109, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
2567, 5nyxN, 0.5004, 4.34, 0.053, 220, 113, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
2568, 5mvjL, 0.5004, 4.09, 0.082, 215, 110, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2569, 5mu2N, 0.5004, 4.31, 0.119, 218, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2570, 5js9E, 0.5004, 4.19, 0.080, 213, 112, UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128
2571, 5icxD, 0.5004, 4.19, 0.080, 214, 112, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
2572, 5f88B, 0.5004, 4.19, 0.080, 220, 112, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
2573, 5d4kB, 0.5004, 4.19, 0.080, 216, 112, CRYSTAL STRUCTURE OF THE HUMAN POLYMERIC IG RECEPTOR (PIGR) ECTODOMAIN
2574, 5cckH, 0.5004, 4.25, 0.099, 220, 111, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC315 FAB
2575, 5bk5G, 0.5004, 4.35, 0.138, 217, 109, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
2576, 4zsoB, 0.5004, 4.17, 0.081, 217, 111, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
2577, 4rgnF, 0.5004, 4.22, 0.080, 221, 112, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2578, 4q6iA, 0.5004, 4.17, 0.082, 210, 110, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2579, 4j1uE, 0.5004, 4.06, 0.113, 211, 106, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
2580, 4hzlH, 0.5004, 4.03, 0.113, 211, 106, NEUTRALIZING ANTIBODY MAB 8 IN COMPLEX WITH THE EPITOPE II OF HCV E2 ENVELOPE PROTEIN
2581, 4hijD, 0.5004, 2.73, 0.136, 99, 88, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND L-RHAMNOSE- (1-2)-ALPHA-D-GALACTOSE-(3-O)-PHOSPHATE-2-GLYCEROL
2582, 4dpaX, 0.5004, 4.28, 0.081, 225, 111, THE 1.05 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 6.0
2583, 4dp7X, 0.5004, 4.30, 0.119, 216, 109, THE 1.08 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 4.0
2584, 3wiiI, 0.5004, 4.13, 0.073, 229, 109, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
2585, 3wiiH, 0.5004, 4.22, 0.084, 214, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
2586, 3skjH, 0.5004, 4.20, 0.080, 216, 112, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY
2587, 3rifH, 0.5004, 4.28, 0.108, 218, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2588, 3rgvA, 0.5004, 4.30, 0.108, 222, 111, A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS
2589, 3qq9L, 0.5004, 4.20, 0.091, 209, 110, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
2590, 3okdA, 0.5004, 4.33, 0.071, 221, 113, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO
2591, 3bn9F, 0.5004, 4.24, 0.081, 221, 111, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
2592, 2ojzI, 0.5004, 4.31, 0.128, 217, 109, ANTI-DNA ANTIBODY ED10
2593, 1yymH, 0.5004, 4.22, 0.090, 238, 111, CRYSTAL STRUCTURE OF F23 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2594, 1xcqA, 0.5004, 4.24, 0.090, 220, 111, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
2595, 1wicA, 0.5004, 4.30, 0.089, 216, 112, SOLUTION STRUCTURE OF THE MSP DOMAIN OF RIKEN CDNA 6030424E15
2596, 1q9oC, 0.5004, 4.37, 0.053, 215, 113, S45-18 FAB UNLIGANDED
2597, 1e4wH, 0.5004, 4.27, 0.072, 223, 111, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
2598, 1cbvH, 0.5004, 4.21, 0.091, 211, 110, AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE- DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE- FAB COMPLEX
2599, 6oz6F, 0.5003, 4.31, 0.119, 215, 109, CRYSTAL STRUCTURE OF MRAY BOUND TO 3 -HYDROXYMUREIDOMYCIN A 
2600, 6nz7L, 0.5003, 4.11, 0.081, 215, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 429 B01 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968 
2601, 6k7oL, 0.5003, 4.20, 0.093, 210, 107, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
2602, 6jbtH, 0.5003, 4.30, 0.138, 219, 109, COMPLEX STRUCTURE OF TORIPALIMAB-FAB AND PD-1 
2603, 6fxnO, 0.5003, 4.31, 0.119, 218, 109, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2604, 6eyoI, 0.5003, 4.18, 0.071, 224, 112, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
2605, 6ea7Q, 0.5003, 4.18, 0.080, 212, 112, STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
2606, 6didH, 0.5003, 4.19, 0.080, 216, 112, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
2607, 6didE, 0.5003, 3.77, 0.075, 536, 107, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
2608, 6didC, 0.5003, 4.07, 0.074, 224, 108, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
2609, 6cjkC, 0.5003, 4.06, 0.121, 217, 107, ANTI HIV FAB 10A 
2610, 6avnH, 0.5003, 4.26, 0.080, 218, 113, CRYSTAL STRUCTURE OF UNBOUND ANTI-HIV ANTIBODY FAB PGV19 AT 2.5 A 
2611, 5xf1C, 0.5003, 4.17, 0.082, 210, 110, STRUCTURE OF THE FULL-LENGTH GLUCAGON CLASS B G PROTEIN-COUPLED RECEPTOR
2612, 5mhrR, 0.5003, 4.16, 0.139, 218, 108, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2613, 5kvfL, 0.5003, 4.24, 0.111, 214, 108, ZIKA SPECIFIC ANTIBODY ZV-64 BOUND TO ZIKA ENVELOPE DIII
2614, 5id1B, 0.5003, 4.31, 0.108, 217, 111, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
2615, 5iczD, 0.5003, 4.28, 0.072, 202, 111, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
2616, 5i30H, 0.5003, 2.84, 0.124, 99, 89, CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 NEUTRALIZING MONOCLONAL ANTIBODY PL-2 FAB FRAGMENT AT 1.9 A RESOLUTION
2617, 4utaI, 0.5003, 2.88, 0.124, 99, 89, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8
2618, 3riaJ, 0.5003, 4.29, 0.080, 220, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2619, 3rhwJ, 0.5003, 4.28, 0.089, 220, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2620, 3fzuL, 0.5003, 4.29, 0.108, 228, 111, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
2621, 2y5tB, 0.5003, 4.22, 0.080, 221, 112, CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE
2622, 2vq1A, 0.5003, 4.16, 0.130, 200, 108, ANTI TRIMERIC LEWIS X FAB54-5C10-A
2623, 2pcpA, 0.5003, 4.30, 0.128, 217, 109, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
2624, 2nr6F, 0.5003, 4.30, 0.128, 219, 109, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2625, 2gsiG, 0.5003, 4.30, 0.090, 224, 111, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
2626, 1ws8C, 0.5003, 4.28, 0.071, 216, 112, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
2627, 1qygH, 0.5003, 4.27, 0.072, 229, 111, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
2628, 1hh4E, 0.5003, 4.28, 0.119, 220, 109, RAC1-RHOGDI COMPLEX INVOLVED IN NADPH OXIDASE ACTIVATION
2629, 1deeD, 0.5003, 3.61, 0.061, 152, 98, CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
2630, 1bz7B, 0.5003, 4.30, 0.128, 219, 109, FAB FRAGMENT FROM MURINE ASCITES
2631, 1aj7H, 0.5003, 4.33, 0.089, 213, 112, IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
2632, 6qeeC, 0.5002, 4.45, 0.088, 219, 113, NANODISC RECONSTITUTED HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)-EQ MUTANT IN COMPLEX WITH UIC2 FAB AND ZOSUQUIDAR. 
2633, 6my5L, 0.5002, 4.04, 0.084, 126, 107, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M;LC-S30BR] 
2634, 6ii4H, 0.5002, 3.97, 0.104, 214, 106, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L4A-14 
2635, 6eqbE, 0.5002, 4.04, 0.113, 218, 106, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN 
2636, 6e4zH, 0.5002, 4.11, 0.055, 217, 110, ANTI-PCSK9 FAB 6E2 BOUND TO THE MODIFIED N-TERMINAL PEPTIDE FROM PCSK9 
2637, 6d11A, 0.5002, 4.39, 0.053, 215, 113, CRYSTAL STRUCTURE OF 1450 FAB IN COMPLEX WITH CIRCUMSPOROZOITE PROTEIN NANP5 
2638, 6a3wD, 0.5002, 3.98, 0.083, 208, 109, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
2639, 5yxnB, 0.5002, 4.21, 0.071, 222, 113, A T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HEPATITIS C VIRUS NS3 PEPTIDE (KLVALGINAV) 
2640, 5y2mI, 0.5002, 4.12, 0.103, 217, 107, CRYSTAL STRUCTURE OF A GROUP 2 HA BINDING ANTIBODY AF4H1K1 FAB IN COMPLEX WITH THE H4N6 DUCK ISOLATE (H4-CZ/56) HEMAGGLUTININ 
2641, 5y2kC, 0.5002, 4.12, 0.103, 217, 107, A HUMAN ANTIBODY AF4H1L1 
2642, 5x2oK, 0.5002, 4.12, 0.103, 217, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
2643, 5wdfH, 0.5002, 4.12, 0.103, 217, 107, CRYSTAL STRUCTURE OF 10E8V4-5R+100CF FAB IN COMPLEX WITH HIV-1 GP41 PEPTIDE
2644, 5vkhA, 0.5002, 4.29, 0.073, 221, 110, CLOSED CONFORMATION OF KCSA Y82A-F103A MUTANT
2645, 5uddN, 0.5002, 4.25, 0.090, 231, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2646, 5mv4B, 0.5002, 4.28, 0.062, 213, 113, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2647, 5mu2B, 0.5002, 4.29, 0.138, 220, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2648, 5mp3L, 0.5002, 4.20, 0.080, 214, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
2649, 5jo5A, 0.5002, 4.18, 0.080, 213, 112, CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.
2650, 5hyqD, 0.5002, 4.17, 0.080, 212, 112, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
2651, 5ff6D, 0.5002, 4.22, 0.091, 211, 110, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
2652, 5cjoH, 0.5002, 4.20, 0.090, 215, 111, CRYSTAL STRUCTURE ANALYSIS OF ELBOW-ENGINEERED-FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN
2653, 5bk3L, 0.5002, 4.20, 0.090, 215, 111, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2654, 4zffH, 0.5002, 4.17, 0.103, 213, 107, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
2655, 4tnwJ, 0.5002, 4.29, 0.128, 218, 109, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2656, 4r7nF, 0.5002, 4.23, 0.111, 216, 108, FAB C2E3
2657, 4r7dB, 0.5002, 4.32, 0.128, 216, 109, FAB HU 15C1
2658, 4qciB, 0.5002, 4.35, 0.071, 213, 112, PDGF-B BLOCKING ANTIBODY BOUND TO PDGF-BB
2659, 4q6iF, 0.5002, 4.15, 0.111, 215, 108, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2660, 4q6iD, 0.5002, 3.02, 0.085, 103, 94, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2661, 4nkoA, 0.5002, 4.25, 0.090, 220, 111, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
2662, 4nbzB, 0.5002, 3.89, 0.097, 180, 103, CRYSTAL STRUCTURE OF TCDA-A1 BOUND TO A26.8 VHH
2663, 4hs6A, 0.5002, 4.30, 0.081, 223, 111, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
2664, 4hihB, 0.5002, 4.25, 0.081, 217, 111, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE.
2665, 4fqlH, 0.5002, 4.39, 0.088, 217, 113, INFLUENZA B HA ANTIBODY (FAB) CR8033
2666, 3ob0H, 0.5002, 4.29, 0.088, 225, 113, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
2667, 3hr5P, 0.5002, 4.23, 0.092, 218, 109, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
2668, 2oqjK, 0.5002, 4.34, 0.099, 220, 111, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
2669, 1zlsH, 0.5002, 4.14, 0.119, 244, 109, FAB 2G12 + MAN4
2670, 1s5hB, 0.5002, 4.28, 0.064, 208, 110, POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
2671, 1deeF, 0.5002, 4.21, 0.082, 216, 110, CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY
2672, 1byoA, 0.5002, 4.31, 0.055, 116, 109, WILD-TYPE PLASTOCYANIN FROM SILENE
2673, 1ahwD, 0.5002, 4.13, 0.093, 241, 108, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2674, 1a6uH, 0.5002, 4.29, 0.081, 224, 111, B1-8 FV FRAGMENT
2675, 6oz6E, 0.5001, 4.28, 0.081, 216, 111, CRYSTAL STRUCTURE OF MRAY BOUND TO 3 -HYDROXYMUREIDOMYCIN A 
2676, 6mv5H, 0.5001, 4.27, 0.128, 216, 109, ANTI-PCSK9 FAB 6E2 BOUND TO THE N-TERMINAL PEPTIDE FROM PCSK9 (E32K) 
2677, 5x2nH, 0.5001, 4.29, 0.089, 209, 112, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2678, 5mv4J, 0.5001, 4.40, 0.071, 219, 113, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2679, 5iopB, 0.5001, 4.26, 0.062, 221, 112, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
2680, 5icxB, 0.5001, 4.31, 0.119, 217, 109, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
2681, 5hj3M, 0.5001, 4.31, 0.119, 218, 109, CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP GPCL.
2682, 5esvH, 0.5001, 4.31, 0.138, 218, 109, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.
2683, 5bk3D, 0.5001, 4.16, 0.091, 221, 110, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2684, 5bk3A, 0.5001, 4.19, 0.080, 213, 112, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2685, 4utaH, 0.5001, 4.19, 0.080, 214, 112, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8
2686, 4mauL, 0.5001, 4.26, 0.054, 215, 111, CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244
2687, 4lmqH, 0.5001, 4.18, 0.120, 217, 108, DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
2688, 4kzdH, 0.5001, 4.19, 0.081, 211, 111, CRYSTAL STRUCTURE OF AN RNA APTAMER IN COMPLEX WITH FLUOROPHORE AND FAB
2689, 4jo2L, 0.5001, 4.21, 0.080, 222, 112, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120
2690, 4jhaH, 0.5001, 4.07, 0.113, 211, 106, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
2691, 4i9wE, 0.5001, 4.12, 0.112, 211, 107, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
2692, 4h1lI, 0.5001, 4.31, 0.099, 214, 111, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY
2693, 3zhlA, 0.5001, 4.19, 0.139, 218, 108, THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 8-14 SCAFFOLD
2694, 3uo1H, 0.5001, 4.18, 0.139, 218, 108, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
2695, 3qjfB, 0.5001, 4.28, 0.120, 115, 108, CRYSTAL STRUCTURE OF THE 2B4 TCR
2696, 3okoA, 0.5001, 4.27, 0.082, 132, 110, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO
2697, 3nh7J, 0.5001, 4.34, 0.110, 218, 109, CRYSTAL STRUCTURE OF THE NEUTRALIZING FAB FRAGMENT ABD1556 BOUND TO THE BMP TYPE I RECEPTOR IA
2698, 2vl5D, 0.5001, 4.26, 0.072, 203, 111, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2699, 2r69L, 0.5001, 4.31, 0.099, 225, 111, CRYSTAL STRUCTURE OF FAB 1A1D-2 COMPLEXED WITH E-DIII OF DENGUE VIRUS AT 3.8 ANGSTROM RESOLUTION
2700, 2r2hA, 0.5001, 4.32, 0.072, 220, 111, STRUCTURE OF S25-2 IN COMPLEX WITH KO
2701, 2brrH, 0.5001, 4.22, 0.111, 219, 108, COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
2702, 1mcpH, 0.5001, 4.34, 0.072, 224, 111, PHOSPHOCHOLINE BINDING IMMUNOGLOBULIN FAB MC/PC603. AN X-RAY DIFFRACTION STUDY AT 2.7 ANGSTROMS
2703, 1ifhH, 0.5001, 4.32, 0.072, 213, 111, A DETAILED ANALYSIS OF THE FREE AND BOUND CONFORMATION OF AN ANTIBODY: X-RAY STRUCTURES OF ANTI-PEPTIDE FAB 17(SLASH)9 AND THREE DIFFERENT FAB-PEPTIDE COMPLEXES
2704, 1byoB, 0.5001, 4.39, 0.080, 219, 113, WILD-TYPE PLASTOCYANIN FROM SILENE
